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SUMMARY 
The most common craniofacial birth defect is cleft defect with an incidence of 1.7:1000 
live births. The current treatments involve many steps of surgical procedures and cause 
morbidity at the donor site when harvesting bone for filling the gap defect. It may be 
possible to treat cleft palate defects by tissue engineering strategies using 
osteoprogenitor cells on a biodegradable distensible electrospun scaffolds to form the 
hard palate. The aims of this project are to select the suitable cell sources, materials, 
chemical supplementation, and mechanical conditions to enhance matrix mineralization 
for repairing the bone part of a cleft palate.  
Human jaw periosteal cells (HJPs), human mesenchymal stem cell derived from bone 
marrow (hBMSCs), and human embryonic stem cell mesenchymal progenitor 
(hESMPs) used in this project showed osteogenic potential by depositing calcium 
deposition on both monolayer and 3D constructs with the requirement of Dex in the 
culture media. Electrospun poly(-caprolactone) scaffolds (PCL) are a suitable 
temporary extracellular matrix for bone tissue engineering. Vascular endothelial growth 
factor (VEGF) is an important protein for new blood vessel formation. The VEGF 
secretion was reduced by Dex supplemented culture media in 3D culture, whereas, it 
was delayed in the monolayer culture. All cell types responded to oscillatory fluid flow 
(OFF) by using a standard see-saw rocker to stimulate osteogenic differentiation. The 
cells were more sensitive to OFF when they were supplemented with Dex for enhancing 
calcium deposition both in monolayer culture and 3D culture and the strongest effect 
was at the top surface of the scaffolds. The composite nano-hydroxyapatite PCL 
electrospun scaffold can enhance matrix mineralization compared to the standard PCL 
scaffold, but there were no additional effects of OFF on these scaffolds. A tri-layer PCL 
scaffold could support and separate two different cell types (human dermal fibroblasts 
and human osteoprogenitor cells: both hESMPs and hBMSCs) and also allow 
SUMMARY 
 
 
osteogenic differentiation for 28 days. The novel tri-layer PCL electrospun membrane 
developed here is a promising scaffold for tissue engineering for cleft palate repair. 
Tissue engineering strategy could benefit treatment cleft palate treatment compared to 
the current treatments (autologous bone graft from iliac crest) to promote bone 
formation at the defect area and allow normal development of facial structure in the 
future.    
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CHAPTER ONE: LITERATURE REVIEW 
1.1 Introduction 
Cleft lip and/or cleft palate is a very common birth defect with an worldwide incidence 
of about 1.7 per 1000 live births (Mossey et al., 2009). Causes of the defect are 
suspected to include 1] environmental factors such as maternal disease, alcohol intake, 
excess anticonvulsant or exposed retinoic acid medication, 2] genetic factors. These 
affect early embryonic development during the forth to tenth weeks of gestation (Stanier 
and Moore, 2004). Cleft defect is a non-life-threatening abnormality but may have 
significant effects on feeding, speaking, hearing, cause teeth and jaw problems, and 
social anxiety. Current treatments should be managed by a multidisciplinary team such 
as plastic surgeons, maxillofacial surgeons and dentists. These specialists would support 
and provide multiple surgical steps over the treatment course of many years (from the 
child is birth up to 20 years old). Where there is a bone defect the treatment is likely to 
include bone harvesting from a donor site. The post-operative complications from bone 
harvesting are 1] a high risk of donor site morbidity, 2] a temporary numbness of the leg 
from lateral femoral cutaneous paresthesia, 3] gait disturbances. Studies by Bergland et 
al., (1986) and Samee et al., (2008) stated that bone harvesting provided limited amount 
of bone available for grafting. Alternative cell sources for bone augmentation should be 
investigated further to improve cleft palate repair. Recently, tissue engineering 
strategies showed much promise for repairing a cleft defect on the alveolar ridge area, 
which supports the teeth. However, the cleft in the hard palate cleft was filled with soft 
tissue. Scar formation in the gap remaining in the hard palate is likely to affect facial 
development (Smahel et al., 2009).   
This project will mainly focus on a tissue engineering approach for the bone part of the 
hard palate repair by investigating 1] selected cell sources, 2] a suitable condition for 
stimulating mineralized matrix formation by bone-like cells, and 3] scaffold materials. 
The current review of the literature will describe the basic principles of bone biology, 
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the development of cleft palate, current treatments of cleft palate, and bone tissue 
engineering as a clinical strategy. 
1.2 The structure of bone 
1.2.1 Anatomy and function of bones 
Bone is a rigid part of the body and serves many functions for movement, supporting 
the body structure, protecting internal organs, maintain mineral homeostasis. It stores 
growth factors, cytokines, and red bone marrow is which where red blood cells are 
produced. The adult human has a total of 206 bones. Bone is comprised of two 
structures: compact (or cortical) bone and cancellous (or trabecular) bone. The compact 
bone is a dense bone, its porosity is less than 5% (Clarke, 2008) and represents about 80 
percent of adult bone. The cancellous bone has porous structure resembling sponge with 
strut thicknesses of around 50-400µm (Seeley et al., 2008) and represents about 20 
percent of adult bone (Roger, 2011). It is located at some internal regions of bone and 
filled with bone marrow.    
1.2.2 Macroscopic anatomy 
Bones are organized into different shapes depending on their functions. The four 
categorises of bone shapes are long bones, short bones, flat bones and irregular bones. 
Long bones include arm and leg bones. Short bones include the small bone in the ankles 
and wrists. Flat bones include the skull bones, mandible (jaw), hard palate, and the ribs 
(Figure. 1.2.2 A). Irregular bones include the vertebrae, sacrum and coccyx. The long 
bone length is longer than their width (Figure. 1.2.2 C). They include diaphysis (a 
hollow shaft), metaphysis (flared and cone shape), and epiphysis (at each end of the 
bone, and covered by articular cartilage). The primary diaphysis composition is cortical 
bone, whereas the metaphysis and epiphysis are trabecular bone. Flat bones have a 
broad surface to provide extensive protection and muscular attachment such as the 
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cranium of the skull, or mandible. They are composed of two layers of thin compact 
bone surrounding trabecular bone (Figure. 1.2.2 B). 
Bone is tightly covered by periosteal membrane at the outer surface apart from where 
there is articular cartilage. The inner surface of cortical bone and trabecular bone are 
covered by endosteal membrane which contacts the bone marrow. Periosteal activity is 
important for bone apposition on the outer surface of bone while endosteal activity is for 
bone resorption and formation on the inner surface.  
 
Figure 1.2.2: The diagram shows a flat bone which consist of 2 layers of compact 
bone and a cancellous bone (B) in between, like a sandwich. (C) The structure of 
long bone consists of diaphysis which has compact bone surrounding the hollow at 
the inner side and the epiphysis which locates at the end of the bone. Reprinted from 
Seeley et al., (2008) with kind permission of McGRAW-HILL. 
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1.2.3. Microscopic anatomy 
At the microscopic level, bone is divided to two types, woven and lamellar bone, 
depending on the orientation of collagen type 1, which is the main component of bone 
matrix. Woven bone is an immature bone which has an irregular collagen fibre 
orientation. It has more mature bone cells per unit of volume, high turnover rate, and is 
more flexible but weaker than lamellar bone (Clarke, 2008). Lamellar bone is the dense 
organised bone which is created by remodelling of the woven bone. In humans, lamellar 
bone starts remodelling 1 month after birth. Most bone structures become lamellar bone 
by 4 years of age. Lamellar bone is composed of highly organized collagen fibres, 
aligned parallel within the same layer (lamellae) (Figure. 1.2.3 B). In humans the 
lamellae arrangement process leads to the formation of osteons surrounding a 
Harversian canal which contains blood vessels, nerves, and lymph vessels at the center 
to form a secondary osteon. Each Harversian canal interconnects with another canal by 
a Volkmann‟s canal. The mature bone cells occupy the small cavities, called lacunae 
which are located between lamellae. The lacunae have a connecting system to other 
lacunae for transferring nutrients which are called canaliculi. The osteon or Harversian 
system is a major structural unit which aligns parallel to the long axis of bone to provide 
strength. Cortical bone is created by many osteons, which combine with interstitial 
lamellae (the lamellae between osteons) and circumferential lamellae (the lamellae 
underlying periosteum and endosteum) (Doll, 2005). Osteons are the main component 
of both cortical and trabecular bone (Clarke, 2008). However, the trabecular bone‟s 
osteon does not have blood vessels at the center (Figure. 1.2.3A) (Seeley et al., 2008).  
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1.2.4. Bone ECM composition 
Bone ECM is composed of inorganic component (about 60% of total bone ECM) organic 
matrix (up to 40% of total bone ECM) and trace amounts of water and lipids. The 
composition of the inorganic components is a mostly hydroxyapatite with small amounts 
of magnesium and carbonate to provide the mechanical compressive strength to bone. 
The organic matrix comprises protein and proteoglycans. Bone proteins can be divided 
into collagenous proteins (about 90%) which are mostly type I collagen and trace 
amounts of type III and V, which provide tensile strength to bone. The other bone protein 
components are non-collagenous proteins (about 10%) which are composed of 
proteoglycans, matrix proteins, cytokines, and growth factors. The proteoglycans regulate 
collagen fibre formation in the bone matrix. Three of the major proteoglycans are: 
osteocalcin (OCN), osteonectin (ONN), and osteopontin (OPN). The roles of bone matrix 
are to regulate bone cell activity, bone mineral deposition and resorption. There are 
cytokines and growth factors present in bone matrix such as TGF-β, BMPs, and VEGF. 
Figure 1.2.3: (A) The transverse section of trabecular bone shows the osteonal 
structure. (B) The osteon structure of compact bone. Reprinted from Seeley et al., 
(2008) with kind permission of McGRAW-HILL 
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Their role is to contribute to bone cell proliferation, activation, and bone remodelling 
(Lamoureux et al., 2007, Clarke, 2008, Salbach et al., 2012). 
1.3 Cell biology of bone  
Bone contains of many cell types for maintaining stability. These are osteoprogenitor 
cells, osteoblasts (matrix-producing cells), osteocytes (matrix-maintaining cells), and 
osteoclasts (matrix-resorbing cells). Each cell has its own definite roles and functions. 
1.3.1 Osteoprogenitor cells 
Osteoprogenitor cells or mesenchymal stem cells (MSCs) are fibroblast-like fusiform 
shaped, undifferentiated cells (Figure. 1.3.1). They give rise to the osteoblasts which 
produce new bone matrix. Bone marrow stroma contain a small population of MSCs 
that are capable of differentiation into either bone, cartilage, fat, or fibrous connective 
tissue depending on the circumstances. MSCs are promising cells for bone tissue 
engineering due to their ability to proliferate and differentiate into osteogenic cells.  
 
Figure 1.3.1: Phase contrast image of an osteoprogenitor cell (hESMPs). Scale bar 
200µm. Image captured by author. 
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1.3.2 Osteoblasts 
Osteoblasts are anchorage dependent cells which require an attachment to a surface to 
grow and survive. They are large cuboidal cells and usually located on the bone matrix 
surface, they rely on a cell-matrix and a cell-cell communication via specific receptors 
for signalling factors such as cytokines, hormones, and growth factors to maintain the 
cellular function. Moreover it has been found that the osteoblasts respond to mechanical 
stimuli (Sommerfeldt and Rubin, 2001). Osteoblasts synthesize and lay down collagen 
type I that is required for new bone formation. From in vivo studies it is known that 
osteoblasts can lay down 0.5-1.5µm of the non-mineralized organic part of bone matrix 
(called osteoid) per day (Sommerfeldt and Rubin, 2001). They also secrete non-
collagenous proteins such as proteoglycans and glycosylated proteins. The glycosylated 
proteins, for example, alkaline phosphatase (early marker of osteoblasts: see chapter 2), 
regulate the mineralization process (Clarke, 2008), proteins bound to the cell surface 
and may help regulate matrix mineralization. Osteoblasts that become fully embedded 
in mineralized matrix transform their role to become osteocytes.  
1.3.3 Osteocytes 
Osteocytes are the terminally differentiated cells of the osteogenic linage. Their shapes 
are smaller than osteoblasts and they have a number of cytoplasmic extensions. They lie 
within the lacunae in mineralized bone to support bone structure and metabolism. 
Osteocytes do not normally secrete alkaline phosphatase (an early marker of osteogenic 
differentiation) but express several other bone matrix proteins (Clarke, 2008). The 
functions of osteocytes are; facilitated intercellular adhesion and mineral exchange 
regulation in the bone fluid within lacunae. Osteocytes can communicate with adjacent 
cells via gap junctions of their cytoplasmic extensions in the canaliculi. Osteocytes can 
survive in the lacunae for decades. In contrast empty spaces in the lacunae can be 
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presented in an aging bone due to apoptosis of the cells or disturbance of cellular 
interactions (Verborgt et al., 2000).   
1.3.4 Osteoclasts 
Osteoclasts derive from hematopoietic stem cells (the cells that give that rise to blood 
cells) which are usually located within endosteal or periosteal surfaces. Osteoclasts are 
multinucleated cells from the fused monocyte progenitor cells, which contain around 6-
12 nuclei, with a ruffled border on the cell periphery. Their function is bone resorption, 
which is the first step in the bone remodelling process. They secrete enzymes in 
lysosomes to increase the solubility of hydroxyapatite. Osteoclasts can resorb bone 
volume around 200,000µm
3
/7days, in vitro (Jeon et al., 2012).   
1.4. Morphogenesis of bone 
Bone is a rigid part of body and serves many functions, for instance, motion, supporting 
the body structure and protecting internal organs. Bone formation starts during the fetal 
period in gestation and has two modes, which are intramembranous and endochondral 
ossification.  
Figure 1.3.2: Transverse section of a trabecula bone showing the three major bone 
cells which affect bone remodelling; osteoblasts, osteocytes and osteoclasts. 
Reprinted from Seeley et al., (2008) with kind permission of McGRAW-HILL. 
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1.4.1. Intramembranous ossification 
This category of ossification takes place during embryonic development. Mostly it is 
responsible for formation of flat bones which are usually present in the craniofacial 
bones such as cranium, mandible and palate. Intramembranous ossification begins with 
MSCs which directly differentiate into mature osteoblasts. These osteoblasts can 
produce bone matrix that is mineralized within a few days. Osteoblasts that remain 
embedded in bone matrix then become osteocytes. As the result, many small trabecular 
of woven bone are created (Figure. 1.4.1 A). The network of trabeculae combines 
together to form trabecular bone (spongy bone). Some osteoblasts still locate at the 
surrounding surface of trabeculae to produce more or thicker trabeculae (Figure. 1.4.1 
B). Finally the woven bone is replaced by the remodelling process with mature lamellar 
bone (blue staining in the Figure. 1.4.1 C) that is more organized and stronger than the 
woven bone. The cells within the trabecular bone space form red bone marrow and the 
cells surrounding the developing bone form periosteum. The osteoblasts from 
periosteum can continue to create bone matrix and develop into compact bone.  
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Figure 1.4.1: Intramembranous ossification: the 12
th
 week of fetus, Paraffin section. (A) 
Osteoblasts at the outer surface create bone matrix and differentiate into osteocytes when they 
embed in the bone matrix. (B) Interconnection of many trabeculae forms cancellous bone. (C) 
The trabecular bone (blue colour) is in the centre and the spaces contain red bone marrow. 
Under the periosteum is developing compact bone. Reprint from Seeley et al., (2008) with kind 
permission of McGRAW-HILL.   
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1.4.2. Endochondral ossification 
The second ossification mechanism of the mammalian skeletal system is endochondral 
ossification. Endochondral ossification is bone production that begins with the 
differentiation of MSCs (osteochondral progenitor cells) into cartilage cells 
(chondroblasts), which produce cartilage. Overtime the chondrocytes are less able to 
receive nutrients and they start to apoptose, then vasculature grows into the centre of the 
bone template. Perichondrium (the membrane at the outer part of cartilage) on the 
diaphysis becomes periosteum and osteochondral progenitor cells become osteoblasts. 
The outer side of the diaphysis area is covered by osteoblasts that produce bone which 
is called the bone collar (Figure. 1.4.2 A). The primary ossification center forms by 
bringing osteoblasts from the blood vessels which have penetrated into the medullary 
cavity. The osteoblasts begin to lay down bone matrix at the primary ossification center 
(Figure. 1.4.2 B). Secondary bone ossification centers form at the epiphysis regions. 
The cartilaginous framework on both sides of the ossification centers are replaced by 
woven bone, via a remodelling process into the lamellar bone (Figure. 1.4.2 C). The 
results of endochondral ossification are growth in two directions either height or width 
from the center of the long bone. Only articular cartilage remains at the joint ends 
(Figure. 1.4.2 D). This process is important in the formation of long bones, and natural 
fracture healing of bone (Yaszemski et al., 1996).  
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Figure 1.4.2: Endochondral ossification. (A) The cartilage was produced by 
chondroblasts. It has bone a collar at the diaphysis area. (B) The penetration of blood 
vessels becomes a primary ossification center and brings osteoblasts to this area. (C) 
Secondary ossification center occurs at the proximal of long bone. (D) The bone is fully 
developed, the cancellous and compact bones are mature, articular cartilage is the only 
cartilage present. Reprint from Seeley et al., (2008) with kind permission of McGRAW-
HILL.   
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1.5.  Bone healing and remodelling  
Incorporation of a bone graft into a defected area is similar to the bone healing process. 
The healing process can be divided into three stages: 1] inflammatory stage, 2] reparative 
stage, and 3] remodelling stage. The inflammatory stage starts within the first hours and 
lasts a few days to produce hematoma which is composed of inflammatory cells and 
fibroblasts. Granulation tissue is produced which then initiates vascular ingrowth and 
MSCs migration.  
In the reparative stage, the cells in the hematoma produce „callus‟ which contain fibrous 
tissue, cartilage and immature bone to envelop the affected region. At the beginning of 
this stage, cartilage formation predominates followed by production of mineralized 
tissue. 
In the remodelling stage, chondrocytes undergo terminal differentiation and become 
apoptotic. The ECM undergoes calcification, called cartilaginous calcification, at the 
junction between the mature chondrocytes and the new bone forming regions with new 
blood vessel invasion. The new bone formed is remodelled by the activity of osteoblasts 
and osteoclasts. 
Bone remodelling maintains bone strength and mineral homeostasis throughout life. The 
homeostatic equilibrium between resorption and formation replaces the old bone, micro-
damaged, or a fracture region with a new bone adapted to withstand the mechanical loads 
and strain applied to that bone. Remodelling of trabecular bone is more active than in 
cortical bone, because of the larger surface area per volume. The remodelling cycle is 
composed of three sequential phases: resorption, reversal, and formation. The length of 
the bone remodelling is thought to be several weeks to complete the process (Kini and 
Nandeesh, 2012).  
The resorption process begins with migration and activation of mononuclear monocyte-
macrophage osteoclast precursors to form multinucleated preosteoclast which bind to 
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bone matrix via the interaction between integrin receptor on cell membranes and RGD 
(arginine, glycine, and asparagine) on matrix proteins. They form deep folds in the 
membrane which are called the „ruffled border‟ and surrounding this is a zone of 
attachment which is called the „sealing zone‟. Osteoclasts resorb bone by lysosomal 
enzymes and proteolysis of the bone matrix and finally the multinucleated osteoclasts 
undergo apoptosis. The reversal phase is a transition phase from bone resorption to bone 
formation. During bone formation, osteoblasts synthesize new collagen and mineral and 
regulate matrix mineralization. The osteoblasts surrounded by matrix become osteocytes 
embedded within lacunae. Osteoblasts secret a range of growth factors including insulin-
like growth factors (IGF), platelet-derived growth factor (PDGF), basic fibroblast growth 
factor (bFGF), transforming growth factor-beta (TGF-β), and bone morphogenetic 
proteins (BMP) to regulate themselves in an autocrine and paracrine manner. When bone 
formation is complete approximately 50-70% of osteoblasts undergo apoptosis (Clarke, 
2008, Jilka et al., 1998).  
The bone remodelling is controlled by the osteoprotegerin (OPG)/receptor activator of 
NF-kappa B ligand (RANKL)/RANK system. These mediators regulate the degree of 
osteoclast differentiation, activation, and apoptosis. RANKL present on the 
preosteoblastic cell surface binds to RANK present on the osteoclastic precursor cell 
membrane. It is a crucial interaction for differentiation, multinucleated cell formation, 
activation, and cell apoptosis. OPG is produced by the cells of the osteoblast linage and 
bone marrow stromal cells and inhibits this interaction by blocking the effect of 
RANKL this is followed by the bone formation on the bone surface (Lamoureux et al., 
2007, Clarke, 2008). 
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1.6. Introduction to cleft palate 
1.6.1. Development of the palate  
Human face development normally begins in the fourth week post conception and is 
followed by the first appearance of palatal shelves at around the sixth week of gestation 
(Stanier and Moore, 2004). The complex processes of forming the mammal an 
secondary palate involves different cell states such as cell proliferation, migration, 
differentiation, and programmed cell death (Ferguson, 1988). In his study of facial 
development in mice, Stanier (2004) explains that there are three stages of palate 
formation; the first stage happens at mouse E12.5 (a twelve and half day old embryo) or 
about the seventh week of gestation in humans, the mammalian palatal shelves on the 
maxillary prominences grow vertically to horizontally above the dorsum of the tongue. 
Followed by, at mouse E13.5, or about the eighth week of gestation in humans the 
connection of palatine shelves at the midline of the palate. The final stage, at mouse 
E14.5 or approximately 9-10 weeks post conception in humans is the combining of the 
palatal shelves in the antero-posterior direction and uniting with the nasal septum 
(Figure. 1.6.1). The epithelial layer on the regions of the palate that fuse together are 
removed by programmed cell death, migration of epithelial cells to the oral and nasal 
epithelia, and trans-differentiation into mesenchyme (Martinez-Alvarez et al., 2000). 
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Figure. 1.6.1: The normal developmental stages of the lip and palate in paired 
horizontal and coronal planes of the head of mice. (Adapted from: Stanier, 2004) (A) 
At mouse E12.5 or about the seventh week of gestation in human, (B) At mouse E13.5 
or about the eighth week of gestation in human, the blue arrows indicate the direction 
of palatal shelves fusion, (C) The mouse E14.5 or approximate 9-10 weeks post 
conception, the palatal shelves have combined in antero-posterior directions (blue 
arrows). Abbreviations: MP, maxillary prominences; P, palatal shelves; T, tongue; E, 
eye; NS, nasal septum; NC, nasal cavity; OC, oral cavity; Ph, philtrum; UL, upper lip; 
PP, primary palate; SP, soft palate; U, uvula. Reprint from Human Molecular 
Genetics, Stanier and Moore, (2004) with kind permission of Oxford journals. 
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1.6.2. Incidence and cause of cleft palate 
The most common craniofacial congenital anomaly is cleft defects that involve the lip 
and/or palate. The incidences of cleft lip with or without cleft palate are between 1/300 
and 1/2500 live births and of cleft palate defect only are approximately 1/1500 live 
births. The incidence of these defects is affected by the geographic area, ethnicity and 
socio-economical status of the patients (Lidral and Murray, 2004). In their study in 
mice, Peters et al., (1998) found that cleft palate may be caused by abnormal 
characteristics of the palatal shelves which are broader and less elevated than in wild 
type mice. Cleft defects can be categorized into nonsymdromic and syndromic types. In 
nonsyndromic types, the patients do not have other physical and development 
disturbances, which is about 70 percent of cleft cases. However, the remaining 30 
percent of patients are of the syndromic type and have physical or mental disabilities 
associated with the defects. The syndromic cleft defects can be subcategorized into 300 
single-gene diseases (Mendalian disorders) which are inherited in families, (Murray, 
2002). The single-gene diseases can be a recessive or dominant, either autosomal or 
sex-linked genes. Environmental factors, for instance, deficiency of nutrients or a toxic 
growth environment such as maternal alcohol or smoking during pregnancy are 
probably involved. 
1.6.3. Current treatment of cleft palate repair  
The standard treatment for cleft lip and/or palate (National Health Service, 2010) states 
that the treatment begins with cleft lip and palate examination for diagnosis, hearing, 
and feeding including consultation with parents. Cleft lip is closed around the third 
months of age. Cleft palate is closed at the age of 6-12 months. Cleft palate is treated by 
using soft tissue to close the gap defect. The objectives of this treatment are to allow the 
acquisition of speech and encourage growth of maxillary bone (Rohrich et al., 1996). 
The patient might have complications after the operation, for instance, ossification of 
the growth suture of the maxilla and defects in the remaining alveolar cleft (Smahel et 
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al., 2009) which leads to maxilla distortion and a narrower, shallower palatal vault and 
short palate (Figure. 1.6.3). As a result, speech problems may occur. Patients are 
assessed for speech when the child starts to produce their first words around 13 months 
of age (Peterson-Falzone et al., 2001). Additional surgical procedures will be performed 
if defects involve the alveolar process (teeth bearing area). Secondary alveolar bone 
graft is usually performed at the age of 8 or 11 years to support tooth eruption. 
Currently, the bone defect is corrected by using autologous bone graft from iliac bone. 
This has a chance of causing donor site morbidity, numbness of legs, and gait 
disturbances. Additional surgery may be required to improve appearance and enhance 
the function of chewing. Ross, (1987b) reported that 73 percent of unilateral cleft lip 
and palate patients required orthodontic treatment to straighten their teeth. The other 27 
percent of patients required surgery to correct the relationship between the maxilla and 
the mandible and increase the efficiency of the teeth during chewing and biting. The 
treatment of cleft palate is over a long period of time.   
 
 
 
 
 
 
 
 
 
1.6.4. Controversy for timing of cleft palate repair  
The protocols for cleft palate treatment are still controversial in that the ideal timing for 
the surgical procedure for closing the cleft defect is not fully established. This depends 
on many factors such as the type of cleft defect (cleft lip, cleft palate, and cleft lip and 
Figure 1.6.3: Diagrams of the complications of post-operation cleft palate which 
might occurred. The dash lines indicated normal maxilla and the black line indicates 
the complication. (A) is narrow maxilla, (B) is shallow palatal vault, and (C) is short 
palate.   
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palate: Figure 1.6.4), patient‟s condition, and the opinion of the medical team. Cleft 
palate children usually have delays in the onset at speech because there is no separate 
barrier between the nasal cavity and the mouth (Peterson-Falzone et al., 2001). The 
reviews of Berkowitz et al., (2005) and Saijo et al., (2010) claimed that a suitable age of 
the patient for undergoing cleft lip repair is around the third months of age, following by 
cleft palate repair is between 6 to 18 months. This timing benefits speech production, 
however, it may affect maxillary growth as previously mentioned. In the Ysunza et al., 
(2010) study, they described that an early cleft palate repair of hard palate at around 4-6 
months of age can enhance speech development, and with orthodontic treatment 
allowed normal maxillary growth. However, some studies found mid face retrusion 
from scar tension in the antero-posterior direction (Ross, 1987b, Ortizmon.F et al., 
1966). In bilateral cleft lip and palate patients, the development of the maxillary arch 
was narrower and shallower than in the non-cleft conditions, in addition, orthodontic 
treatment only provided small improvements in the maxillary structure (Smahel et al., 
2009). Delay of cleft palate treatment may reduce maxillary growth disturbance. 
Because of this the two-stage procedure was introduced so as to balance the 
requirements for maxillary growth and speech development. The studies of 
Schweckendiek, (1978) and Prydso et al., (1974) reported that the defect of the soft 
palate could be repaired in the first year of age. Patients were found to improved speech 
development after this treatment and difficulties with speech diminished with age. The 
remaining defect on the hard palate was repaired at 12-14 years of age. This period of 
time is after complete maxillary growth has occurred to avoid maxillary growth 
disturbance. In contrast, Rohrich et al., (1996) followed up the patients who received 
early (10.8 months of age) and delayed (40.8 months of age) hard palate closure. The 
results showed that they did not significantly differ in the disturbance of maxillary 
growth. However, the delayed treatment group had significantly greater speech 
difficulties which can lead to hearing loss, and also incidence of palatal fistula (the 
abnormal connection between oral and nasal cavities) than the other groups. They 
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designed a procedure to complete a cleft palate repair before 2 years of age to allow the 
development of integrated speech and reduce risk of hearing loss (Rohrich and Gosman, 
2004).  
The suitable timings for cleft palate repair are still controversial and various surgical 
treatments are performed to treat cleft patients. Tissue engineering is a new strategy 
with potential to substitute for the missing organ (bone tissue and oral mucosa tissue) in 
cleft palate repair. 
 
 
 
 
 
 
 
 
 
1.7. Tissue engineering for cleft palate/maxillofacial repair  
A new treatment strategy for bone regeneration is tissue engineering. This technique 
would eliminate problems such as donor site morbidity, immune rejection, and pathogen 
cross-contamination. The conceptual model for bone tissue engineering is to take cells 
from the patient's tissues and then seed them back into a temporary scaffold before 
implantation back into the patient (Figure. 1.7).     
Figure 1.6.4: The variety of cleft lip and/or palate. The left side on top of picture is 
normal lip and palate. (A) Cleft in soft palate, (E) Cleft in hard palate; B,F: 
Unilateral and bi-lateral cleft lip; C, G: Unilateral and bi-lateral cleft lip involving 
hard palate; D,H: Unilateral and bi-lateral complete cleft lip and palate. 
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A clinical study by Moy et al., (1993) found that the quantity of bone formed at the 
maxillary sinus after implantation of a mixture of cortical bone graft from chin and 
hydroxyl apatite (HA) granules was much more than after implantation of HA granules 
alone, about 44.4% and 20.3%, respectively. Therefore it seems that including cells in a 
bone tissue engineering procedure will increase the success rate of bone repair in the 
clinic. The cell sources for hard tissue engineering should incorporate with the 
surrounding area and be able to undergo osteogenic differentiation. For the polymeric 
scaffolds used in tissue engineering, many factors must be considered such as 
biocompatibility, porosity, mechanical integrity, and biodegradability. Tissue 
engineering techniques have been used for cleft defect reconstruction; Hibi et al., 
(2006), showed that the combination of a gel matrix, platelet-rich plasma (PRP), and 
autologous MSCs from bone marrow harvested from their patient's iliac crest, filled the 
alveolar cleft defect in a 9 year-old patient. The bone volume increased to 79.1% at 9 
months post-operative. They also found that the maxillary lateral incisor and canine 
teeth which were located adjacent to the defect erupted 2 years post-operation. This case 
Figure.1.7: The concept of tissue engineering is to remove cells from the patient. The 
cells would be cultured and then seeded on a polymeric scaffold in a growth factor 
supplemented culture medium. Then, the cell seeded scaffold which forms a functional 
tissue would be implanted to the defect site.  
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study indicated that tissue engineering is promising for repairing cleft palate, however, 
cell sources and tissue engineering materials haven't been optimized. PRP which 
contains fibrinogen and chemical factors such as vascular endothelial growth factor 
(VEGF) was added to enhance matrix formation and tissue regeneration. The clinical 
results of tissue engineering repair are variable depending on each patient, considering 
factors such as gender, age, habit such as sucking behaviour, systemic conditions, and 
anatomy. The different regions of the maxillofacial bone will have different 
vascularization and functional loads. Therefore, the challenges in tissue engineering are 
to control these environments and, cell differentiation in vitro before implantation. This 
strategy will reduce subsequent healing time.        
1.8. Stem cells as an alternative source for bone tissue engineering  
Stem cells are categorized into: 1] embryonic stem cells which are collected from 
embryos at the blastocyst stage and 2] adult stem cells which are collected from tissues 
throughout the body such as bone marrow, adipose tissue, dental pulp, and periosteal 
tissue. The characteristics of stem cells are firstly: self-renewal, as they undergo a 
number of cell divisions while still maintaining their non-differentiated cell state and, 
secondly, differentiation potential to other cell types including osteoblastic cells. 
1.8.1. Human embryonic stem cells derived mesenchymal progenitor (hESMPs)  
Cultured human embryonic stem cells have been used in cell therapy and tissue 
engineering (Karner et al., 2007). They have an unlimited ability to proliferate and the 
ability to differentiate in to the three germ lines which create all the cell types in the 
body. However, embryonic stem cells might induce a tumour risk. There are also many 
ethical issues to be considered when using them for research because a human embryo 
has to be destroyed. A study by Karlsson et al., (2009) developed hESMPs derived from 
an embryonic stem cell line which have been specifically pre-differentiated into the 
mesenchymal linage in a commercial laboratory. They are a middle stage between 
embryonic stem cells and mesenchymal progenitor cells and have self-renewal and 
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differentiated potential into osteoblasts, chondroblasts, and adipocytes. These cells 
showed fibroblastic morphology and expressed markers similar to adult MSCs. hESMPs 
have advantages for use in research as they are homogeneous and easy to culture. It has 
been shown that they can grow in media without animal components, which makes 
them promising for cell toxicity, drug development, and tissue engineering in a clinical 
situation. In a study by de Peppo et al., (2010), hESMPs were used to screen metal 
scaffolds to investigate cell attachment, proliferation, and osteogenic differentiation. 
They showed gene expression profiles highly similar to the human MSCs. Their cell 
proliferations were significantly higher compare to the autologous cell MSCs. 
Therefore, hESMPs are a good cell model to select a suitable scaffold material for MSC 
differentiation.  
1.8.2. Adult stem cells  
Adult stem cells are found in tissues throughout the body such as bone marrow, blood, 
adipose tissue, dental pulp (Sloan and Waddington, 2009) and periosteal tissue. The 
properties of adult stem cells are their ability to self-renew (with limited cell division 
due to a cellular senescence) and a multi-differentiation potential (Wagner et al., 2008). 
They are undifferentiated cells which can be differentiated into many cell types for 
tissue or organ regeneration.  
1.8.2.1. Bone marrow mesenchymal stem cells (hBMSCs)   
Bone marrow mesenchymal stem cells (hBMSCs) are used for regenerative medicine. 
They are capable of self-renewal and can be differentiated to adipocytes, chondroblasts, 
and osteoblasts under specific culture media (George et al., 2006). They can be 
harvested from human donors, then the cells are grown and expanded in the laboratory, 
finally, they can be used as autologous cells and introduced back to the same patient that 
donated them. This procedure would be a patient-specific treatment and avoid immune 
rejection. In case studies by Hibi et al., (2006) which performed in the 9 year old female 
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patient and Behnia et al., (2009) which performed in the 10 and 14 years old patients, 
autologous hBMSCs were seeded in biodegradable scaffolds to repair an alveolar cleft. 
The results showed new bone formation at the defect area post-operation. Sufficient 
bone was produced for the next step of treatment, which is orthodontic treatment. 
hBMSCs are typically collected from iliac crest (hip bone), therefore, there may be 
complications after isolation such as pain at the site of operation, imbalance, arterial and 
nerve injury and risk of infection. In addition, there are a limited amount of MSCs in 
bone marrow or about 0.01percent of the total of the mononucleated cells obtained. 
Moreover, hBMSCs have reduced progenitor and differentiation potential as the passage 
number increases (Jaquiery et al., 2005, Banfi et al., 2000, Caplan, 2005). Other cell 
sources may have advantages for use in bone regenerative medicine. The cell sources 
should have osteogenic potential, no risk of immunogenicity, and be easy to harvest. 
Recently, periosteal cells have been researched for using in bone regeneration, these 
cells have the ability to differentiate to chondroblasts and osteoblasts (Soltan et al., 
2009, Frey et al., 2013, Samee et al., 2008).    
1.8.2.2. Human jaw periosteum cells (HJPs) as osteogenic progenitors. 
Periosteum is a tri-layer membrane that covers the entire external surface of bone except 
at the joint surface (Olbrich et al., 2012). It aids in growth, remodelling, and healing of 
bone. The inner layer of the periosteal membrane consists of MSCs which can 
differentiate into chondroblasts and osteoblasts, these are similar to the MSCs which are 
collected from bone marrow aspiration (Soltan et al., 2009). The osteogenic potential of 
periosteal cells seems to be retained in aging donors, in contrast, this potential in bone 
marrow MSCs is reduced (Stolzing et al., 2008). There are controversies about a 
suitable harvesting area of MSCs for the reconstruction of facial bone defects. The 
original of the facial skeletal is the cranial neural crest, and the rest of the skeleton (limb 
and body) forms from mesoderm. Therefore, the periosteal tissue from the two different 
areas might be different in bone formation and bone healing (Opperman, 2000). In 
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previous animal studies Fujii et al., (2006) and Choi et al., (2002) showed different bone 
formation patterns from periosteum grafts between tibia and facial areas when they were 
grafted into suprahyoid muscle. The periosteum graft from facial bone induced 
intramembranous ossification (bone formation from fibrous tissue) alone. Whereas the 
periosteum graft from tibia induced endrochondral ossification (bone formation from 
cartilage). The case studies in alveolar augmentation by D‟Addona and Nowzari, (2001) 
showed that the intraoral bone graft produced bone formation without cartilage 
formation. A case report by Trautvetter et al., (2011) used mandibular periosteal cells 
seeded on polymer base scaffolds for maxillary sinus augmentation. Post-operative 
evaluation showed a mature bone appearance at 4 months. Dental implants were placed 
afterwards in the repaired area without any complications. This study reported that 
donor site morbidity and time of operation were significantly reduced compared with 
the autologous bone graft from iliac crest harvesting. However, these bone tissue 
engineering grafts were transplanted in the pre-osteogenic stage. The time for the 
healing process to take place may be longer than for autologous bone graft (mature 
osteogenic stage). These previous studies showed that HJPs might be a promising cell 
source for bone tissue engineering. 
1.9. Scaffold for bone tissue engineering  
A scaffold can mimic the native extracellular matrix structure (ECM) with micro- 
and/or nano-fibres and provide an initial area for new tissue regeneration. The strategy 
of bone tissue engineering is to improve function and reconstruct damage or congenital 
defects by using engineered materials and biological methods. These methods consist of 
the osteogenic cells and suitable carriers, which are solid structures for supporting cell 
attachment, migration, proliferation and differentiation. In other cases the chemical 
agents are added to scaffolds then they are implanted into the defect areas, without cells. 
The chemical agents will attract the cells which surround the wound site of the patient. 
The cells will migrate and attach to the implanted scaffold. Another function of 
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scaffolds is to transfer cells from the laboratory to the patient for therapeutic 
replacement.  
Various fabrication techniques for reconstruction scaffolds for bone tissue engineering 
have been developed in the last decade, including solvent casting, particulate-leaching 
(Mehrabanian and Nasr-Esfahani, 2011), phase-separation, freeze drying (Zhang and 
Ma, 1999), self-assembly, gas foaming, printed 3D structure (Leukers et al., 2005) and 
electrospinning (Lu et al., 2013). The requirements of the scaffold will vary depend on 
the type of the reconstructed tissue. The requirements of scaffolds for bone tissue 
engineering are biocompatibility, biodegradablility, porosity, mechanical stability, ease 
of manufacture, sterilizability, and handleability. Features such as pore size and surface 
area need to be optimized for the application. In their review, Salgado et al., (2004) 
described the ideal properties of bone tissue engineering scaffolds  
 Biocompatibility: scaffolds should incorporate into the surrounding tissue without 
immune rejection. 
 Porosity: the pores should be highly interconnectivity to stimulate cell attachment, 
growth, nutrient diffusion, and metabolic waste removal. 
 Pore Size: the pore diameter is an important factor for cell penetration, bone matrix 
production, and novel vasculature formation. 
 Surface properties: the characteristics of the surface area of the scaffold influences 
cell attachment and proliferation. 
 Osteoinductivity: the scaffold material should facilitate osteogenic differentiation.  
 Mechanical properties and biodegradability: the scaffold should have sufficient 
strength to maintain a space for cell growth but totally degrade when tissue regeneration 
is complete. 
 
The scaffold factors including diameter and pore size affect the biological response. The 
scaffolds with poor porosity found less cell infiltration than high porosity scaffolds. In 
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addition scaffolds containing micro-fibres (about 3-4µm) showed that the cells could 
align on a single fibre and connect to adjacent fibres. The cells were able to penetrate 
below the surface of the scaffold. In contrast, scaffolds containing nano-fibres (about 
200-300nm) showed most of the cells on the surface of the scaffold due to less 
penetration (Soliman et al., 2011). The pore size of the porous hydroxyapatite scaffold 
for bone ingrowth in 50µm sized pores was sufficient and 300µm sized pore was 
optimum (Chang et al., 2000a). For vascularization the scaffold should have at least 
400µm sized pores (Woodruff et al., 2012). The result of smaller fibre diameter is a 
reduction in porosity and pore size but a higher fibre area and mechanical strength (Rim 
et al., 2013). The ECM is found in different architectures in the human body. For 
example in the skin and early states of bone formation ECM architectures are randomly 
woven fibres but in a tissue adapted to tension such as tendon to collagen is a highly 
organized aligned fibres. Therefore an ideal scaffold for tissue engineering should 
mimic native ECM at the affected site. 
The advantages of solvent casting, particulate-lenching, phase-separation and freeze 
drying techniques are that they are simple procedures and minimal equipment is 
required. However, these techniques are dependent on the materials and solvents which 
needed to be optimized and sensitive to fabrication parameters. Self-assembly technique 
is suitable for producing a fine nanofibre scaffold due to organization of peptide 
sequences but the main disadvantages of this technique are that it is a complicated, 
elaborate process, and very expensive. The advantages of gas foaming are that organic 
solvent are not required and high temperatures, but the scaffold products are highly 
interconnected pore structure which will affect their strength. For printed 3D structures, 
the advantage is a control over structure and porosity, however, there are limited 
polymer materials that can be used and the equipment is very expensive (Subia et al., 
2010). Most of the above techniques are not capable of producing polymeric fibre 
scaffolds ranging from microscale to nanoscale with special orientation, high surface 
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area, and adjustable pore geometry. Electrospinning technique is a promising technique 
for desired scaffold fabrication. 
1.10. Electrospinning 
1.10.1. Introduction 
Electrospinning is a versatile technique to prepare scaffolds for tissue engineering. It 
uses electric force to produce the polymer fibre in a certain diameter from a few 
micrometers to a few hundred nanometers. This technique can be used with many types 
of polymer. The advantages of electrospinning are the control over specific orientation, 
high surface area, and pore geometry of the fibres. It is a non-invasive technique that 
does not require high temperatures for fibre production, and is cost effective. However, 
this technique has a low production rate, making it difficult to scale-up (Rim et al., 
2013, Blackwood et al., 2008, Delaine-Smith et al., 2014a).  
1.10.2. Spinning mechanism and theory 
The electrospinning technique was first described by Sir Geoffrey Ingram Taylor in 
1964 (Burger et al., 2006). His work referred to the water droplets in the high electrical 
field. A high voltage was applied to a contained solution and the solution became 
charged with the electrostatic repulsion. The effect of repulsion counteracted the surface 
tension of the solution. The droplet was erupted and stretched which was called a Taylor 
cone. The fluid jet from the tip of the cone was emitted when the charge of the solution 
overcome the surface tension (Taylor, 1964). The solution jet dries during the path to 
the collector. The solution jet has 2 phases: the first phase, is called the stable phase 
which the jet emits from the needle tip at a straight line and an elongation of fibre along 
this phase. When the jet gradually evaporates, the solution concentration changes and 
thus the jet is a high velocity. The second phase, is called unstable phase, the jet present 
a random whipping movement to produce a thinner and non-woven fibre on the 
collector (Reneker et al., 2000).   
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1.10.3. Electrospinning and tissue engineering 
Electrospun scaffolds have been developed to be used for tissue engineering in recent 
years as ECM to support cells.  More than 100 types of polymer have been used in the 
electrospinning technique both synthetic and natural polymers (Burger et al., 2006). 
Since different native tissues have the specific requirement for a functional scaffold 
such as skin, nerve, heart, tendon, and bone, the electrospun scaffold technique can 
adjust and produce fibres which are suitable for the tissues. Many studies have used the 
electrospun scaffolds for supporting structure or cell delivery vehicles such as skin 
(Blackwood et al., 2008), nerve (Daud et al., 2012), heart (Zong et al., 2005), tendon 
(Yin et al., 2010), and bone (Ma et al., 2011). Furthermore, electrospun scaffolds can 
deliver bioactive agents such as drugs, proteins, and DNA if made with degradable 
polymers (Luu et al., 2003). The results in the rate of agent release depend on the 
methods of incorporation a bioactive agent into the scaffold (Liu et al., 2012). The 
properties of electrospun scaffold depended on the specific polymers and conditions. 
Therefore the choice of materials and conditions could be considered for the 
application. 
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1.10.4. Electrospinning rig set up 
The electrospinning apparatus consists of four main components: 1] a high voltage 
electricity source which applies the force to extend the charged to polymer solution, 2] a 
syringe pump which controls the dispensing rate of the polymer solution, 3] a syringe to 
carry the polymer solution and needle which  charges the polymer solution  in the high 
electric field, and 4] a ground platform for collecting the fibres such as an aluminum foil 
covered drum collector (Katta et al., 2004). Various types of collectors are designed to 
fit the purpose such as a flat plate or a rotating drum. The flat plate may produce an 
uneven scaffold distribution mat. Therefore, the rotating drum as a collector was used in 
this project (Figure. 1.10.4).  
  
Figure. 1.10.4: Schematic of electrospinning apparatus. The green box is a high 
voltage electric supply and a ground is a collector, a rotating drum type. The red box 
is a syringe pump to hold a syringe and put force through a polymer solution to the 
collector. The blue line as a polymer solution jet is dispensed from the tip of syringe to 
the rotating drum. 
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A syringe pump forces the polymer solution which is contained inside a syringe. A high 
voltage electric source is applied between the needle and the ground collector. The 
electric charge carries the polymer solvent to form a cone and ejects a jet of the liquid at 
the tip of needle. The jet travels through the collector while the solvent evaporates and 
leaves behind the dry polymer fibre on the collector. The fibre morphology can be 
influenced by various process parameters such as applied voltage and needle collector 
distance (called working distance) (Table 1.10.4). However bead formation may occur 
on the resultant polymer fibres. 
Factors The fibre structure 
Polymer concentration 
 Too low 
 Too high 
 
The jet breaks up to form beading and droplets 
The jet can't be initiated cause the droplets dry 
out at the tip of capillary  
Working distance  
 Too close 
 Too far 
 
Wet fibre and beading structure 
Beading morphology 
Polymer flow rate 
 Low flow rate 
 High flow rate 
 
Decreased fibre diameter 
Increased fibre diameter and beading 
morphology 
Applied voltage 
 Decreased voltage 
 Increased voltage 
 
Increased fibre diameter 
Decreased fibre diameter and beading 
formation (Zuo et al., 2005). 
Humidity 
 High humidity (>60%) 
 
Fibres do not dry properly and a formation of 
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pore on the fibre surface which are called 
“breath figures”. The breath figures created 
from the air condenses on the fibre surface 
due to the jet cooled then they evaporated and 
formed pores (Casper et al., 2004). 
Temperature 
 High temperature 
 
Decreased fibre diameter 
 
Table 1.10.4: Factors that influence the morphology of an electrospun scaffold 
 
1.11. Polymer 
Table 1.11, lists some commonly used scaffold materials, including 4 polymers used for 
tissue engineering relevant to this project: Polyhydroxybutyrate-polyhydroxyvalerate: 
PHPV, Poly (ε-caprolactone): PCL, Polylactic acid: PLA, and Polyurethanes (PU). 
These scaffolds have all been approved by the Food and Drug Administration (FDA) for 
tissue replacement in medical devices, for instance in craniofacial reconstruction. 
Materials Origin Characteristics 
Collagen  
 
Natural Low immune activation 
Favorable cell adhesion  
Supporting to morphology 
modification, migration, and 
differentiation of cells 
Low mechanical properties (Kleinman 
et al., 1981) 
Chitosan Natural Hemostatic 
Raise to osteoconductive and wound 
healing 
Poly(hydroxybutyrate)  Natural A natural resource 
Limited usefulness by its brittleness  
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(Chen and Wang, 2002)  
Poly(ε-caprolactone)  Synthetic Aliphatic polyester family 
U.S. Food and Drug Administration 
approved  
Hydrolysis degradation (Hutmacher et al., 
2001) 
Produced biocompatible by-product 
(Langer and Tirrell, 2004) 
Slow degradation 
Lack of toxicity 
Low cost (Yoshimoto et al., 2003) 
Good mechanical properties 
Polylactic acid (PLA) 
 
Synthetic Weak mechanical properties 
Controllable degradation by blending 
with Poly(glycolic acid):PGA 
Hydrolysis degradation 
By-produces might generate 
inflammation, in vivo   (Cheung et al., 
2007) 
Polyurethane (PU) Synthetic Biocompatibility. 
Degradable and nondegradble 
materials. 
Adjustable the wide range of 
biological and mechanical, and 
degradable properties. 
Toxicity of degradable products is a 
major problem (Gunatillake and 
Adhikari, 2003). 
 
 
  
Table 1.11: Advantages and disadvantages of natural and synthetic polymers used in 
bone tissue engineering 
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1.11.1. Polyhydroxybutyrate-polyhydroxyvalerate   
PHBV copolymer is a completely biodegradable plastic, the copolymer of 
hydroxybutyrate (HB) and hydroxyvallerate (HV) monomer produced and mixed by the 
fermentation of microorganisms (Alcaligenes eutrophus) (Kotnis et al., 1995) (Figure. 
1.11.1). The usefulness of polyhydroxybutyrate (PH) is limited because of its 
brittleness, deficiency in thermal stability and difficulty of manufacture. These 
weaknesses are overcome by adding polyhydroxyvalerate (PV) into the polymer to 
increase the flexibility and firmness. PHBV has been used in various application areas 
such as disposable personal hygiene, packaging and medical devices. The beneficial 
properties of PHBV are its biodegradability by slow hydrolytic degradation (Holland et 
al., 1987). 
PHBV has been evaluated for tissue response in vivo, Gogolewski et al., (1993) found 
that PHBV does not cause any adverse reaction such as pus or necrosis. However the 
animals, which were implanted with PHBV showed a continuous inflammatory 
response over three months. The high inflammatory response at the implanted area was 
related to the amount of HV ingredient. Although Shishatskaya et al., (2004) showed in 
vivo that there was no inflammatory affect at the implanted area where highly pure 
medical grade PHBV, which was not contaminated from protein or lipid of bacteria, 
was implanted. The PHBV polymer films were implanted, in vivo, and degraded until 
material was undetectable over an 18 month period (Sultana and Khan, 2012). 
Sombatmankhong  et al., (2007) reported that PHBV scaffolds are biocompatible with 
fibroblastic cells by evaluating initial cell attachment and proliferation. In addition, 
enzyme activity (ALP: alkaline phosphatase) of human osteoblasts (Saos-2) seeded on 
PHBV indicated that the cells were osteogenic from 24-72hr after culture. 
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Figure 1.11.2: Chemical formula of caprolactone and polycaprolactone   
 
1.11.2. Poly(-caprolactone) 
PCL is a biodegradable and biocompatible material, which is made from aliphatic 
polyester (Figure. 1.11.2). PCL is degraded by hydrolysis and its breakdown products 
are biocompatible. Monocryl
®
 sutures are made from PCL. Several studies reveal that 
they have been used clinically and approved by the U.S. FDA for human use 
(Hutmacher et al., 2001, Reed et al., 2009). PCL has a slow degradation rate that is 
suitable for the bone part of a tissue engineering scaffold. The yield of PCL hydrolysis 
is the 6-hydroxycaproic acid which is a natural metabolite (Mishra et al., 2008). 
Because the material degrades slowly by hydrolysis PCL has been suggested as a bone 
replacement for a load-bearing area until bone cells grow into the mature phase and 
have sufficient ability to form functional tissue. Hutmacher et al., (2001) showed that a 
PCL scaffold could maintain its mechanical properties for 5-6 months and was 
completely metabolized over 2 years. Moreover, many people have used PCL as a 
material for in vitro studies and demonstrated that human fibroblastic and osteoblast-
like cells attached, proliferated, produced extracellular matrix, and developed tissues 
(Delaine-Smith et al., 2014a, Tuan and Hutmacher, 2005, Williams et al., 2005). 
Furthermore, PCL is cheap and it is possible to produce in large quantities.  
 
 
  
Figure 1.11.1: Chemical formula of Polyhydroxybutyrate-polyhydroxyvalerate 
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1.11.3. Polylactic acid (PLA) 
PLA is a Poly (α-hydroxy esters) (Figure. 1.11.3). It is biocompatible, biodegradable 
and FDA approved for medical use (Bye et al., 2013, Tu et al., 2003, Ma and Zhang, 
1999). PLA has the potential to provide an environment for attachment, growth, and 
differentiation of cells (Sikavitsas et al., 2005). The degradation of PLA is by hydrolysis 
to break the polyester bonds and this yields lactic acid as a by-product. Shishatskaya et 
al., (2004) reported that the degradation period of this scaffold is about 6 months. The 
drawbacks of PLA implanted materials are the residual products. These decrease the pH 
of the adjacent area and stimulate an inflammatory reaction. In addition, the by-products 
of PLA materials could increase the rate of degradation of the polyester. Thomson et al., 
(1995) observed that the degradation of the scaffold became more rapid when the acidic 
concentration of the adjacent area was increased in vivo. The acidic environment might 
induce an inflammatory reaction or tissue necrosis. Moreover, PLA has insufficient 
mechanical strength to support the reconstruction of hard tissue.    
 
 
 
 
 
Figure 1.11.3: Chemical formula of the monomer of poly (lactic acid)  
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1.11.4. Polyurethane (PU) 
PUs have been used for biomedical purposes in cardiovascular implants for many years. 
But it was withdrawn from the market because of surface microcracking. In recent years 
improvements have been made in its toughness, elasticity, durability, biocompatibility, 
biodegradability, and it has been incorporated in several biomedical implant 
applications. PU consists of the three basic segments including;  
P – (D(CD)n – P) n 
Where P means the polyol which called the soft segment, D means the di-isocyanate 
which can react with either P or C, and C means the chain extender which is either a 
hydroxyl or amine group. The D and C combination creates the hard segment of PU. 
PU has tunable biological, mechanical, and physicochemical properties by adjusting the 
combination of hard and soft segments resulting in PUs with different properties as 
desired for the final application (Takahara et al., 1992, Guan et al., 2005). 
Biodegradable PUs have been used in bone tissue engineering due to their elastic 
mechanical properties and low degradation rate. PU scaffolds can be produced by many 
methods including; electrospinning, salt leaching, and thermally induced phase 
separation (Guelcher, 2008). However, the degradation-products of PU particularly the 
diisocyanate component is a potential toxic chemical component (Gunatillake and 
Adhikari, 2003).  
1.12. Bioactive composite electrospun scaffold 
Electrospun scaffolds can mimic the physical structure of native ECM. However, there 
are problems associated with synthetic polymer electrospun scaffold. These are; lack of 
cell recognition sites on the surface, hydrophobicity and no specific osteoinductive or 
osteoconductive properties of the majority of materials used in electrospinning. 
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Therefore, bioactive materials will be introduced in the polymer production for bone 
tissue engineering.  
Composite materials by definition are composed from 2 or more components. Native 
bone is made from mostly collagen type I and HA that consists of calcium phosphate. 
Many studies in bone tissue engineering have developed electrospun scaffolds 
consisting of biodegradable materials and calcium phosphate particles or HA. 
Electrospun collagen type I has been used in tissue engineering, though they have the 
low mechanical properties and do not maintain their structure in a culture media 
environment for longer than 10 days (Jha et al., 2011). Therefore they are not material 
of choice for bone tissue engineering which needs time for cell development and 
mineralization, and also good mechanical properties. Nano-sized HA had been 
deposited on a knitted micro-porous silk scaffold by using a soaking process to produce 
a biocompatible, wettable, and osteoconductive scaffold that facilitates the attachment 
and ingrowth of cells into the implanted scaffold. The scaffold was also observed to be 
osteoinductive meaning that it could induce undifferentiated stem cells of 
osteoprogenitor cells to become osteoblast-like cells (He et al., 2013, Swetha et al., 
2010). Utilising electrospinning, composite fibres can be created and produced in the 
form of composite blending (Nandakumar et al., 2010), submerging in a simulated body 
fluid, and the alternate soaking process (Meng et al., 2013). The traditional simulated 
body fluid (SBF) method typically requires an incubation time of more than 7 days for 
coating with continuous HA deposition via ion charging between the material surface 
which presents the negative charge (carboxyl and hydroxyl groups) and the positive 
charge (calcium ions) in the SBF. In vitro studies showed that HA alternate soaking 
process on PLA scaffold enhanced OCN expression and also increased mechanical 
strength (Jaiswal et al., 2012). On the other hand, Meng et al., (2013) found that calcium 
phosphate apatite surface coating didn‟t enhanced the cell adhesion, cell proliferation, 
or osteogenic differentiation.          
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1.13. Vacular endothelial growth factor (VEGF)  
VEGF is a cellular glycoprotein which has an important role is the regulation of new 
blood vessel formation (vasculogenesis). Senger et al, (1983) discovered a vascular 
permeability factor from ascites tumor which rapidly produced a microvascular 
permeability, in vivo. They also found a similar result from the culture media of tumor 
cells, in vitro. Later VEGF research found that the VEGF family is composed of seven 
types; VEGF-A is the most vasculogenesis capable protein and can induce endothelial 
cell proliferation, vessel, and bone formation. The VEGF-A human gene has four 
different isoforms, VEGF-121, VEGF -165, VEGF-189, and VEGF-206. VEGF-189 
and VEGF-206 are completely separated from ECM which is necessary for epiphyseal 
vascularization (secondary ossification) in endochondral bone formation. Whereas the 
VEGF-165 is mostly bound to ECM which takes an important role for primary 
ossification center (metaphyseal angiogenesis). VEGF-A binds to the VEGF receptors-1 
(VEGFR-1), VEGFR-2, and the VEGF co-receptor neuropilin-1 (NRP1) on many cell 
surfaces such as hematopoietic stem cells, monocytes, neurons, and osteoblasts (Otrock 
et al., 2007, Thi et al., 2010). VEGFR-1 acts as the antagonist receptor to inhibit 
endothelial cell proliferation, while VEGFR-2 acts as the agonist for vasculogenesis. 
NRP1 can bind to VEGF-1 directly and also mediate the conversion of VEGF165 to 
VEGFR-2. Clinical studies found that an overexpression of VEGF can cause diseases 
such as cancer and diabetic retinopathy in eyes. Several studies reported that late stage 
of human osteoblast-like cells produce VEGF. VEGF production is stimulated by 
hypoxic conditions, BMPs, transforming growth factor beta (TGF-β), prostaglandin, 
fibroblast growth factor 2 (FGF-2) and 1α,25-dihydroxyvitamin D3. In contrast, the 
production of VEGF is reduced by glucocorticoids (Maes and Carmeliet, 2008). Thi et 
al., (2010) reported that VEGFR-2 plays an important role in mediating fluid flow shear 
stress induced VEGF secretion by osteoblasts, in vitro. Fluid flow may release PGE2 as 
mechano-signaling factor therefore this signal may stimulate VEGF production (see 
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1.17). Another hypothesis is that VEGF release by mechanical stimulation may induce 
vasculogenesis by two pathways. Firstly, the autocrine pathway may increase VEGFR-2 
by actin adaptation of osteoblasts. The other is a paracrine pathway, the signal may 
communicate to other endothelial cells, osteoblasts, and osteocytes which are necessary 
for bone formation and fracture healing. 
1.14. Mechanical force 
1.14.1. Introduction 
Bone in healthy people is a dynamic tissue in which there is a balance between bone 
resorption and formation over time. The effect of mechanical forces on living bone has 
been studied for many years. Researchers found that the force below a bone micro 
damage threshold in a particular area affected the bone architecture by adaptation 
(Frost, 1994). For example, the bones of racket-holding arm in tennis players are much 
stronger than there of the other side. Mechanical force is applied to their arm whilst they 
play tennis. In contrast, an astronauts bone mass decreases during long term space 
flight, since no gravity is present to enable sufficient loading on their bones. Various 
mechanical loading parameters such as compressive, tensile, or torsional strain and fluid 
shear stress may affect bone. Several studies have evaluated the effect of mechanical 
stimuli on osteoprogenitor cells used for bone tissue engineering (Li et al., 2004, Chen 
et al., 2010, Delaine-Smith et al., 2012). 
1.14.2. Mechanical regulation of bone cells.  
Typically in cortical bone, osteocytes are in lacuna and their cell processes are in 
canaliculi (Figure 1.14.2). The space between lacunae and canaliculi is filled with 
interstitial fluid. The fluid flows produced depend on the pressure gradients within the 
bone matrix. The oscillatory fluid shear stress on osteocytes was estimated to be 
approximately 0.8-3Pa (Weinbaum et al., 1994, Mi et al., 2005). Verbruggen et al., 
(2014) predicted the effect of shear stress on the cell membrane of osteocytes under a 
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physiological environment, in vivo by using computational methods. The shear stress 
was in the range of 0.1-2.2 Pa which had been shown in in vitro studies to enhance 
osteogenic differentiation (Delaine-Smith and Reilly, 2011, Bacabac et al., 2004). 
Osteoprogenitor cells located in the intramedullary cavity (bone marrow) may also be 
affected by fluid flow while there are volumetric changes in the cavity, muscle activity, 
and capillary filtration (Kwon et al., 2010). Osteoprogenitor cells reside not only in the 
bone morrow but also in many soft tissues including; vascular smooth muscle, capillary, 
and periosteum tissue. These tissues significantly deform under a physiological loading, 
therefore one would expect that fluid flow can affect the osteoprogenitor cells within 
these tissues (Chen et al., 2010).  
How mechanical loading affects MSCs differentiation is still not clear, both in vivo and 
in vitro. Fluid flow can be applied to cells in vitro using a bioreactor (Datta et al., 2006, 
Sittichokechaiwut et al., 2010). Specific bioreactors design should be considered to 
enhance the current standard of tissue engineering. The important loading regime should 
be elucidated to ensure the best conditions of differentiation and extracellular matrix 
production, either in vitro: before implantation, or in vivo: after implantation.  
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Figure 1.14.2: Schematic showing the anatomical area of osteocytes and 
osteoprogenitor cells in different areas. The figure on left side is a structure of cortical 
bone which has osteons arranged concentrically. An osteocyte locates in a lacuna and 
its processes connect with another osteocyte throughout the canaliculli. The space 
between the cells, lacuna, and canaliculli are filled with interstitial fluid. Fluid flow 
induced shear around the pericellular matrix could affect the biochemical response of 
the osteocyte. The figure on right side is a schematic of osteoprogenitor cells which 
locate in the intramedullary cavity and the mesenchymal tissues such as blood vessels 
(lower right corner). Fluid flow and hydrostatic pressure may affect the osteoprogenitor 
cells in intramedullary canal when bone deforms. The cells in mesenchymal tissues are 
subjected to the flow during the movement of tissues. Reprinted from (Chen et al., 2010) 
with kind permission of Elsevier.          
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1.15. Methods of mechanical stimulation 
1.15.1. Introduction 
Bone is a dynamic organ able to adjust its architecture and resist physical forces. 
Mechanotransduction is a cell process which converts a mechnical stimulus into a 
cellular chemical response. The mechanotransduction mechanism of MSCs have been 
elucidated through both in vivo and in vitro studies by subjecting cells to various 
mechanical stimuli. The optimum conditions for mechanical stimulation such as 
amplitude, frequency, and duration are unknown. The MSC response to mechnical 
stimuli may also depend on the age of the donor, site of origin, stage of cell 
differentiation, and culture conditions. The cell culture environment, whether two-
dimensional (2D) or three-dimensional (3D) affects the cells by affecting cell 
morphology, cellular matrix adhesion, cellullar migration, gene and protein expression, 
and mechnical response (Pedersen and Swartz, 2005). Three mechanical stimulation 
regimes which have been studied for osteogenic differentiation will be discussed here; 
compression, tension, and fluid flow induced shear stress.   
1.15.2. Compression 
Cells will experience compressive strain when they are pressed by something. Two 
types of compressive loading which have been frequently studied are direct contact 
compression (Figure. 1.15.2 B) and hydrostatic pressure (Figure. 1.15.2 A). Hydrostatic 
pressure is an indirect contact pressure from the loading platform to the cells. The 
advantages of this pressure are simple to setup, homogenous pressure, no physical 
obstacle of the media to press the cells. The direct contact compression is a technique 
more close to the physiologic compression in the bone or cartilage. The side effects of 
the compressive pressure may produce a fluid shear stress from fluid moving in and out 
of the scaffold and nutrient transportation. Tanaka S. M. et al., (2005) suggested that the 
compression loading induce fluid flow was more influent than the direct strain created 
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by compressive loading. Compression loading can stimulate both osteogenic and 
chondrogenic differentiation in hMSCs (Chen and Jacobs, 2013). Studies by Saitoh et 
al., (2000), in vivo, showed that mechanical compression could stimulate cartilage 
formation in the mid-palatal suture by reprogramming MSC-like cells from osteogenic 
to chondrogenic. Orr et al., (2006) reported that the compressive strength could induce 
pressure gradients, resulting in stimulation of the interstitial fluid flow in the lacunar-
canalicular space. In our group, Sittichokechaiwut et al., (2010), found that the short 
term of compressive cyclic loading and rest periods could enhance matrix production in 
hBMSCs in a 3D structure. These results also showed that compressive force on the 
scaffold could induce osteogenesis as well as dexamethasone (Dex).  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.15.2 : Schematic of typical compression loading patterns. (A) Hydrostatic 
pressure (or indirect contact pressure), (B) direct contact pressure. Adapted from 
Delaine-Smith and Reilly, (2011) with kind permission of Elsevier. 
CHAPTER ONE 
66 
 
1.15.3. Tension  
Tensional force arises by flexion of tendons or the muscle contraction pulling on bones. 
Cells will experience tension strain when they are stretched and their substrates also 
increase in length. The most two popular methods of tension which have been studied in 
vitro are uniaxial (or multi axial) grip tension (Figure. 1.13.3 B) and substrate bending 
(Figure. 1.15.3 A). Most studied involved cells seeded on flexible substrates. For 
example, the grips may be attached at the ends of a substrate and the cells seeded in the 
middle of the substrate. The cells are subjected to tensile strength when the substrates 
are pulled. In substrate bending, for example, the cultivated cells are subjected to 
tension strain when the substrates are bent by placing on two pivot points. The stretch 
can be; static or dynamic. For static stretch, the sample is held at a fixed strain for a 
period of time. For dynamic stretch, the sample is stretched cyclicly. Glucksmann A., 
(1942) and Takahashi et al., (2003) found that tensile stretch could transform a 
cartilaginous tissue into bone. Both tension stretch techniques may also create 
compressive stretch because of the Poisson effect which means contraction in the 
perpendicular direction to the direction of stretching. The cyclic tension may also 
applied fluid shear stress to the cells when the culture media moves over the cells. Cells 
seeded within a gel based scaffold (3D culture) which has mostly uniform deformation 
may receive the tensile loading homogenously. In contrast, a randomized fibrous 
scaffold on which cells attach in various directions on the fibres might receive 
heterogeneous strain.      
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1.15.4. Fluid flow-induced shear stress 
Fluid flow is the most widely used method of mechanical stimulation of osteocytes and 
osteoblasts. Several studies have shown that osteocytes and osteoblasts could response 
to the fluid flow-induce shear stress similar to that is experienced in bone in the lacunar-
canalicular system (Orr et al., 2006). Various apparatus configurations have been 
utilized to study the effect of shear stress on cells (monolayer „2D‟ culture). Typical 
apparatus that have been used include the cone and plate apparatus (Hermann et al., 
1997), the parallel plate flow chamber (Li et al., 1996), the rotating disc apparatus 
(Reutelingsperger et al., 1994), the oscillatory orbital shaker system (Thomas et al., 
2011), and oscillatory fluid flow (OFF) by using a standard see-saw rocking system 
(Zhou et al., 2010, Delaine-Smith et al., 2012). Firstly, the cone and plate apparatus 
comprises with a cone axis and a flat-plate for growing the cells. The fluid flow is 
homogenous relating to the velocity and the space between the cone and plate surface. 
The parallel plate flow chamber consists of two slits opening at the ends of a rectangular 
Figure 1.15.3 : Schematic of typical tension loading configurations. (A) Substrate 
bending technique: The cells seeded on substrate are subjected to three point bending 
which results in tension strain on the convex surface. (B) Grip tension technique: The 
cells are seeded on substrate which is attached with the grip at the both end side. The 
substrate is pulled resulting in a uniaxial strain formation. Reprint from Delaine-Smith 
and Reilly, (2011) with kind permission of Elsevier.      
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chamber. A uniform laminar flow within a pressure gradient is created on the cell 
culture surface. See-saw rocking system comprises typical cell culture wells containing 
media placed on a standard see-saw rocker. The fluid flow relates to the speed, and flip 
angle of the rocker, in addition to the height, and viscosity of the culture media. The 
practical attractions of this apparatus include; simplicity of the apparatus, ease of culture 
media exchange, ease to monitor, both physically to visualize under a microscope, small 
volumetric culture media requirements, no special chamber requirement, and 
economical cost. 
Various types of fluid flow have been studied including a unidirectional flow, divided 
into a steady perfusion and pulsatile flow, and oscillatory fluid flow. Pulsatile flow 
represents a typical continuous blood flow. Oscillatory flow represents the flow induced 
by the repetitive strain of tissue during locomotory (movement) activity. Steady 
perfusion has been reported to increase bone volume in 3D structures (Grayson et al., 
2008). In addition, oscillatory fluid flow showed the ability to stimulate osteogenic 
differentiation and mineralization in both osteoprogenitor cells (hESMPs) with 
osteogenic induction medium and mature bone cells in monolayer (Delaine-Smith et al., 
2012, Lim et al., 2013).   
In 3D culture, it is difficult to quantify how much fluid flow are subjected to the cells. 
The cells arrangement on the scaffold may relate how much the fluid flow affects the 
cells (Figure. 1.15.4 A). Cells attached on a single layer on the scaffold surface may 
receive the similar experience as 2D culture on the parallel plate flow chamber (Figure. 
1.15.4 B). However, the cells seeded on the hydrogel or bulk scaffold could transfer 
fluid flow to the cell surrounding structure similar to in vivo conditions (Delaine-Smith 
and Reilly, 2011).  
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1.16. Mechanical stimulation of osteoprogenitor cells in 3D culture. 
Traditional cell culture on 3Dl scaffolds in static conditions, in vitro, leads to limitations 
such as providing non-homogenous nutrient and oxygen diffusion and eliminating waste 
products. In vitro studies, the distances between cells within the nonwoven polymer 
scaffold and the scaffold surface over which nutrients and oxygen can diffuse are 
around 100-200µm (Carrier et al., 2002, Volkmer et al., 2008). As a result in there will 
be necrotic cells at the core and living cells at the outer shell of the construct over a long 
time in culture (McCoy and O'Brien, 2010). Recent studies showed a severe reduction 
in osteogenic differentiation and cell proliferation in 2% of oxygen condition compared 
with normal atmospheric oxygen, 21% of oxygen conditions (Malladi et al., 2006). To 
overcome these limitations of static culture, mechanical loading was introduced to 
enhance the quality of osteogenic differentiation and cell proliferation. Several 
Figure 1.15.4: Schematic of fluid flow-induced shear stress the 3D culture (A) and 
monolayer ‘2D’ culture (B). The directions of flow and flow magnitude in 3D culture are 
variable between regions. In contrast, the direction of flow in 2D culture is much more 
homogenous. Reprint from Delaine-Smith and Reilly, (2011)  with kind permission of 
Elsevier. 
(A) 
(B) 
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bioreactors were innovated for 3D constructs such as flow perfusion bioreactor (Datta et 
al., 2006), spinner flask (Mauney et al., 2004), cyclic compression (Sittichokechaiwut et 
al., 2010). These bioreactors showed an enhancement of osteogenic differentiation by 
osteoprogenitor cells. Therefore the mechanical stimuli influence the bone tissue 
engineering, in vitro. A porous scaffold with superior mechanical properties (able to 
withstand to load bearing) is ideal for bone tissue engineering when subjecting the 
construct to mechanical stimuli for enhancing osteogenic differentiation (McCoy and 
O'Brien, 2010).  
1.17. Mechanical stimulation of MSCs  
MSCs differentiation can be stimulated in vitro under suitable conditions. The 
differentiation of MSCs into osteoblast has been extensively studied by adding chemical 
supplements or growth factors. This has previously been found that Dex may lead to 
osteonecrosis because of diminished stimulated VEGF secretion (Li et al., 2005). 
Therefore using Dex may not a desirable method for MSC implanted materials to be 
used clinic. Optional methods for the osteogenic differentiation of MSCs which 
withdraw the possible side effect of supplement additives are required. Therefore, 
external mechanical stimulation may be an optional method to overcome this problem. 
In physiological conditions, mechanical stimulation has an important role in the growth, 
development, and maintenance of cells and tissues with both differentiated and 
undifferentiated MSCs are mechanosensitive in vitro. Engler et al., (2006) found that 
MSCs can differentiation towards a specific linage depend on the geometry and stiffness 
of their environment. However the mechanical properties of natural bone marrow 
environment have not been measured yet (Gurkan and Akkus, 2008). For tissue 
engineering, it is important to elucidate which regimes of mechanical stimulation will 
enhance bone matrix production and calcium deposition, in vitro. Moreover, MSCs 
could be pre-committed into a specific linage by appropriate condition in vitro, which 
might overcome an inappropriate microenvironment in vivo (Engler et al., 2006).      
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1.18. Mechanotransduction 
Mechanotransduction is a cellular mechanism which translates mechanical stimuli into 
the biochemical signals by using mechanosensitive receptors. This mechanism can be 
found in many types of cells such as osteocytes, osteoblasts and MSCs. Over the past 
decade studies have evaluated cellular mechanotransduction by several pathways. The 
effects of mechanical stimulation are translated via cellular components such as stretch-
activated ion channels and G-protein coupled receptors in the cell plasma membranes. 
These cell components can respond when the cell membrane changes its shape. The 
result of this process is an influx of calcium and other ions into the cells (Figure. 1.18 
a,h). The cell glycocalyx is a pericellular carbohydrate rich protein layer on the cell 
surface which is a potential sensor of external forces (Figure. 1.18 b). For example, on 
endothelial cells or in osteocyte‟s lacunar-canalicular system, the glycocalyx could 
respond to the fluid shear stress that moves over the cells to induce intracellular calcium 
influx and cyclooxygenase-2 (COX-2) gene expression. COX-2 is a critical enzyme for 
PGE2 production during bone repair in both endochondral and intramembranous 
ossification (Einhorn, 2003) and osteopontin signalling (Reilly et al., 2003, Bonnet and 
Ferrari, 2010). Osteopontin is a glycosylated protein expressed in bone matrix. Its 
functions are to regulate cell proliferation and phagocyte activity in macrophages and to 
regulate mineralization in ECM (Sodek et al., 2000). Gap junction signalling also 
respond to external stimulations such as oscillatory fluid flow (Figure. 1.18 c). The 
effect of that stimulus is release of PGE2 and up-regulation of osteopontin (Saunders et 
al., 2001, Schiller et al., 2001) which enhances the mineralization of bone cells in vivo 
(Yoshida et al., 2002).  
Another part of mechanotransduction is the theory that integrin pulling causes 
cytoskeletal deformation. (Figure. 1.18 d,e). Integrins are transmembrane protein 
receptors which connect cytoskeleton filaments and ECM through focal adhesion 
(cellular junction between cell and ECM). The presence of tensile forces on cytoskeletal 
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is transferred to the nucleus membrane for activating ion-channels and changing DNA 
function (Ingber, 2006) (Figure. 1.18 g). Janmey and Mcculloch, (2007) and Orr et al,. 
(2006) reported that when cultured cell are exposed to fluid shear the magnitude of 
membrane deformation would induce a stress of only 0.1% of the shear stress applied in 
endothelial cell monolayer. They suggested that the physiological fluid flow was too 
small to stimulate stretch-activated ion channels. They necessary need the force 
enlargement to create strain. Some mechanical sensors may be more sensitive than the 
cell membrane or protrude into the ECM. One structure that projects from the cell 
membrane into ECM is primary cilium. Primary cilia have been found to respond to 
mechanical stimuli in many cells such as renal epithelial cells and osteocytes (Janmey 
and McCulloch, 2007). Hoey et al., (2012), reported that OFF could enhance 
mechanotransduction and mediate osteogenic differentiation in hBMSCs.  
Osteoprogenitor cells responded to OFF by increasing intracellular calcium, producing 
nitric oxide (NO) and PGE2, activating mitogen-activated protein kinases (MAPKs) and 
ERK1/2, and regulating osteopontin gene expression (You et al., 2001). The activation 
of MAPKs and ERK1/2 will stimulate Runt-related transcription factor (Runx2) which 
is an important transcription factor for controlling osteogenic differentiation-related 
genes; such as ALP, OCN, bone sialoprotein, and collagen type I (Liu et al., 2010). OFF 
will increase intracellular calcium and is balanced by the released calcium from the 
(triphosphoinositol) IP3 pathway from the storage organelles (Riddle et al., 2006). 
Osteopontin is a key factor at ECM involving bone cell attachment, regulation a late 
marker in osteogenic differentiation and mineralization (You et al., 2001, Bancroft et 
al., 2002).  
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Figure 1.18: Schematic summarising the mechanotrasduction of MSCs, osteoblasts, 
osteocytes and many other cells when fluid flow, pressure, or tissue strain is applied. 
Reprinted from Bonnet and Ferrari, (2010) with kind permission from Nature 
Publishing group. 
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1.19. Aims and objectives of research project 
Hypothesis 
The main hypothesis of the project is that tri-layer scaffolds seeded with human primary 
osteoprogenitor cells can be differentiated into osteoblastic cells on one side and 
fibroblastic cells on the other side. This strategy could be used in the future to fill the 
space in the roof of the mouth in patients with cleft palate. 
Objectives 
The objectives of my PhD project were to understand how to engineer bone tissue by 
selected cell sources, materials, and conditions for developing cleft palate repair. The 
combination of tri-layer scaffolds was in collaboration with another student who is 
selecting the soft tissue part. In our design the tri-layer scaffold can separate the two 
different cell types where one is human dermal fibroblastic cells (HDFs) and the other 
side could be human primary mesenchymal stem cells (hESMPs and hBMSCs). This 
method can allow normal facial development and decrease the surgical steps required to 
reconstruct the cleft palate. Therefore, from these objectives, the aims of this study 
were: 
1. Evaluate suitable conditions to stimulate osteogenic differentiation of human 
mesenchymal progenitor cells including; hESMPs, hBMSCs, and HJPs.  
1.1 Suitable osteogenic media conditions will be selected to be used for stimulating 
osteogenic differentiation of HJPs. 
1.2 Various concentrations of Dex supplements for inducing osteogenic differentiation 
on hESMPs and HJPs will be tested. 
1.3 The effect of Dex on vascular endothelial growth factor (VEGF) secretion of the 
cell types will be determined. 
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2. Finding the appropriate materials for the scaffold.  
2.1. Appropriate scaffold materials will be selected by evaluating cell attachment, 
viability, and matrix mineralization.  
2.2. The potential of a composite hydroxyapatite PCL electrospun scaffold (HA-PCL) 
to support cells will be investigated.   
2.3. Both PCL and HA-PCL physical and mechanical properties will be characterized. 
2.4. A suitable percentage of HA incorporated into PCL scaffold will be selected for 
osteogenic differentiation. 
3. Evaluate OFF stimulate osteogenic-progenitor cells. 
3.1. The ability of OFF to stimulate osteoprogenitor cells (hESMPs, hBMSCs, and 
HJPs) in both the monolayer and 3D culture will be examined. 
3.2. The effect of OFF on VEGF secretion of hESMPs and hBMSCs under monolayer 
and 3D culture will be evaluated.  
4. Study how a tri-layer scaffold separates two cell types on either side.  
4.1. The osteogenic differentiation and also separation of osteoprogenitor cells 
(hESMPs and hBMSCs) on one side and HDFs cells on the other side at suitable times 
(28 days for culturing osteoprogenitor cells and 7 days for culturing HDFs) will be 
visualised. 
4.2. The mineralization of the osteoprogenitor cells and the separation of co-culture will 
be evaluated using confocal fluorescence microscopy. 
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CHAPTER TWO: MATERIALS AND METHODS 
2.1. Materials 
1. Primary human dermal fibroblasts were isolated from skin donated by patients 
undergoing abdominoplasty or breast reduction under informed consent. (Ethical 
approval for the tissue acquisition was granted by the local ethical approval committee 
of the NHS Trust, Sheffield, UK). The tissue and isolated primary cells were stored in 
the Kroto Research Institute‟s tissue bank, University of Sheffield (License number 
12179). 
2. Primary human jaw periosteum cells were isolated from periosteum membrane 
which was donated by 2 patients undergoing maxillofacial operations who‟s periostium 
was removed because of jaw fracture with informed consent. The periostium was 
considered to be waste tissue in these operations. (Ethical approval for the tissue 
acquisition was granted by the local ethical approval committee of the NHS Trust, 
Sheffield, UK).  
3. Human bone marrow mononuclear cells (Lonza®,Castleford, UK). 
4. Human embryonic stem cell-derived mesenchymal progenitor hES-MP 002.5 
(hESMP) cells (Cellartis, Gothenburg, Sweden). 
5. Poly(-caprolactone) (PCL), 80kDa (Sigma, Dorset, UK) to produce electrospun 
scaffolds. 
6. Polylactic-D-acid (PLA), 152kDa (Sigma, Dorset, UK) to produce electrospun 
scaffolds. 
7. Polyhydroxybutyrate-co-polyhydroxyvalerate 8% (PHBV) in ratio PHB92:PHV8 
(Goodfellow, Huntingdon, UK) to produce electrospun scaffolds. 
8. Dichloromethane (Sigma, Dorset, UK) for dissolving polymers for electospinning. 
9. Nano-hydroxyappatite (HA) powder, particle size less than 200nm, 97% pure 
(Sigma, Dorset, UK). 
CHAPTER TWO 
77 
 
10. Human dermal fibroblasts basal culture media: Dulbecco‟s Modified Eagle‟s 
Medium (DMEM) (Biosera, East Sussex, UK) supplemented with 10% Fetal calf serum 
(FCS), 2mM L-glutamine (L-G) and 1% of 100mg/mL peniciliin and streptomycin 
(P/S) (All products obtained from Sigma, Dorset, UK). 
11. HJPs and hBMSCs basal culture media: Minimum Essential Medium Alpha Eagle 
(α-MEM) (Lonza®, Castleford, UK) supplemented with 10% FCS, 1% L-G, and P/S. 
12. hESMPs basal culture media: Minimum Essential Medium Alpha Eagle (α-MEM) 
(Lonza
®
, Castleford, UK) supplemented with 10% FCS, 1% L-G and P/S, and 4ng/ml 
fibroblast growth factor-basic recombinant human (bFGF) (Invitrogen, Paisley, UK)  
13. Fibroblastic media (FM): basal DMEM supplemented with 50µg/mL ascorbic acid-
2-phosphate (AA) (Sigma, Dorset, UK). 
14. Media with the supplements required for matrix mineralisation but NOT the 
osteogenic factor dexamethasone (Dex) was termed „supplemented media‟ (SM): basal 
α-MEM supplemented with 50µg/mL AA and 5mM β-glycerolphosphate (β-GP) 
(Sigma, Dorset, UK). 
15. Dex containing osteogenic media (SM+Dex10, SM+Dex100): basal α-MEM 
supplemented with 50µg/mL AA, 5mM β-GP, and either 10nM or 100nM 
Dexamethasone (Dex) (Sigma, Dorset, UK), respectively.  
16. Trypsin-EDTA (Sigma, Dorset, UK). 
17. Porcine gelatine (Sigma, Dorset, UK). 
18. Phosphate buffered saline (DulbeccoA) (OXOID Limited, Hamshire, England ). 
19. Collagenase from Clostridium histolyticum (Sigma, Dorset, UK). 
20. Dimethyl Sulfoxide (DMSO) (Sigma, Dorset, UK). 
21. DNaseI (Stemcell®, France). 
22. Trypan blue dye (Sigma, Dorset, UK) for detecting dead cells. 
23. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) cell viability 
assay (Sigma, Dorset, UK). 
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24. MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl) -2-(4-
sulfophenyl)-2H-tetrazolium) (CellTiter 96
® 
Aqueous Non-radioactive Cell 
Proliferation Assay) (Promega, Southampton, UK). 
25. DAPI (4‟-6-Diamidino-2-phenylindole) (Sigma, Dorset, UK) at 1mg/mL  
26. Phalloidin-TRITC (Phalloidin–Tetramethylrhodamine B isothiocyanate) (Sigma, 
Dorset, UK) at 0.5mg/mL  
27. Live/Dead staining: Live-cell SYTO© 9 (Life technologies, Paisley, UK) and dead 
cell Propiodium Iodide (Molecular Probe
®
, Oregon, US) 
28. Picro-Sirius red stain: at 1mg/mL direct red dye and saturated Picric acid (Sigma, 
Dorset, UK) for collagen staining. 
29. Alizarin red staining (Sigma, Dorset, UK): at 1mg/mL diH2O, pH 4.2, for calcium 
staining. 
30. Xylenol Orange tetrasodium salt (Sigma, Dorset, UK): at 20µM in culture media 
for labelling mineralized nodules. 
31. Quant-iT™ PicoGreen® dsDNA Reagent assay Kits (Invitrogen™, Paisley, UK) for 
total cellular DNA quantification. 
32. Alkaline Phosphatase Yellow (pNPP) Liquid Substrate System for ELISA (Sigma, 
Dorset, UK) for quantitative determination of cellular alkaline phosphatase (ALP) 
activity. 
33. Human VEGF standard ELISA Development Kit (PeproTech®, London, UK) for 
measuring of VEGF secretion in cell culture supernatants.   
34. 2,2‟-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) liquid substrate 
(Sigma, Dorset, UK) for colour developing in VEGF quantification assay. 
35. Formaldehyde (37%, grade 1 for SEM) (Sigma, Dorset, UK). 
36. Hexamethyldisilazane (HMDS) (Sigma, Dorset, UK) for SEM. 
37. Human mesenchymal stem cells multi-color flow cytometry kit contained four 
different antibodies conjugated fluorochromes [CD146 conjugated with 
carboxyfluorescein (CFS), CD90 conjugated with allophycocyanin (APC), CD105 
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conjugated with peridinin chlorophyll protein complex (PerCP), and CD45 conjugated 
with phycoerythrin (PE)] and their isotype controls for each antibody (R&D system, UK ). 
38. Brilliant Violet 421™ anti-human CD105: CD105 conjugated with Brilliant Violet 
(BV) and its isotype control (BioLegend, US) 
39. Microcentrifuge tube (Eppendroft, Hamburg, Germany) 
40. PBS without calcium (Ca2+) and magnesium (Mg2+) (Sigma, dorset UK) 
41. Non-enzymatic cell diassosiation solution (Sigma, dorset UK) 
42. Compensation particles (BD™ CompBeads, Oxford, UK) 
43. BD LSRII flow cytometer (BD Biosciences, UK) (the Mellanby Centre, Medical 
school, University of Sheffield).  
44. Electrospinning apparatus consistes of a syringe pump (Genie™ Plus, Kent 
Science, USA), a high voltage electric source (Genvolt, UK), a rotating motor 
(Heidolph Instrument, Germany). 
45. BOSE ElectroForce 3200 (ELF3200) for mechanical testing (ElectroForce System 
Group, BOSE, Minnesota, USA) 
46. Standard see-saw rocker (STR6) (Stuart equipment, Staffordshire, UK) for 
producing oscillatory fluid flow. 
47. Spectrophotometer (ELx800, BioTek, UK) 
48. FLx800 microplate fluorescence reader (BioTek, UK) 
49. ImageXpressTM is an epifluorescent microscope (Axon Instrument, Inc., UK) 
50. Zeiss Axiokop 2 FS MOT laser-scanning confocal microscope (upright) provided 
with LSM 510 Meta detector (Carl Zeiss MicroImaging GMBH, Germany) 
51. Chameleon Ti:sapphire tunable (700-1060nm) multiphoton laser (Coherent, CA, 
USA) 
52. Argon/2 laser with wavelength 488nm (LSM 510 laser module, Carl Zeiss, 
Germany) 
53. HeNe laser with wavelength 543 nm (LSM 510 laser module, Carl Zeiss, 
Germany) 
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54. EC-plan-Neofluar objective with magnification 20X (Carl Zeiss, Germany) 
55. Ziess LSM Image Browser software package (Carl Zeiss, Germany) 
56. Scanning electro microscope (SEM, Philips XL-20 SEM, Netherlands) 
57. Micro-computed tomography (micro-CT) (Skyscan 1172, Kontich, Belgium) (the 
Mellanby Centre, Medical school, University of Sheffield) for quantifying bone volume. 
58. X-ray diffractometer (XRD) D500 Diffractometer (Siemens, Germany) 
59. X-ray photoelectron spectroscopy (XPS) (Axis Ultra DLD spectrometer) (Kratos 
Anlytical, UK) 
60. Casa XPS software (Casa Software Limited, Devon, UK) for processing XPS 
spectra. 
61. Photoacoustic Fourier transform infrared spectroscopy (PAS-FTIR) (Nicolet Nexus 
8700 FT-IR, Thermo Fisher Scientific Inc, USA)  
62. Omnic 7.4 software (Thermo Scientific, UK) for processing PAS-FTIR spectra. 
63. Medical grade steel ring (2cm diameter, 1.2cm inner hole diameter) (produced by 
NHS medical workshop) for seeding cells and immobizing cell in the cell culture 
medium during experiment.  
64. Medical grade stainless steel dental wire (0.8mm diameter) (OthoCare®, Bradford, 
UK) for immobizing and flattening scaffold in the culture medium during experiment. 
65. CellCrown™ (made from polyethylene terephthalate: PET) (Scaffdex®, Tampere, 
Finland) for seeding cells and immobizing cells in the cell culture medium during 
experiments. 
66. Laboratory digital balance (Mettler toledo, UK)  
67. Image processing software: image analysis and processing in Java-base (ImageJ) 
(developed by National Institutes of Health, USA) 
68.  Image processing software: LSM Image Browser (downloaded from Carl Zeiss 
microscopy)  
CHAPTER TWO 
81 
 
69. Image processing software: CT-Analyser (CTAn) (kindly obtained from Dr Les 
Coulton, the Mellanby Centre, Medical school, University of Sheffield) for measuring 
the percentage of bone volume. 
70. Image processing software: CT-Volume (CTVol) (kindly obtained from Dr Les 
Coulton, the Mellanby Centre, Medical school, University of Sheffield) for constructing 
visual model. 
71. Data analysis software: GraphPad Prism6, SPSS (Statistic 21, IBM) 
72. Graphic program: Adobe Photoshop (Developed by Adobe System) for arranging 
graphs and images. 
2.2. Methods 
2.2.1. General cell culture conditions 
Cells were grown in T-75 flasks and cultured by using the appropriate basal culture 
media at 37°C in 5% CO2 and a humidified atmosphere. The cells were observed daily 
for cell morphology, colour of the medium, and cell density. The medium was changed 
every 2-3 days. Passages were performed when cells reached 80% confluency. To begin 
with, the medium was removed and washed twice with PBS; 2.5ml of trypsin-EDTA 
solution was used to enzymatically release the cells from the old tissue culture plate. 
The enzyme was stopped by using a fresh basal culture media. Cell suspension was 
centrifuged at 1,000 revolutions per minute for 5 minutes. The supernatant was removed 
and a known volume of the basal culture media was added. The cell pellet was 
resuspended in 1ml medium, 40µl of cell working solution was mixed with another 40µl 
of trypan blue dye. A number of cells were counted by using a hematocytometer. 
Finally, a minimum 10
5
 cells were transferred to a new flask or seeded onto samples. 
Cryopreservation of cells for future experiments used DMSO as a cryoprotectant at 10% 
final concentration in FCS. The cells were transferred to a cyrovial and stored at -80ºC 
for one day and then moved to -196 ºC the next day for long term storage. 
CHAPTER TWO 
82 
 
Culture condition Compositions 
SM basal α-MEM supplemented with 50µg/mL AA and 
5mM β-GP. 
SM+Dex10 basal α-MEM supplemented with 50µg/mL AA, 5mM β-
GP, and 10nM Dex 
SM+Dex100 basal α-MEM supplemented with 50µg/mL AA, 5mM β-
GP, and 100nM Dex 
Table 2.2.1: Complete list of culture conditions on both monolayer and 3D 
cultures. 
2.2.2. Human dermal fibroblasts (HDFs) 
The cells were kindly provided by Julio Bissoli (Kroto Research Institute, the 
University of Sheffield). Briefly, the cells were extracted from dermis layer of skin 
where dermal fibroblastic cells are found. Firstly, the harvested skin were removed from 
the epithelium layer and then mechanically separated from the dermis tissue. They were 
then added to 10-15ml of collagenase A solution overnight at 37 ºC for dissociating the 
tissue. The working solution was washed with PBS to remove the collagenase, 
following with centrifugation at 2000 rpm for 10 minutes to obtain a cell pellet. The cell 
pellet was resuspended and placed into T-25 flasks. The first culture following the cell 
isolation was called the primary culture (or passage 0, P0). The unattached cells were 
removed from the flasks and the remaining cells that were attached onto the flasks were 
subcultured by dividing 1:10 dilutions for passaging. These cells were called a 
secondary culture (or passage 1, P1). The cells that were used for experiments from 
passage 2 to 8 to ensure their initial functions were maintained. 
2.2.3. Human jaw periosteal cells (HJPs) 
Human jaw periosteum consists of three-layers; the inner layer is called cambium layer 
which contains osteoprogenitor cells; the following layer contains mostly fibroblastic 
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cells and the outer most layer contains mainly collagen fibres. The periosteum tissues 
were harvested from the upper (maxilla) or lower (mandible) jaw of two patients 
undergoing maxillofacial treatment in the University of Sheffield, Dental School; with 
informed consent. The periosteum tissues were stored in the α-MEM basic culture 
media, at 4ºC for less than 24 hours before they underwent  cell isolation. The 
periosteum tissues were control bacterial contamination with 1% of 100 mg/ml P/S in 
PBS, then mechanically separated into smaller tissue pieces. They were added to 0.25% 
collagenase type II and incubated at 37 ºC for 3 hours (Samee et al., 2008). The working 
solution was resuspened with α-MEM basic culture media; centrifuged at 2000 rpm for 
5 minutes to obtain cell pellet, the supernatant was then emptied to remove the 
collagenase. The cell pellet was resuspended and placed into T-25 flasks and 2ml of 
fresh basic culture media was added to the flasks every 2-3 day for 7 days. After 7 days 
the old culture media and non-adherent cells were removed. The adherent cells are 
expected to be MSCs, under basic culture media (Dominici et al., 2006, Chao et al., 
2012). It has been suggested that HJPs can be used between passages 3 to 10 (De Bari et 
al., 2006), however, cells were only used between passages 3-8 for all experiements. 
From studies comparing DMEM and α-MEM as suitable basal culture media for HJPs; 
the HJPs cultured in α-MEM showed better cell proliferation than those cultured in 
DMEM. Therefore α-MEM was used for all HJP experiments. The HJPs morphology 
obtained from 2 donors exhibited 2 different cell shapes; HJPs-1 cell morphology was 
more cubiodal shape, while HJPs-2 was spindle cell shaped (Figure. 2.2.3).      
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2.2.4. Human mesenchymal stem cells from bone marrow (hBMSCs) 
The bone marrow mononuclear cell samples were purchased from a registered company 
(Lonza
®
) for each of the 3 donors. The samples consisted of hematopoietic cells and 
MSCs. MSCs are isolated based on their ability to adhere to plastic tissue culture dishes 
(Chao et al., 2012, Dominici et al., 2006). To receive maximum yield of the MSCs from 
the frozen cell samples; the cell samples were placed in a distilled water bath at 37ºC 
until the last ice crystal melted. The cell solutions were transferred to pre-warmed basal 
culture media containing 0.1mg/ml DNaseI. The viable cells were counted by using a 
heamatocytometer and trypan blue dye. The dead cells were presented as dark blue in 
contrast to the live cells and were therefore excluded. The cells were plated at a density 
of 1.25x10
5 
cells per cm
2 
in T-25
 
flasks. 2ml of fresh basic culture media was added to 
the samples every 2-3 day for 7 days. Non-adherent cells were removed and replaced by 
fresh culture media. The adherent cells which were fibroblast-like cells showed a 
number of fibroblastic colony forming units (CFU-f) (Figure. 2.2.4). The cells from this 
stage were called passage 0 and were cultured until reaching 70-80% confluence. The 
Figure 2.2.3: Phase contrast images of the HJPs cells from two donors on day 7 of 
culture. (A) The cell morphology of HJPs-1 shows a distinct cuboidal cell shape. (B) The 
cell morphology of HJPs-2 shows a spindle cell shape similar to fibroblast-like cells. 
Images captured by author. Scale bar = 200µm. 
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adherent cells were detached from the flasks with Trypsin-EDTA and were re-plated at 
a density of 4x10
3 
cells per cm
2 
in T-75
 
flasks. The cells were serially sub-cultured up to 
passage four for experiments (Lee et al., 2013).   
 
 
 
 
 
 
 
 
 
 
 
 
2.2.5. Cell characterization 
The Mesenchymal and Tissue Stem Cell Committee of the International Society for 
Cellular Therapy suggested the criteria to clarify cells as MSCs that 1] MSCs must 
adhere to plastic tissue culture surface under a standard culture condition, 2] MSCs 
showed express the surface antigens (Ag); CD 73 (known as an ecto 5‟ nucleotidase), 
CD 105 (known as an endoglin), CD 90 (known as a Thy-1), and CD 146 (known as a 
melanoma cell adhesion molecule: MCAM) (Tormin et al., 2011), and lack expression 
Figure 2.2.4 : Phase contrast images present the adherent cells of human MSCs which are 
fibroblast-like cells and form fibroblastic colony forming units (CFU-f) over 28 days. 
Scale bar is 200μm.  
 
CFU-f 
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of the surface antigens; CD 45 and CD 34 which normally indicate hematopoetic stem 
cells (Ogata et al., 2005), and CD 14 (known as monocyte and macrophage markers) 
(Zieglerheitbrock and Ulevitch, 1993) by using flow cytometry, “CD” is an abbreviation 
for cluster of differentiation (Boxall and Jones, 2012), 3] MSCs are be able to 
differentiate to chondroblasts, adipocytes and osteoblasts (Dominici et al., 2006).  
Flow cytometry is a method for identification and characterization of MSCs. It is used 
to characterise cell properties, count cells, sort cells, and identify biomarkers. It allows 
each cell to be characterised and sorted from a heterogenous cell mixure depending on 
the specific proteins on the cell that are labelled with fluorescent antibodies. The 
usefulness of this method is that it is fast, objective and quantitaive record of fluorescent 
signal from individual cells and can physically separate the cells of interest.  
The cells cultured in the T-75 flasks were removed from the culture media and washed 
with PBS without calcium (Ca
2+
) and magnesium (Mg
2+
). 6 ml of non-enzymatic cell 
diassosiation solution was added and incubated at 37ºC and monitored to detach cells 
from the flask. This was followed by neutralising with basal culture media and 
centrifuging at 1000 rpm for 5 minutes. The supernatant was removed and 1 ml of 
FACS solution (0.1%BSA, 0.1% sodium azide in PBS solution) was added to resuspend 
and count the cells. The desired cells were divided into the microcentrifuge tube, 
centrifuged, and the supernatant removed. The following tabulated list of all 
components for analysing all types of MSCs which have been used in all experiments 
(hESMPs, HJPs, and hBMSCs) (table 2.2.5 A). Then they were incubated at room 
temperature for 45 minutes under dark environment.   
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Conditions Staining 
buffer 
(µl) 
Primary 
antibody 
(µl) 
Isotype control 
antibody (µl) 
Excitation 
and emission 
(nm) 
Unstained 50 0 0  
All Isotypes 30 0 5 µl X 4 Isotypes  
CD90/APC 45 5 0 660/20 
CD105/BV 45 5 0 450/50 
CD146/ CFS 45 5 0 530/30 
CD-45/PE 45 5 0 575/26 
All antibodies 30 5 µl X 4 antibodies 0  
 
Table 2.2.5 A: Complete list of components and experiment parameters for MSCs 
characterization of hESMPs, HJPs, and hBMSCs by using FACS. 
For each experiment, anti-rat Ig, ĸ-chain and negative control CompBeads™ particles 
were stained with the corresponding fluorochrome-stained antibodies. Compensation 
particles were used to optimize the setting of fluorescence compenstation for analysing 
with multicolour flow cytometry. The advantages of the compensation particles are that 
they provide more accurate results and reduce overlap from the combination of 
fluorescence-stained antibodies.  
The staining process followed the company instructions briftely; 100µl of staining 
buffer was added into a microcentrifugation tube. One full drop (approximate 60µl) of 
the CompBead™ anti-rat Ig (positive particles) and the other full drop of the negative 
control particles were added into each tube and vortexed. 10µl of primary antibody was 
added to the tube, and incubated for 30 minutes at room temperature in a dark 
environment. 1ml of FAC buffer was added to each tube and vortexed. All samples 
including the cells and the CompBead™ were centrifuged at 6000 rpm for 2 minutes 
CHAPTER TWO 
88 
 
and the supernatant removed. 300 µl of FACs buffer solution was added to each tube 
and kept at 4ºC, under dark environment.  
Conditions Staining 
buffer 
(µl) 
Primary 
antibody 
(µl) 
Excitation and 
emission (nm) 
Unstained 100 0  
CD90/APC 90 10 660/20 
CD105/BV 90 10 450/50 
CD146/ CFS 90 10 530/30 
CD-45/PE 90 10 575/26 
 
Table 2.2.5 B: Complete list of components and experiment parameters for 
CompBead™ characterization of control compensation particle set by using FACS. 
The stained CompBead™ and negative control particles were analyzed on a BD LSRII 
flow cytometer with 4 lasers as 355, 405, 488, and 633 nm. Using excitation and 
emission setting as listed in table 2.2.5 B compensation was adjusted automatically 
using the BD FACS Diva acquistion software. Then, the samples were analysed using 
the same settings. Data of flow cytometry data were analysed as geometric means of 
fluorescence intensity.   
2.2.6. Cell culture in monolayer 
In the monolayer experiments (termed „2D‟) cells were detached from T-75 flasks, and 
counted to calculate cell number. The determination of cell number and volume of 
media depended on the length of experiment, cell shape, and size of cell culture well 
plate. The required cell and culture media volumes were mixed into one container and 
were resuspened to ensure even distribution. They were then divided into individual cell 
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culture wells. Sterile 0.1% Gelatin in PBS was precoated on the well plate half an hour 
before cell seeding to enhance cell attachment of the hESMPs.   
2.2.7. Electrospinning rig set up  
Polymer electrospun scaffolds were created from a specific polymer concentration in a 
suitable solvent as detailed in chapter 5. A polymer solution was made by dissolving in 
either dichloromethane (DCM) or a mixture of DCM and methanol. The solutions were 
left on a magnetic stirrer plate overnight to ensure homogeneity. The electrospinning 
apparatus was set up as seen in (Figure. 1.10.4). Scaffolds were synthesized at 17 kV, 
with a flow rate of 40μl/min, a working distance of 17 cm, and a drum rotation speed of 
300 rpm. The solutions were released by 4 needles (0.6 mm internal diameter) to the 
rotating drum, ground collector. The collector was covered with aluminum foil to 
support a fibrous sheet. After emptying the polymer solution in the syringes, the fibrous 
sheets were moved to a vacuum at room temperature for 24 hours to allow any excess 
solvent to evaporate. The fibrous sheet was then stored in a self-sealed plastic bag at 
4ºC and used within 6 months.  
2.2.8. Physical characterisation 
 Electrospun scaffold without cells 
The morphology of electrospun scaffolds was observed and their morphologies were 
analysed by measuring fibre diameter by SEM from two different sample batches. The 
SEM is an electron microscope which can visual the surface topography and 
composition of the samples. SEM has a wide range capacity of magnification from 10 to 
500,000 times while a light microscope has a limitation of magnification of only 250 
times. The scanning process begins with an electron gun emitting the electron beams to 
interact on the sample surface. The secondary electron beams are released and detected 
by the special detectors.   
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The scaffold sample was cut into a 10 mm diameter circle shape and mounted onto a 
specimen stub using an electrically conductive double sided adhesive tape. The 
scaffolds were sputter coated with an gold ultrathin layer became the sample surface 
must be electrically conductive to avoid electrical charge. The sample was visualised 
with accelerating voltages of 20kV and spot size of 3.0. 
 Electrospun scaffolds with cells 
The sample for visualising by SEM was required to be completely dry due to the SEM 
chamber being under high vacuum. A living cell sample was removed from culture 
media and washed with PBS 3 times (5 minutes each) and fixed with 10% formalin in 
PBS for 20 minutes at room temperature to preserve the cell structure. A dehydration 
step was untertaken to replace water in the cells with ethanol. The samplewas 
submerged in the following series: 35%, 60%, 80%, 90% of ethonol in distilled water, 
and 100% ethonol for 15 minutes at each concentration. Following this, the solution was 
replaced with HMDS as a drying agent by submerging the sample in 1:1 ethanol and 
HMDS solution for 1 hour and subsequencely rinsing with 100% HMDS for 5 minutes 
twice. The sample was then removed and left to dry in a desicator for at least 1 hour, the 
sample was stored in a dry and clean place until coated with the gold layer and 
visualised. 
Scaffold porosity was calculated by determining the density of the scaffold and the 
density of the bulk material. To determine the scaffold density, the scaffolds were cut 
into 1cm
2
 squares, the thickness measured with a micrometer, and the weight 
determined using a laboratory analytical balance, which can measure mass in the sub-
milligram range, to determine the scaffold volume. The scaffold porosity was calculated 
using the following formula:  
 = (1 - /0)*100 
(where  refers to the density of scaffold and 0 refers to the density of the bulk 
material) 
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 Mechanical characterisation 
The mechanical characteristics of electrospun scaffolds was determined by using a 
BOSE ELF 3200 with WinTest 4.1 software package. The scaffold was cut into 
cylindical shapes, 5 mm in width and 12 mm in length. The scaffold was gripped at both 
ends of the sample with 6 mm guage length and strained until the maximum 
deformation was 6mm (100% strain). The force was recorded using a 22 N load cell. 
Both the force and displacement results were plotted to generate a stress against strain 
graph. The graph was used to determine the Young‟s modulus of elasticity and the yield 
strength of each scaffold. 
Young‟s modulus is a ratio of stress divided by strain in the elastic region of the stress 
against strain curve. The elastic region where the material can return to its initial shape 
after the strain has been removed, this value represents the stiffness of the material. 
Yield strength is the first stress point at the which material begins plastic deformation. 
The yield strength is the maximum point on the curve after the region of elastic 
deformation. Ultimate (tensile) strength is the maximum point of stress which begins as 
the material show a necking shape before the material is broken.     
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2.2.9. Hydroxyapatite characterisation 
 X-ray Diffraction (XRD) 
XRD is a crystal analytical technique that does not destroy the sample. The data 
obtained includes a chemical composition, morphology, and crystal structure by using 
the principle of Bragg diffraction. W. L. Bragg and W. H. Bragg in 1913 explained that 
the crystal structures arrange in the parallel planes which have aspecific distance. The 
incidenced x-ray beams at a specific angle could produce the intense peak of reflected 
beams. The Bragg‟s law formula is:  
n=2dsin 
(Where n refers to integaer,  refers to the incidence wavelength, d refers to the distance 
between the parallel planes in the crystal structure,  refers to the angle between the 
incidence radiation and the crystal parallel plane). 
XRD could determine a sample in either a thin film or a powder. An intense peak 
reveals where the particular atoms are arranged in the structure and the data is compared 
Figure 2.2.8: The stress-strain curve of the standard electrospun PCL scaffold. Young’s 
elastic modulus of elasticity can be determinated from the gradient of the maximum 
slope in the elastic region. Linear elastic deformation is the recoverable deformation 
region and it’s slope is the Young’s Modulus. Yeild strength is the stress point when the 
sample initially deviated after the elastic region. Plastic deformation is the permanent 
deformation that occurs after yeild.   
 
Standard PCL scaffold 
Linear elastic 
deformation 
Plastic deformation 
Yield strength 
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with known standard data. Morover, this technique may quantify the amount of atoms 
and the crystalline size of the sample. However, the limitations of XRD are single 
crystal detemination and the length of particle size for analysing must be between 
0.1µm-40µm. 
The sample was flatened on the holder and measured by a x-ray diffractometer using 
copper K-alpha (Cu Kα) radiation (lamda=1.54(A)) at 40kV and 30mA to obtain the 
date. The range of 2 between 25º to 35º was measured with at a scan speed of 0.1 
degrees per minute (Ishikawa et al., 1993). The data was compared with a known 
standard graph to identify the sample component.        
  Fourier transform infrared spectroscopy (FTIR)  
FTIR is a chemical component analytical technique that is widely used in biomaterials. 
This technique can identify the presence of functional groups in a sample molecule. 
Mostly the biomaterials are opaque which obstructs analysis of the material with a 
direct transmission analysis in the mid-infrared regions (Rehman and Bonfield, 1997). 
Reduction in material density can change the original material components. An 
alteration in the infrared (IR) wavelength from mid-IR region to near-IR region which 
avoids the opaque side effect of materials may limit the obtained data, therefore photo-
acoustic sampling (PAS)-FTIR may be used as a solution to these problems. The 
principle of this technique is that a specific frequency of IR beams are absorbed when 
they equal the vibrational frequency of a melocular bond in the sample. Subsequently 
they are converted into heat and diffused to the sample surface and the surrounding 
environment. A gas thermal expansion generates the PAS signal which could be 
identified by the detector (Rehman and Bonfield, 1997). Advantages of this technique 
are that there is no sample preparation, and there is more depth of detection than any 
other FTIR technique.      
The sample was scanned in the sample chamber of the PAS cell which was purged with 
dry helium gas. The obtained spectra was recorded in the IR range between 400-4000 
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cm
-1
 at 8 cm
-1 
resolution with 128 scans. The carbon black specimen was scanned for 
calibration before scanning the sample and the received data were processed using 
Omnic 7.4 software package. 
 X-ray photoelectron spectroscopy (XPS) 
XPS is a chemical analysis technique of the surface of material to reveal a chemical 
elemental composition and an empirical formula. A sample is irradiated with x-ray 
beams resulting in electrons being released to the ultra-high vacuum chamber. An 
electron detector measures the electron binding energy (y-axis) which represents the 
specific element and the number of released electrons which represents the amount of 
elements on the sample (x-axis). The limitation of this technique is that it is not suitable 
to analyse samples which contain water as water might evaporate and change the 
material structure during the reading. 
The obtained XPS data were used an Axis Ultra DLD spectrometer. The material 
surface was scanned at 160eV pass energy, 1ev step size from 1200 to -5eV to reveal 
the XPS spectra. The data was determined using Casa XPS software. The sample scans 
were performed in duplicate. 
2.2.10. Scaffold preparation 
A day before experiments began, scaffolds were cut into either a circular shape by using 
a circular cork borer (15mm diameter) or an ecliptic shape (15mm in width and 35mm 
in leigth) (Figure. 2.2.10.1 A) by using a scalpel blade. The scaffold mat was wraped 
with aluminium foil. A template was drawn with pen on the cover of the aluminium foil 
and then cut with a scalpel blade. The appropriate sized scaffolds were soaked with PBS 
to increase the hydrophilicity of the scaffold. The scaffolds were sterilised with 0.1% 
peracetic acid in PBS under steady rocking conditions for 3 hours. Peracetic acid is an 
anti-microbiological agent and has therefore been used to sterilise scaffolds; however a 
side effect of peracetic acid can be damage the nano-HA particles on the scaffold (Kim 
et al., 2006a). Therefore in experiments where HA scaffolds were used all scaffolds 
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(HA containing and control polymer scaffolds) were sterilised with 80% ethanol in 
distilled water for 2 hours. After sterilisation, the scaffolds were washed three times 
with PBS, left for 5 minutes in each wash to ensure the removal of either the peracetic 
acid or ethanol remaining. Two different scaffold immobilizers were used during cell 
culturing; a customised bended medical grade stainless steel wire (Figure. 2.2.10.1 C) 
and a CellCrown™ application (Figure. 2.2.10.2 A). The steriled CellCrown™ and 
scaffold were assembled and submerged overnight in the basal culture media which 
contained FCS to enhance cell attachment, under sterile and room temperature condition 
(Figure. 2.2.10.2. B-D). For the wire-held group, the scaffolds were placed in a 12-well 
plate and stainless steel rings were placed on top; 1mL of basal culture media was added 
to each well and left overnight to allow for serum protein attachment under sterile and 
37ºC incubator condition. Before cell seeding, the cell culture media was removed. 
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Figure. 2.2.10.1 : (A) Electrospun PCL scaffolds were cut into ecliptic shapes. (B) 
The scaffolds were laid flat in the 6-well plate . (C) The bent wire is placed on top of 
the scaffold. Images captured by author.   
Figure 2.2.10.2 : (A) CellCrown™. (B) The scaffolds were inserted into the CellCrown™ 
and (D) inverted side. (C) The scaffold inserted CellCrown™ were cultured in the 12-
well plate. Images captured by author.   
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2.2.11. Cell seeding for 3D culture 
A cell seeding study was carried out to determine the most effective of cell seeding 
techniques; (Figure. 2.2.11 A) small volume technique + 1hr, (Figure. 2.2.11 B) small 
volume technique + 2hr; (Figure. 2.2.11 C) low volume of media technique, and 
(Figure. 2.2.11 D) large volume of media technique.  
There were no significant differences between the methods used however the large 
volume technique presented less variation than the others; therefore the large volume 
technique was chosen for all future experiments. After the culture media was removed, 
1mL of media was added to each well. The media leaked through the scaffolds until the 
inner and outer parts of the immobilized materials were at equilibrium. The small 
volume suspension (no more than 100µl) was seeded on top of the inner ring and left for 
24 hours in a cell culture incubator for cell attachment. The following day the wire-
holder group of scaffolds were removed to fresh well plates (Figure. 2.2.10.1 B) and 
fresh wire was placed on top to ensure immobilisition and that the scaffolds were 
submerged in the culture media (Figure. 2.2.10.1 C). The scaffolds inserted in the 
CellCrown™ were also moved to a fresh well plate (Figure. 2.2.10.2 D). All cell seeded 
scaffolds were cultured with fresh culture media along with the required supplements on 
day1. 
 
 
 
 
 
 
 
  
Figure 2.2.11: Schematic of cell seeding methods. A: small volume technique+1 hour, 
B: small volume technique+2 hours, C: low volume of media technique, and D: large 
volume of media technique. In the technique A, B, and C, after the samples were 
incubated, the appropriate media were added until 1mL into the well plate. The cells 
were allowed for attachment for overnight in the cell culture incubator. 
Low 
media 
Large 
media 
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Conditions Number of cell per sample Cell density  
Monolayer culture  10,000 11 cells/mm
2
 
3D culture 
Experiment 5.4 
General experiment 
Experiment 6.3 
 
50,000 
100,000 
200,000 
 
1473 cells/mm
2
 
2,946 cells/mm
2 
2,946 cells/mm
2 
Table 2.2.11: Complete list of seeding cell densities on both monolayer and 3D 
cultures. 
2.2.12. Assessment cell viability and cell number 
 MTTassay 
MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay is a 
colorimetric assay for examining relative cell number and viability by using metabolic 
activity. The yellow dye of MTT (tetrazole) is reduced by mitochondrial reductase 
enzyme in living cells to purple formazan (Figure. 2.2.12.1). Acidified isopropanol is 
added to dissolve the product of purple formazan into a dark blue or purple formazan 
salt solution. The colour of the solution is removed and measured with a 
spectrophotometerat wavelength 570nm.  
Cell-seeded scaffolds were washed with PBS, and then 0.5mg/mL of MTT in PBS was 
added into the sample in the volume 0.5 and 1.0mL for 2D and 3D samples, 
respectively. The scaffolds were then incubated in a cell culture incubator for 40 
minutes. The purple formazan product was dissolved using 0.125% acidified 
isopropanol (25µL of HCL with 20mL of isopropanol), subsequently 100 µL of the 
dissolved solution was pipetted into 96-well place and the OD read spectrophotometer.  
 
 
 
 
Figure 2.2.12.1: Schematic presentation of MTT is reduced in living cells by 
mitochondrial reductase enzyme, resulting is purple insoluble formazan salt. 
Picture from (Peter and Peter, 2009). 
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 MTS assay 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) 
is an alternative colorimetric method for measuring cell viability. MTS is a tetrazolium 
compound, which is bioreduced by dehydrogenase enzyme by the active cells in the 
same way as MTT. The result of the reaction is a soluble pink formazan product. The 
amount of formazan production is directly evaluated by using an optical density plate 
reader at a wavelength of 490nm in a 96-well plate. The advantage of the MTS assay is 
that it allows the direct detection of the viability of the cells seeded on the scaffold 
through the formation of the soluble product (Figure.2.2.12.2). They is no need for an 
elution step which is a difficult to perform accurately in 3D cultures. 
In the first step, the cell-seeded scaffolds were washed with PBS, MTS working 
solution was added (made from 1:10 of MTS (initial concentration) in PBS), incubated 
at 37°C in a cell culture incubator for 3 hours for 3D experiments and for 30-45 minutes 
for monolayer experiments. 200µL was pipetted into a 96-well plate; the absorbance of 
the samples were measured in a plate reader and the absorbance values are related to the 
number of metabolically active cells. 
 
 
 
 
 
 
 
Figure 2.2.12.2: The schematic of yellow MTS is bioreduced by the active cells into pink 
formazan that is a soluble water by-product. 
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 Resaurin reduction test (Alamar blue®) 
The resazurin reduction test has been used for examining cytotoxicity and cell 
proliferation in different types of cells such as fibroblasts, cancer cell lines, mouse cells, 
and human cells. The test has increased in popularity due to it being a simple method, 
minimally toxic to cells, non-carcinogenic and cost-effective. The method can also 
measure continuous cell growth and the samples can be used for further experiments. 
The blue, non-fluorescent colour of the resazurin solution is reduced to resorufin which 
is pink and highly fluorescent in the media (Figure. 2.2.12.3). The pathway of reduction 
is not completely known. It may occur due to the intracellular activity of mitochondria 
enzyme or in the medium as a chemical reaction. The test can be measured by an 
absorbance or a fluorescence micro-plate reader, however, the fluorescence 
measurement has greater sensitivity than the absorbance reading (O'Brien et al., 2000). 
The resazurin working solution is a 0.1mM or 25.1µg/mL of the resazurin salt solution 
in basal culture media (1mM of resazurin salt powder in distilled water as stock 
solution, MW=251.16). The media was removed from the cell seeded scaffolds, and 2 
mL of resazurin working solution was added. The samples were wrapped in aluminum 
foil and incubated for 4 hours at 37°C. 200μL of pink resorufin product was transferred 
to a 96-well plate, and measured with a spectrofluorometer at an excitation wavelength 
of 540/35, and emission wavelength of 630/32nm.   
  
 
 
  
  
Figure 2.2.12.3: A schematic presentation of non-fluorescent resazurin reduction to 
fluorescent resorufin. Adapted from (O'Brien et al., 2000) with kindly permission Wiley. 
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 DNA quantification 
Fluorescent dye (PicoGreen
®
) was used to evaluate double stranded DNA (dsDNA). 
The dye specifically binds to dsDNA, enhancing the fluorescent properties of dsDNA. 
The cells were added to the cell digestion buffer to extract cellular DNA; stored at -
80°C for 10 minutes; incubated at 37°C for 1 hour and vortexed for 15 seconds. 
PicoGreen
® 
working solution was made by mixing a 20-times dilution of TE buffer and 
200-times dilution of PicoGreen
®
 reagent as commercially available in distilled water. 
100μl of the 1:1 ratio mixture of samples and PicoGreen® working solution was 
transferred into opaque 96-well plates, mixed well, and incubated for 10 minutes at 
room temperature. The expression of fluorescent dye in the samples was evaluated by a 
spectrofluorometer at excitation 480nm, and emission 520nm (Oliveira et al., 2006). 
The intensity of fluorescence emission was plotted against the known DNA 
concentration (calf thymus DNA) to create a standard curve (n=6). As a result, the 
formula from the standard curve was created to convert a number of fluorescence 
emission intensities to a volume of DNA (ng/ml):  
DNA (ng/ml) = (Fluorescence emission – 17.827) / 3.7593 
 
 
 
 
 
 
 
  
(A) 
(B) 
Quantitation using the PicoGreen® reagent 
Figure. 2.2.12.4: Linear quantitation of calf thymus DNA by using PicoGreen reagent, from 
0 to 2000 ng/ml with linear regression analysis (A),The data points in the red circle region 
from 0 to 200ng/ml are shown in figure B.  
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2.2.13. Analysis of cell-deposited collagen using picro-sirius red staining 
Picro-sirius red staining has been used for many years to stain collagen in 
histochemistry and quantify collagen in the culture plate. Picro-sirius red is an anionic 
dye; it can bind to a cation (the guanidine group of arginine) on the collagen molecule. 
This assay is a simple procedure and has been stated to specifically label collagen types 
I and III (Tullberg-Reinert and Jundt, 1999). 
The media was removed from the cell-seeded scaffolds and they were washed 3 times 
with PBS. Samples were then fixed with 10% formalin for 20 minutes at room 
temperature, and washed 3 times with PBS. Picro-sirius red solution was made by 
dissolving 1mg/ml of Sirius red powder in saturated picric acid, 1mL was added to each 
well, and placed under mild shaking for 18 hours. The dye was removed, washed with 
distilled water until no more dye solution was eluted, and air-dried. The stained collagen 
was observed by light microscopy. The samples were destained with 0.2M sodium 
hydroxide (NaOH) and Methanol in a ratio 1:1 under mild shaking for 15 minutes. 200 
µL of the dissolved solution was pipetted into the 96-well plate and assessed in an 
absorbance plate reader at 490nm.  
2.2.14.  Assessment of osteogenesis 
 Alkaline phosphatase activity 
ALP is an enzyme which can be used to predict the early stages of osteogenic 
differentiation. ALP can hydrolyze inorganic pyrophosphate (PPi) and generate 
inorganic phosphate (Pi) to promote mineralization. PPi can inhibit mineralization 
(Douglas et al., 2012, Orimo, 2010). Cells were evaluated for ALP activity by washing 
3 times with PBS. 500μL of cell digestion buffer was added;10% of cell assay buffer 
(1.5M Tris-HCL, 1mM ZnCL2, 1mM MgCL2 in double-distilled water, ddH2O) in 
ddH2O, and subsequently 1% of Triton X-100 and samples were left at 37°C for 30 
minutes. The cells which were cultured onto tissue culture plates were scraped to 
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remove cell lysate (the mixture of cell debris and cell digestion buffer solution) into a 
micro-centrifuge tube and left overnight at 4°C. Whereas the cells seeded onto scaffolds 
were dipped into cell digestion buffer in a micro-centrifuge tube; vortexed briefly, and 
left overnight at 4°C. The samples were then placed in a -80°C freezer for 10 minutes, 
then in a 37°C for 15 minutes and switched back and forth 2 more times; vortexed for 
15 seconds, and centrifuged at 1,000 rpm for 5 minutes. 10μL of cell lysate was mixed 
with 190μl of Alkaline Phosphatase Yellow Liquid Substrate for ELISA in a 96-well 
plate and incubated at 37°C for 10 minutes. The samples were measured by absorbance 
plate reader at 405nm every minute for 30 minutes. The enzyme activity was calculated 
as nmol para-nitrophenol/min (nmol pNP/min). The plate reader was calibrated so that 1 
absorbance value equals 22.5nmol product. The ALP activity was normalized by 
dividing by the DNA quantification from the same sample.  
 Alizarin red Staining 
A measurement of calcium deposition in vitro is Alizarin red staining. Alizarin red 
binds to calcium-containing mineral which can be observed as an orange-red colour by 
eye and under a light microscope. The amount of stain can be measured by extracting 
the red dye with 5% perchloric acid from monolayer culture plates and scaffolds.  
After the samples were measured by the resazurin reduction assay, they were washed 3 
times with PBS, fixed with 10% formalin for 20 minutes at room temperature and 
washed again 3 times with PBS. 1ml of 1mg/ml alizarin red in dH2O, adjusted to pH 4.1 
by adding ammonium hydroxide and left at room temperature for 20 minutes under a 
standard rocking platform. The unstained dye was removed with distilled water until no 
more red colour was eluted, and left to dry. The monolayer samples were observed by 
light microscopy. The stained samples were dissolved by adding 500µl of 5v/v% 
Perchloric acid into each well for 30 minutes under shaker at room temperature. 150 µl 
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of the dissolved solution was transferred to a 96-well plate and the OD measured at 
405nm (Hild et al., 2011).   
 Xylenol orange (XO) fluorescence staining 
XO (C31H28N2O13SNa4) is a non-toxic fluorochrome label when bound to calcium ions 
(Wang et al., 2006, van Gaalen et al., 2010). This staining has been using for labelling 
sequentially formed bone in vivo by intraperiotoneal injection at differenct time points 
(van Gaalen et al., 2010) and in vitro to detect the mineralized matrix of vital 
osteoblastic cells on hydroxyapatite component biomaterials (Kuhn et al., 2010). 
Advantages of this stain are the continuous monitoring of osteogenic response without 
requiring the sacrifice of the samples; the ease of the method and a high-throughput. 
20mM stock solution of XO powder was made up with distilled water and stored at 4ºC. 
The stock XO solution was added to the culture medium in a 1:1000 dilution, with a 
final concentration of 20µM. The final concentration was added to the samples for a 
minimum of 12 hours before imaging (Kuhn et al., 2010). The XO solution was 
removed and washed with PBS twice and replaced with fresh medium without β-GP to 
reduce the fluorescent backgroud from unbound XO. Visualised images of XO staining 
were taken with a confocal microscope at an exitation wavelength of 543nm. XO also 
absorbs into HA particles therefore no-cell control scaffolds were also stained to assess 
the effect of HA incoportation into polymer scaffolds on XO staining. 
 Micro-computed tomography (micro-CT) imaging 
To evaluate mineralised matrix in tissue engineering construct 2D histological and x-ray 
radiographic techniques were used in combination. The x-rays beams pass through the 
target area and are absorbed at a detector and presented in a 2D representation. 
Recently, 3D techniques have been developed and applied in vivo and in vitro for 
detecting osteoporosis and bone aging. This application has been used recently in bone 
tissue engineering (Tuan and Hutmacher, 2005, He et al., 2010). For the micro-CT 
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technique, the samples were taken in many different angles of radiographs, followed by 
a computed reconstruction which produced 3D models of the samples.  
The samples were fixed with 10% formalin in PBS for 20 minutes and washed twice 
with PBS. 12 samples were stacked by separating using foam sheets and were placed on 
a 20 mm diameter brass tray. The samples were adjusted to a width and height parallel 
to the scanning plane. The micro-CT parameters were set at 17.5µm/voxel resolution, 
the two images at each point were merged to present more accurate image, the filter was 
1 mm of aluminium and a rotation step of 0.8º, 360º was applied. Approximately 750 
slices were obtained. Two software packages (CTan and CTvol) provided by Skyscan 
were used to quantify the percentage of „bone volume‟ (in this case „bone volume‟ 
refers to any mineralized composite e.g. a composite HA-PCL electrospun scaffold and 
cell mineralized deposited collagen and HA) and to reconstruct the 3D structure of the 
samples, respectively. The region of interest (ROI) was cubic with dimensions of 18 
mm in length and 35mm in width which covered the entire sample stack chosen for 
scanning. For measuring bone volume percentage (%BV), a cylindrical ROI with a 
diameter of 1.2 mm (inner diameter of metal ring) and height of 390µm (approximate 
scaffold thickness) was chosen. The ROI was sectioned into top, mid, and bottom 
portions with 130 µm in each (Figure 5.11.1, chapter 5). Micro-CT measurment of the 
samples were received by evaluating on the threshold of the grey scale index (GSI). The 
threshold values were evaluated by analysing the GSI distribution. After scanning data 
set were divied into two different arbitrary thresholds (see result in the experiment 5.11, 
chapter 5). The first threshold was set in the range 30-70 GSI to analyse the standard 
PCL scaffold; the second threshold was set in the range more than 70 GSI to analyse the 
calcium deposition or hydroxyapatite (Figure 5.11.3, chapter 5). The value of a 
particular portion was presented as a percentage of the bone volume (%BV). The %BV 
of without cells on both unfilled PCL and HA-PCL samples as control was subtracted.   
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2.2.15.  Fluorescent staining of cell nucleus and cytoskeleton 
 DAPI and TRITC 
DAPI (4',6-diamidino-2-phenylindole) is a fluorescent dye which binds to A-T rich 
regions on dsDNA. DAPI can pass through both live and fixed cells; however, the 
efficiency of staining for live cells is less than that for fixed cells (Zink et al., 2003). 
DAPI absorbs at a maximum wavelength of 358nm (ultraviolet) and emits at a 
maximum wavelength of 461nm which is detected by a blue filter in fluorescence 
microscopy (ImageXpress
TM
) or confocal microscope at an excitation wavelength of 
800nm. 
Phalloidin binds to F-actin in fixed cells; either muscle or non-muscle cells. Phalloidin 
is an extracted peptide from the mushroom Amanita phalloides. The dye is mostly used 
in imaging applications conjugated with a fluorescent tag.  
TRITC (Tetramethyl Rhodamine Iso-Thiocyanate) is a commonly used reagent for 
fluorescent conjugation with phalloidin. TRITC is excited at a wavelength of 540-
547nm and emitted at a wavelength 570-573nm. 
Cells seeded onto scaffolds were fixed in 10% formalin for 20 minutes at room 
temperature, then washed 3 times with PBS. 1% Triton X-100
®
 in PBS was added to the 
samples and left for 10 minutes for cell membrane permeabilization, samples were then 
washed with PBS. The working solution of DAPI and Phalloidin-TRITC was a 1:1000 
dilution of DAPI and a 1:250 dilution of Phalloidin-TRITC stock (commercially 
available) in PBS. The DAPI and Phalloidin-TRITC at the final concentration of 1µg/ml 
of DAPI and 2 µg/ml of Phalloidin-TRITC were added to the samples, samples were 
covered in aluminum foil and left for 15 minutes. Samples were washed twice with 
PBS, and visualized by fluorescent microscopy. 
 
CHAPTER TWO 
107 
 
 CellTracker™ 
Two colours of CellTracker™ were used, CellTracker™Red and CellTracker™Green. 
CellTracker™ (Molecular Probe®) is a fluorescent marker in which the dye binds to the 
inside of the cell cytoplasm. The stained cells are still viable and pass the fluorescence 
to daughter cells through approximately four cell divisions (Yang et al., 2001). In a 
study by (Puelacher et al., 1996) bovine periosteal cells were stained with 
CellTracker™ Green. The dye was freely passed to the cell cytoplasm. The glutathione 
S-transferase-mediated reaction will conjugate partially the chloromethyl into thiol 
components in the cells. Then, the fluorescent dye thiol-ether product is permanently 
trapped inside the cell cytoplasm. The stained cell preparation was optimized for human 
jaw periosteum to be seeded on to the scaffolds. The optimal concentration of the 
fluorescent dye and revolutions of the centrifuge (rounds per minute) were assessed 
using fluorescence microscopy. The suitable CellTracker™ staining cell conditions 
demonstrated that 10µM of CellTracker™ combined with 1000 rpm centrifugation gave 
the highest fluorescence resolution images and cell number compared with the other 
groups. Moreover, preliminary experiments showed that adding CellTracker™ to the 
cells in monolayer in the T-75 flasks prior to trypsinization, was more effective than 
adding it to a cell suspension. Therefore this method was adopted for the remainder of 
the experiments. Trypsin-EDTA was then added to the flasks which were centrifuged at 
1000 rpm to obtain the cell pellet. The cells was mixed with trypan blue solution in a 1:1 
ratio; counted using a haemocytometer and seeded on to the scaffolds.   
 Live/Dead staining 
Live/Dead staining can distinguish between live and dead cells via the expression of 
two fluorescent colours. The fluorescence dies can penetrate into cells depending on the 
cell membrane permeability. The Live/Dead stain is a mixture of SYTO
©
9 which is the 
green-fluorescent nucleic acid stain and propidium iodide (PI) which is the red-
fluorescence nucleic acid stain. The stains differ in their spectral expression and their 
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ability to penetrate healthy cells. SYTO
©
9 can generally bind to both live (intact 
membrane) and dead cells (damaged membrane). In contrast, PI can only penetrate cells 
with damaged membranes and this reduces the green-fluorescent staining. Therefore, 
the cells with intact cell membranes express green-fluorescence and the damaged 
membrane cells express red-fluorescence. 
Cells seeded onto scaffolds were washed with PBS. The working solution of Live/Dead 
staining is a 1:1000 dilution of SYTO
©
9 and a 1:100 dilution of PI (commercially 
available) in PBS. 1mL of the final concentration at a 5µM of SYTO
©
9 and 10µg/mL of 
PI were added to the samples; covered with aluminum foil and left on a shaker at room 
temperature for 30 minutes. The samples were then washed with PBS and PBS was 
added to each sample to just cover the sample and they were visualized with 
fluorescence microscopy.      
2.2.16. Mechanical loading of cells 
 Application of oscillatory fluid flow (OFF) to cells  
Oscillatory motion is motion that moves back and forth repeatly in a constant cycle. 
OFF conditions were applied using a standard laboratory rocking platform „a see-saw 
rocker‟. Cells were subjected to OFF when they were placed on a see-saw rocker 
(Figure. 2.2.16). The rocking platform which was used in the experiments had a fixed 
maximum tilt angle of 6º and an adjustable speed. During all OFF experiments, cells 
were cultured in 6 well-culture plates which contained 2 ml of culture media in each 
well. Pre-coated well plates with 0.1% sterilised gelatin were required to enhance cell 
attachment for only the hESMPs experiment. The samples were subjected to OFF at 
room temperature, atmosphere CO2 (0.04% CO2) for 1 hour a day, 5 days a week for all 
experiments (Delaine-Smith and Reilly, 2011). Control condition were as described in 
chapter 4.  
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2.2.17. Assessment of vascular endothelial growth factor (VEGF) secretion 
using enzyme-linked immunosorbent assay (ELISA)  
ELISA is a quantified laboratory technique used to determine the concentration of 
specific antigens (Ag) or antibodies (Ab) in cell lysates and other solutions. A 
polystyrene plate was used to support and capture the Ag test. The developing colour of 
samples from a colourless to an intense solution which was measured by a absorbance 
plate reader at the optimum wavelength. The obtained results compared to a standard 
curve to convert the absorbance to the concentration of the samples in each well. The 
disadvantage of the direct ELISA is that the Ag can bind to the polystyrene plates 
poorly, resulting in a potentially inaccurate measurement. To overcome this limitation, 
sandwich ELISA have been used by a matching pair between Ag and specific Ab. This 
technique can enhance sensitivity and a specificity of the quantified assay into 
picogram, therefore sandwich ELISA is a suitable technique to quantify cytokine and 
hormones in supernatant.  
Figure. 2.2.16 : Image of a standard see-saw rocker to conduct OFF. The static group 
was placed beside the standard see-saw rocker. The rocking groups were placed on the 
standard see-saw rocker. Image was captured by author. 
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An ELISA kit was used for quantification of VEGF production in the cells. The 
supernatant was collected to measure the VEGF production produced by cells after 48 
hours after the media was changed. The assay protocol was followed according to the 
manufactures instructions. Briefly, the 96-well immunomicro plates were each coated 
with 100µl of 0.5µg/ml antigen-specific Ab (capture Ab), then the plate was sealed and 
incubated overnight. All methods were performed at room temperature. The plates were 
then washed four times with wash buffer solution (0.05%Tween-20 in PBS). The wells 
were blocked with 300 µl of 1% bovine serum albumin (BSA) in PBS, and incubated 
for 1 hour. After being washed, 100 µl of standard or supernatant were added to the 
wells in duplicate, incubated for 2 hours and washed. They were then incubated with 
100 µl of 0.25 µg/ml biotinylate antigen-specific Ab (detection Ab) for 2 hours. The 
plates were washed and then incubated with 100 µl of avidin-horseradish peroxidase 
conjugate at 1:2000 in diluent (0.1% BSA in the wash buffer) per well for 30 minutes. 
After washing, the colour solution in the well was developed for 20 minutes by adding 
100 µl of 2,2‟-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) ABTS liquid substrate. 
Absorbance was measured by using an absorbance microplate reader at a 405nm 
wavelength. The absorbance was normalised by dividing by the fluorescent unit of 
resazurin reduction test from the same sample.        
2.2.18.   Statistical analysis 
Statistical analysis was performed using SPSS (IBM SPSS statistics 21). Calcium 
deposition and collagen production were analysed by One-way ANOVA. Cell viability, 
DNA quantification, ALP activity, and VEGF secretion were analyzed by Two-way 
ANOVA (for two factors), followed by Tukey‟s multiple comparison test. Data was 
expressed as mean values ± SE (standard error of mean). Numbers of replicates are as 
stated in each figure legend. „N‟ represents a biological repeat (separate experiment) and 
„n‟ represents a technical repeat (different samples within one experiment). The 
differences were considered to be statistically significant when the p-value was less than 
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or equal to 0.05 (p≤0.05). Prism6 (GraphPad) was used to analyse the frequency of 
distribution of fibre diameter of the materials.  
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CHAPTER THREE: CELL CHARACTERIZATION AND 
EVALUATION OF THE MOST SUITABLE CULTURE 
MEDIUM FOR OSTEOGENIC INDUCTION ON 
MONOLAYER CULTURED hESMPs AND HJPs 
A key requirement of bone tissue engineering for cleft palate repair is a cell source 
which has osteogenic differentiation potential. Cells that have been used in many 
clinical studies for intra-oral bone repairs such as alveolar cleft bone graft and maxillary 
sinus augmentation for dental implantation, as mentioned in the previous chapter are: 
hBMSCs (Behnia et al., 2009, Hibi et al., 2006) and HJPs (D'Addona and Nowzari, 
2001, Trautvetter et al., 2011). Therefore, the selected cell sources that will be used in 
this chapter are hESMPs as a model cell for MSCs and HJPs. However, there is little 
information about the best culture conditions for osteogenesis differentiation using Dex 
for hESMPs and HJPs. 
3.1 Introduction   
hESMP 002.5  is a human embryonic stem cell-derived mesenchymal progenitor cell 
line. The cells were derived from human embryonic stem cells (hESCs). The hESMPs 
do not express pluripotent hESCs markers but are reported to express surface markers 
similar to human MSCs; CD105, CD166, CD10, and CD13. According to the literature 
hESMPs have been used in several studies as a model cell for bone tissue engineering. 
hESMPs were chosen for these studies due to 1] their homogeneity, to avoid the donor 
variation that occurs in a primary human cells (Marolt et al., 2010), 2] their ability to 
maintain their cell viability up to passage 20 (Karlsson et al., 2009) whereas usually 
primary human cells may lose their stem cell potential after passage 8 (Khoo et al., 
2008, Min et al., 2011) and 3] they are straightforward cells to culture with high 
proliferation capability. Both hESMPs and human MSCs are similar in that they require 
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Dex for osteogenic differentiation. The osteogenic induction medium for MSCs is 
supplemented with ascorbic acid (AA), beta-glycerophosphate (β-GP), and Dex. AA is 
very important in the production of a stable collagen (hydroxyproline) which is a major 
component of ECM of bone. β-GP is important to provide an inorganic phosphate for 
the mineralization of osteoblastic cells whereas Dex is a glucocorticoid steroid drug 
which can stimulate osteogenic differentiation of MSCs (Advani et al., 1997, Coelho 
and Fernandes, 2000). This study also evaluates the effect of osteogenic differentiation 
of progenitor cells on VEGF secretion. VEGF is an important vasculogenesis growth 
factor which is produced by many cells including osteoblasts. Vasculogenesis is 
important as for a tissue engineered bone to survive in vivo as it needs to induce blood 
vessel formation to supply nutrients and oxygen into the cells within the implanted 
structure. Primary human dermal fibroblasts were used to evaluate the suitable 
concentration of AA for producing collagen.   
In bone reconstruction surgery, an autologous bone graft is the gold standard due to its 
biochemical properties and ability to integrate to the surrounding tissue. Periosteum is a 
tri-membrane that covers the outer surface of all bones except at the joints of long bones 
while endosteum lines the inner surface of all bone (Olbrich et al., 2012) (see chapter 1). 
Cells that are extracted from periosteum are called periosteal cells which are a sub-
population of MSC. In this study, periosteal cells were extracted from HJP. Studies 
showed that HJP derived cells could be a promising source for cell based therapies for 
bone tissue engineering due to less risk of donor site morbidity, reduced time of 
operation and also easy harvesting technique compared to the extraction of autologous 
bone graft from iliac crest (Trautvetter et al., 2011). HJP is easy to harvest during 
wisdom tooth removal (a routine dental procedure). Whereas the mononuclear bone 
marrow cells are harvested from the inner (trabecular) part of the bone. Fujii et al., 
(2006) and Choi et al., (2002) reported that facial periosteum graft induced 
intramembranous ossification was similar to maxillofacial skeletal osteogenesis. The 
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tibia periosteum graft induced endochondral ossification in a similar way to limb 
skeletal osteogenesis. The approach of using HJPs in the construction or formation of 
bone may be an optional method for bone reconstruction. Flow cytometry showed that 
human periosteal cell expressed specific cell surface markers; Stro-1 for progenitor cells 
and ALP for osteoblastic cells (Ball et al., 2011). They also reported that the surface 
marker expression of MSCs on periosteal cells was maintained up until passage 10 
while ALP showed a high expression up until to passage 5 before starting to decline. 
Cicconetti et al., (2007) found that maxillary and mandibular periosteal cells did not 
express the negative markers of CD34: an endothelial cell marker, CD45: a leukocyte 
marker while they did express the mesenchymal phenotypic markers of CD 105, 
CD49a, CD63, CD90, and CD140b. 
DMEM was used in the Stolzing group or α-MEM was used in the Yang and Cicconetti 
groups in the culturing of HJP cells (Stolzing et al., 2008). There are controversies in 
the selection of medium for HJP cell culture due to the differences in cellular 
bioactivities and expressions. Ascorbic acid-2-phosphate (AA) and fibroblast growth 
factor-basic recombinant human (bFGF) have been used to increase MSCs proliferation 
and maintain their multipotency (Ramasamy et al., 2012). 
The aims of present study were to characterise the cells have been using in my study 
and evaluate suitable culture conditions for cell proliferation and osteogenic 
differentiation for both HJPs and hESMPs that have not been previously optimised. In 
order to do this; 
1. Analysed three cell sources for bone formation; hESMPs, HJPs, and hBMSCs. 
2. A comparison was made between DMEM and α-MEM  
3. The effects of AA, bFGF, and a combination of AA and bFGF supplementation on 
primary HJPs was investigated. 
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4. The effect of varying the concentration of Dex (without Dex, 10nM, and 100nM) on 
cell proliferation and osteogenic differentiation of both hESMPs and HJPs was tested. 
5. The effect of Dex on VEGF secretion of hESMPs was analysed. 
3.2 The effect of AA on collagen production of HDFs  
The aim of this study is to evaluate the concentration of AA for collagen production by 
HDFs.  
3.2.1 Results 
The cell viability of HDF cells was assessed using a MTT cell viability test after day 7, 14, 
and 21. The cell viability increased in all conditions (5, 25, 50, and 100µg/mL) from 7 to 
21 days (Figure 3.2.1 A). The cell viability was highest in the 100µg/mL group which was 
significantly different, whereas the 5µg/mL group was the lowest at every time point 
(p<0.05). Collagen production per viable cell of the 50µg/mL group was slightly higher 
than the other groups at every time-point (Figure 3.2.1 B). The 5µg/mL group was 
significantly lower at all the experiment time-points (p<0.05).  
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Figure 3.2.1: The effect of varying concentration of AA: 5, 25, 50, and 100µg/mL on 
HDFs on monolayer culture  after 7, 14 and 21 days. The cell viability (A) and collagen 
production of HDF cells were measured using MTT cell viability test and picro-sirius red 
staining, respectively. (B) Collagen production was normalised to MTT absorbance. 
Photoimages of picro-sirius red staining of HDF cells cultured on a monolayer in 
different concentration of AA after 7 (C), 14 (D), and 21 days (E). Data is presented as 
mean ± SE, (N=1, n=3), * = p<0.05 comparison between 5 µg/mL of AA and the other 
groups, # = p<0.05 comparison between 100 µg/mL of AA and the other groups, α = 
p<0.05 comparison between 5 and 50 µg/mL of AA, Two-way ANOVA, Tukey’s multiple 
comparison test. 
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3.3. Osteoprogenitor cells characterisation  
3.3.1. Materials 
hESMPs (passage number 4 to 8), 2 different donors of HJPs (passage number 6 to 8), 
and 3 different donors of hBMSCs (passage number 2 and 3) were evaluated for surface 
antigen expression. Further information about hBMSCs is in table 3.3). The method for 
surface antigen fluorescence staining has been described in chapter 2.  
Donor(Lot No.) Date of cryopreservation Age Gender 
Passage 
No. 
hMSCs-1 :080900C 4
th
 June2008 30 Male 2 
hMSCs-2 :080917A 6
th
 June 2008 23 Male 2 
hMSCs-3 :080926B 9
th
 June 2008 40 Female 2 
 Table 3.3: Information of the human mononuclear cells obtained from three different 
donors. 
Immunophenotypic analysing results 
hESMPs (Figure 3.3.1), a combination from 2 donors of HJPs (HJPs-pool), and a 
combination from 3 donors of hBMSCs (hBMSCs-pool) were used to detect the 
expressions of cell surface antigens by using flow cytometry. The results showed that 
both hESMPs and hBMSCs-pool expressed the MSCs markers CD146, CD105, and 
CD90 in the majority of cells (more than 95%), while they did not express the 
hematopoietic maker (CD45) or less than 15% (Table 3.3.1). This implies that the cell 
population‟s MSCs following the minimal criteria for MSCs specified by the 
international Society for Cellular Therapy (ISCT) (Dominici et al., 2006). Surprisingly, 
the HJPs-pool expressed CD105 and CD90 in the majority of cells (more than 95%) but 
did not express the CD146. CD45 was also little expressed as expected or less than 
10%. 
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Figure 3.3.1: hESMPs were stained with CD146, CD105, CD90, and CD45 and 
analyzed by flow cytometry. (A) Sorting gate from a representative hESMPs 
sample for CD 146, CD105, CD45 and CD90 expressions. (B-E) Colour 
histograms represented FACS profile of hESMPs single cell and grey histograms 
represent the corresponding isotype controls.  
 
(A) 
(B) (C) 
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Cell types CD146 CD105 CD90 CD45 
hESMPs (cell line) + 
96.7 
+ 
99.9 
+ 
86.1 
- 
0.8 
HJPs-pool - 
8.6 
+ 
96.4 
+ 
98.9 
- 
7.4 
hBMSCs-pool + 
95.7 
+ 
100.0 
+ 
99.6 
- 
11.0 
 
 
 
 
 
3.4. Osteogenic differentiation of hESMPs in a monolayer culture  
3.4.2. Results 
After 7 days, hESMP cell morphology showed changes under SM+Dex100 medium 
from a fibroblastic cell shape to a cuboidal shape which is similar to a typical 
osteoblastic cell shape (Cheng et al., 1994, Kaveh et al., 2011) (Figure 3.4.1). DNA 
increased in all conditions (SM, SM+Dex10, and SM+Dex100) from day 7 to 14. The 
SM group had higher cell numbers than the other groups on day 14. However by day 21 
there were no significant differences between the groups (Figure 3.4.2 A). The SM 
group had the lowest ALP activity normalized to DNA, whereas the SM+Dex100 group 
was the highest ALP activity at all time-points (Figure 3.4.2 B). The VEGF secretion 
(during a 48 hours collection period) was normalized to DNA (µg/ml) of hESMPs after 
day 7, 14 and 21. The secretion of VEGF at all conditions increased over the 3 weeks. 
The VEGF secretion by the SM group was significantly higher than the SM+Dex100 
groups by 171% on day 14 (p<0.05). From 14 to 21 days, the amount of VEGF secreted 
by cells in both the SM+Dex10 and SM+Dex100 groups was higher compared to the 
SM group, however there were no differences between the groups by day 21 (Figure 
Table 3.3.1: Surface antigen expression patterns of hESMPs, HJPs-pool (combination of 
HJPs from 2 donors), and hBMSCs-pool (combination of hBMSCs from 3 donors) were 
measured. Their expressions were decided into 3 categories: 1] positive (+) when more 
than 70%, 2] weakly positive (+-) when 20-70%, and 3] negative (-) when less than 20% 
of the population showed the specific marker (Marolt et al., 2010). 
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3.4.2 C). Total calcium deposition of hESMPs when cultured with varying 
concentrations of Dex was measured after 21 days. Total calcium deposition was 
highest in the SM+Dex100 group followed by SM+Dex10 and SM groups. However, 
there were no significant differences between the SM+Dex10 and SM+Dex100 groups 
(Figure 3.4.3 A). Total collagen production by hESMPs when cultured with varying 
concentrations of Dex was measured after 21 days. All culture groups were not 
significantly different. However, the cells cultured with SM+Dex100 showed the lowest 
total collagen followed by SM+Dex10 and SM groups (Figure 3.4.3 B). The 
photographs of whole well alizarin red staining show that the SM+Dex100 group 
contained the darkest staining after 21 days in cell culture (Figure 3.4.3 C: upper row) 
indicating that this group had a higher calcium deposition than the SM+Dex10 and SM 
groups. In contrast, the picro-sirius red staining showed an inverse relationship between 
picro-sirius red staining in the cells with an increased concentration of Dex (Figure 
3.4.3. C: lower row), indicating that the SM group had the highest collagen production. 
 
 
 
 
 
 
 
 
 
  
Figure 3.4.1: Microphotographs of the morphology of hESMPs under different culture 
media. (A) Cells in supplemented media (SM: AA and β-GP) were more fibroblastic in 
shape (yellow arrow heads) while (B) cells in SM+Dex100nM (AA, β-GP, and 100nM 
of Dex) media were more cuboidal in shape similar to osteoblastic cells (white arrow 
heads) after day 14. Scale bar : 200µm 
(A) (B) 
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Figure 3.4.2: The effect of varying concentrations of Dex: supplemented media (SM), 
supplemented media with 10nM of Dex (SM+Dex10), and supplemented media with 
100nM of Dex (SM+Dex100) on hESMPs in monolayer culture  after 7, 14 and 21 days. 
DNA quantification measured by Quant-Ti™ PicoGreen® (A), ALP activity normalised to 
DNA (µg/ml) (B), and VEGF secretion ( during a 48 hour collection period) normalised 
to DNA (µg/ml) (C). Data are presented as mean ± SE, (N=2, n=3), and * = p<0.05 
comparison between SM and SM+Dex10, # = p<0.05 comparison between SM and 
SM+Dex100,  = p<0.05 comparison between SM+Dex10 and SM+Dex100, using Two-
way ANOVA, Tukey’s multiple comparison test.  
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Figure 3.4.3: The effect of varying concentrations of Dex: supplemented media (SM), 
supplemented media with 10nM of Dex (SM+Dex10), and supplemented media with 
100nM of Dex (SM+Dex100) on hESMPs in monolayer culture after 21 days, hESMPs 
calcium deposition (A) using alizarin red staining and hESMPs collagen production (B) 
using picro-sirius red staining. (C) The photoimages show a representative set of alizarin 
red staining (upper row) and sirius red staining (lower row) of hESMPs. (A,B) Data is 
presented as mean ± SE, (N=2, n=3), *=p<0.05 comparison between the SM and 
SM+Dex10 groups, # =p<0.05 comparison between the SM and SM+Dex100 groups, 
using two-way ANOVA, Tukey’s multiple comparison test. 
(B) hESMPs collagen production 
SM SM+Dex10 SM+Dex100 
(C) 
(A) hESMPs calcium deposition 
# 
* 
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3.5. Comparisons of different culture media on the stimulation of human 
jaw periosteal cells (HJPs) 
3.5.1  Results 
The HJPs-1 cell viability in the α-MEM media increased over time for 7 days. The plain 
α-MEM media group had the highest cell viability (Figure 3.5.1 A: left). Whereas HJPs-1 
cell viability cultured in the DMEM media was slightly reduced from day 1 to 4 (Figure 
3.5.1 A: right). This was followed by an increasing of cell viability from day 4 to 7 with 
no difference between the different groups. However, the overall comparison of the 
cells cultured whether in α-MEM or DMEM after 7 days showed that the α-MEM group 
was higher than the group culture in DMEM media.   
HJPs-2 cell viability in the α-MEM media slightly increased on day 1 to 4, followed by 
a sharp increase on day 4 to 7. There were no differences between the conditions 
(Figure 3.5.1 B: left). The cells cultured in the DMEM media had similar cell viability 
pattern as in the α-MEM media (Figure 3.5.1 B: right). However, the comparison of 
cells cultured between α-MEM and DMEM found that the cell viability in the α-MEM 
groups was higher than the DMEM groups. The overall cell viabilities of HJPs-1 were 
significantly lower than the HJPs-2, around 4 fold, whether they were cultured in α-
MEM or DMEM media over 7 days (Figure 3.5.2). Cell viability for HJPs-2 cultured in 
α-MEM was significantly higher than for the DMEM (p<0.05). Indicating the cells 
cultured in the α-MEM group had higher cell proliferation than the DMEM group. In 
addition, the HJPs-2 had a higher cell proliferation rate than the HJPs-1.  
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Figure 3.5.1 The effect of culture medium, α MEM (left) and DMEM (right) which were 
divided into 4 different groups: 1] basic culture medium (plain), 2] basic culture 
medium containing ascorbic acid-2-phosphate (AA), 3] basic culture medium containing 
a human beta-fibroblast growth factor (bFGF), and 4] the combination of AA and bFGF 
were assayed by the resazurin reduction test for HJPs-1 (A) and HJPs-2 (B) on a 
monolayer cell culture after 1, 4, and 7 days. (A) HJPs-1 was cultured in α-MEM and 
DMEM. (B) HJPs-2 was cultured in α-MEM and DMEM. Noticeably, the scale bar of y 
axis on Figure A is from 0 to 200 but Figure B is from 0-1000 fluorescence unit. 
mean±SE, (N=1, n=3), * = p<0.05, Two-way ANOVA, Tukey’s multiple comparison 
test.  
 
(A) 
(B) 
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Figure 3.5.2: Comparison of the effect of basic culture medium α-MEM (left) and 
DMEM (right) assayed by the resazurin reduction test of HJPs-1and HJPs-2 on a 
monolayer cell culture after 1, 4, and 7 days. mean±SE, (N=1, n=3), * = p<0.05 
comparison between the HJPs-1 and HJPs-2 cell viability, α = p<0.05 comparison 
between the HJPs-2 cultured in the α-MEM and DMEM, Two-way ANOVA, Tukey’s 
multiple comparison test.  
 
α 
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3.6. The effect of varying concentrations of Dex on Osteogenic 
differentiation HJPs cultured as monolayer. 
3.6.1. Results 
On day 7 the cells under the SM groups were fusiform in shape similar to fibroblastic 
cells (Figure 3.6.1 A for HJPs-1 and D for HJPs-2, red arrow heads). While the cells in 
the SM+Dex10 and SM+Dex100 groups were of more cuboidal cell shape similar to 
osteoblastic cells (Figure 3.6.1 B for HJPs-1 and E for HJPs-2 under the SM+Dex10 
medium, white arrow heads and C for HJPs-1 and F for HJPs-2 under the SM+Dex100 
medium, yellow arrow heads) (Cheng et al., 1994, Kaveh et al., 2011). The cell viability 
of HJPs-1 increased overtime for 28 days in all conditions and the SM+Dex10 group 
was higher than the other groups after 21 to 28 days (Figure 3.6.2 A). ALP activity 
normalized to DNA (µg/ml) was lowest in the SM group of HJPs-1, in contrast, the 
SM+Dex100 group had the highest ALP activity compared to the other groups (Figure 
3.6.2 C). There were no differences between the SM+Dex10 and SM+Dex100 groups 
(p<0.05). The cell number of HJPs-2 increased overtime for 21 days in all conditions 
except the SM group slightly decreased between day 14 to 21 (Figure 3.6.2 B). The 
SM+Dex10 group showed a significantly higher DNA content than the SM group after 
21 days (p<0.05). Indicating that both HJPs-1 and HJPs-2 in the SM+Dex10 had a 
higher cell proliferation than the other groups. ALP activity normalized to DNA of the 
SM group of HJPs-2 was the lowest at all time-points. In contrast, the ALP activity of 
the SM+Dex10 group was the higher than the other groups after day 21, significantly 
(p<0.05). Total calcium deposition was highest in the SM+Dex10 group both for HJPs-1 
and HJPs-2 (Figure 3.6.3 A and B). The cells cultured in the SM+Dex10 group showed 
the darkest staining after 28 days for HJPs-1 (Figure 3.6.3 C) and after 21 days for HJP-
2 (Figure 3.6.3 D). Both HJPs-1 (E) and HJPs-2 (F) in the SM groups had significantly 
higher collagen production than the other groups after 21 days for HJPs-2 and 28 days 
for HJPs-1, while, the lowest total collagen production was in the SM+Dex100 groups 
(p<0.05). 
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Figure 3.6.1: Microphotographs of the morphology of Human jaw periosteal cells (HJPs) cultured in varying concentrations of Dex after 7 days. (A) 
The HJPs-1 and (D) HJPs-2 in supplemented media (SM) which contained AA and β-GP were more fibroblast fusiform in shape (red arrow heads). 
(B) The HJPs-1 and (E) HJPs-2 in SM+Dex10 media which contained 10nM of Dex were more cuboidal in shape similar to osteoblast-like cells 
(white arrow heads). (C) The HJPs-1 and (F) HJPs-2 in SM+Dex100 media which contained 100nM of Dex were more expanded in shape (yellow 
arrow heads). Scale bar : 200µm. 
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Figure 3.6.2: The effects of varying concentrations of Dex (SM, SM+Dex10, and 
SM+Dex100) on HJPs-1 from 7 to 28 days and HJPs-2 from 7 to 21 days on a monolayer 
culture in α-MEM. The cell viability measured by resazurin reduction test of HJP-1 (A) 
and HJP-2 (B), ALP activity normalized to DNA (µg/ml) of HJP-1 (C) and HJPs-2 (D). 
mean±SE, (N=2, n=3), * = p<0.05 comparison between the SM and SM+Dex10, # = 
p<0.05 comparison between the SM and SM+Dex100 groups, and  = p<0.05 
comparison between the SM+Dex10 and SM+Dex100 groups, Two-way ANOVA, followed 
by Tukey’s multiple comparison test. 
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(C) Alizarin red staining 
Figure 3.6.3: The effects of varying concentrations of Dex (SM, SM+Dex10, and 
SM+Dex100) on monolayer culture of HJPs. Total calcium deposition using alizarin red 
staining of HJPs-1 was assayed after 28 days (A) while the HJPs-2 was assayed after 21 
days (B). Collagen production using picro-sirius red staining assay of HJPs-1 was 
assayed after 28 days (E) and the HJPs-2 were assayed after 21 days (F). Photoimages of 
alizarin red staining of HJPs cultured on a monolayer in different concentration of Dex 
after 28 days for HJPs-1 (C) and after 21 days for HJPs-2 (D). mean±SE, (for Figure A, 
B, C and D (N=2, n=3) and figure E and F (N=1, n=3)), * = p<0.05 comparison between 
the SM and SM+Dex10, # =p<0.05 comparison between the SM and SM+Dex100 groups, 
and  = p<0.05 comparison between the SM+Dex10 and SM+Dex100 groups, one-way 
ANOVA, followed by Tukey’s multiple comparison test 
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3.7 Discussion  
Bone tissue engineering may become an option for clinical cleft palate reconstruction. 
One important part of this strategy is the osteogenic cell source and the biochemical 
agents used for bone formation and vasculogenesis. The main aims of this chapter 
were to evaluate suitable cell sources and culture condition for proliferation and 
osteogenic differentiation of both hESMPs and HJP cells, and the effect these 
conditions have on VEGF secretion of hESMPs in monolayer culture. In order to do 
this the first experiments evaluated a suitable concentration of AA as a component in 
the osteogenic induction medium for MSC cells. The experiment showed that the effect 
of increasing the concentration of AA on HDFs was higher cell viability over time 
indicating higher cell proliferation. In our experiment we found that the best concentration 
of AA is 50µg/mL which gave a higher collagen per viable cell than the other 
concentrations. Phillips et al., (1994) and Choi et al.,(2008) reported that AA can stimulate 
cell proliferation and up-regulate collagen synthesis in HDFs and also in MSCs. ECM 
which is a collagen component mediates the chemical and mechanical signals to enhance 
cell proliferation and differentiation (Hitomi et al., 1992), and also provide the cell 
attachment (Wei et al., 2012). Therefore, the optimized concentration of AA for future 
experiments was chosen as 50µg/ml. A limitation of this study lack of control group (the 
no AA supplementation) however the studies of Pinnell (1985) and Geesin et al, (1988) 
showed that AA could stimulates collagen production on HDFs compared to the control 
group.  
All cell types that have been used in this thesis were analysed for their surface antigen 
expression. Both hESMPs and hBMSCs were confirmed to be MSCs by expression of 
cell surface antigens (CD146, CD105, and CD90) and no expression of CD45 
indicating that the cell population contained MSCs. CD45 would indicate the presence 
of heamatopoetic cells which may contaminate the osteoprogenitor cells. However, in 
the HJPs-pooled cells surface antigen failed to bind with the CD146 antibody. CD146 
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is known as a melanoma cell adhesion molecule and it has been found that it has 
positive expression in human bone marrow cells that contribute to the vascular niche 
whereas a negative expression in the cells that contribute to the osteoblastic niche 
(Watt et al., 2013). Human MSCs reside in either osteoblastic or vascular niches 
which are the specific sites near the endosteal membrane or sinusoidal vessels in adult 
tissue, respectively (Yin and Li, 2006). Therefore HJPs may derive from osteoblastic 
niche because the periosteum is a similar membrane to the endosteal membrane while 
both hESMPs and hBMSCs derive from vascular niche. However, the HJPs detected 
in this study were also of late passage number (passage number 8), and it‟s possible 
that the CD146 cell surface antigen may reduce in expression over passage number 
(Osipova et al., 2011).    
A limitation of this study is that in many cases only 2 experiments were performed in 
triplicate, however, some interesting differences were identified were found to be 
significant as follows. It is known that a combination of Dex, AA and β-GP can be used to 
enable calcified matrix deposition by MSCs. Both the hESMPs and HJPs used in these 
experiments are relatively understudied cells compared to bone marrow derived MSC 
hence there is limited literature on the optimum conditions to enable differentiation and 
bone matrix formation by these cells. Therefore hESMPs were evaluated to investigate 
whether they respond to osteogenic medium in the same way as mature MSCs. Our study 
found that the DNA in the SM+Dex100 group increased between the first to second weeks 
but slightly decreased after the second week onwards indicating that cells proliferated but 
then cell proliferation slowed after they differentiated into osteoblastic cells, there may 
also have been some cell death. Media supplemented with Dex promoted ALP activity (an 
early marker for osteogenic differentiation) over time points and total calcium deposition 
(a late marker for osteogenic differentiation) after 21days in a dose dependant manner, 
however, it reduced collagen production. This experiment showed the lowest cell 
proliferation and collagen production in the high concentration of Dex group 
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(SM+Dex100) whereas the lower concentration of Dex (SM+Dex10) and without Dex 
(SM) show no differences both cell proliferation and collagen production. Dex is a 
synthetic corticosteroid which is usually used to support osteogenic differentiation in 
MSCs. The supplementation of Dex in culture media would change the cells phenotype to 
be osteoblastic cells (Cheng et al., 1994) and irreversible enhance ALP activity (Hitomi et 
al., 1992). However, Dex also reduced cell proliferation and collagen production in the 
high concentration (100nM) which has been found in several studies on bone marrow 
stromal cells (Walsh et al., 2001, Advani et al., 1997, Chen, 2006). In this study the 
calcium deposition play a role as a late marker of osteogenic differentiation but they did 
not prove the matrix mineralising phenotype. An additional assay such as osteogenic gene 
expression: RUNX2, OCN, or OPN that could have been performed alongside the 
presented data to make the conclusions more robust.  
VEGF is an important cytokine to recruit endothelial cells for vasculogenesis and is an 
essential cytokine in bone formation and bone healing after fracture. In this study it 
was shown that VEGF secretion (during a 48 hour collection period) increased over 
time for 21 days. The SM+Dex10 group secreted the highest amount of VEGF per 
viable cell compared to the other groups after 21 days. Wang et al., (2012) found that 
the 10nM of Dex significantly increased VEGF secretion of human umbilical cord 
MSCs (hUC-MSCs) compared to treating with 100nM of Dex (p<0.01). The VEGF 
gene composes of a promoter region called AP-1 which is a potential binding site to 
initiate transcription factors and lead to regulate gene expression (Tischer et al., 1991). 
A complex formation between Dex and Dex-glucocorticoid receptor can inhibit the 
VEGF induction by binding on the AP-1 promoter regions. Resulting in, prevention of 
AP-1 dependent transcription processes and inhibition of VEGF production (Heiss et 
al., 1996, Jonat et al., 1990). This implies that Dex affected the VEGF secretion from 
the cells in a concentration dependent manner. Interestingly, the VEGF secretion per 
viable cell increased over time and by day 21 there was no difference between the 
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groups (SM, SM+Dex10, and SM+Dex100). The increase over time may be related to 
cell density; one could speculate that there is less oxygen available per cell at higher 
densities. It is known that expression of VEGF is highly sensitive to the oxygen. Pham 
et al., (2002) showed that hypoxia induced angiogenesis by up-regulation of VEGF in 
rat alveolar epithelial cells in monolayer culture. Several studies both in vivo and in 
vitro reported that cells cultured under a hypoxia condition (2% O2) for at least 30 
minutes could up-regulate hypoxia inducible factor-1 (HIF-1), which can enhance 
VEGF secretion compared to the normal O2 condition (Semenza, 1999, Machein et al., 
1999, Wang et al., 2007). At this stage it is not clear why the inhibitory effect of Dex 
on VEGF diminishes over time in culture, but it may be related to the osteogenic 
pathways which are stimulated by Dex and are known to up-regulate VEGF 
overcoming the Dex inhibition that occurs in more immature MSCs. Furumatsu et al., 
(2003) in vitro study found that the VEGF secretion on hBMSCs under continuous 
10nM of Dex supplementation for 3 weeks showed an increasing of VEGF secretion 
while they also majority expressed OCN gene, indicating that the osteoblastic cells 
may secrete the VEGF for their own survival.  
HJPs have been chosen for this study, but there was limited information in the 
literature on the suitable culture conditions for osteogenic differentiation. Therefore, 
the first step for HJPs culture was to compare the various types of culture media to 
stimulate proliferation of HJPs. A limitation of this study is that only one experiment was 
performed in triplicate, however, some interesting differences were identified and found to 
be significant. The cell number of HJPs from 2 donors increased in the α-MEM media 
while the additional supplements did not affect cell proliferation. A study by Coelho et 
al., (2000) and Chen et al., (2009) reported that α-MEM media is suitable to use for 
isolation and culturing bone marrow cells. The α-MEM media itself includes Vitamin 
B12, AA and non-essential amino in addition to the components of DMEM media. 
This medium may facilitate HJPs cell proliferation and enable HJPs to differentiate 
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into the osteoblastic linage in a similar way as bone marrow cells. Several studies used 
α-MEM to culture these types of cells. However, Nakamura et al., (2008) found that 
human MSCs cultured on both DMEM media and specific MSC basal medium were 
no different in their cell behaviour including growth rate and an osteogenic 
differentiation. The difference in cell proliferation between the two HJPs sources may 
be due to variation between patients, and site of extraction. HJPs are a heterogeneous 
population of cells. Therefore fluorescence activated cell sorting or fibronectin coated 
culture plate could distinguish the MSCs from the heterogeneous cell population for 
the future work (Ogura et al., 2004, De Bari et al., 2008). For the remaining 
experiments the α-MEM media was used to culture HJPs. 
The next aim was to optimize osteogenic media condition for HJPs. This study 
showed that HJPs from two donors had the ability to undergo osteogenic 
differentiation similar to hESMP osteogenic progenitors. Both donors of HJPs have 
different characteristics with regards to cell morphology and cell proliferation, but 
similar conditions were required; 10nM of Dex (SM+Dex10) for osteogenic 
differentiation, and a reduction of collagen production at the high concentration of 
Dex (SM+Dex100). Li et al., (2005) and Walsh et al., (2001) reported that the higher 
concentrations of Dex and prolonged treatment can induce osteoporosis by three 
mechanisms: 1] reduction in cell number of osteogenic precursor cells and activity of 
osteoblastic cells, 2] increase in cell number and activity of osteoclast cells, and 3] 
reduced VEGF secretion. Consistent with a clinical study by Dempster et al., (1983), 
Walsh and Avashia, (1992), and Labar et al., (2010) found that patients treated with 
prednisolone which is a derivative of glucocorticoid group, similar to Dex, reduced the 
active period of osteoblastic cells for bone formation and increased resorption surface 
areas, compared to control groups. HJPs have been used in many studies as an 
osteoprogenitor cell source (Samee et al., 2008). Cicconetti et al., (2007) found that 
HJPs from maxilla and mandible under a basic culture media expressed surface 
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markers similar to MSC markers. HJPs could express the high levels of positive 
markers of CD 105, CD 49, CD 63, CD90, and CD 140. The differences are most 
likely due to patient variability and site of tissue harvesting (Marolt et al., 2010). 
Akintoye et al., (2006) found that the expression of periosteal cell specific markers 
was different depending on the harvesting site and patient variability caused by factors 
such as individual habit, age, and health. Our studies found that the ALP activity of 
hESMPs was higher than the HJPs possibly indicating that the hESMPs had more 
osteogenic potential than the HJPs. The reason may be that the HJPs were derived 
from adult donors in which only a sub-population of cells could undergo osteogenic 
differentiation (Caplan, 2005). Whereas, the hESMPs derived from embryonic stem 
cells had a homogenous population of cells which were able to undergo osteogenic 
differentiation (Karlsson et al., 2009). The expression profile of MSCs can be different 
depending on the harvesting site, it has been found that the orofacial bone marrow 
(OBM) shows more osteogenic differentiation and quantity of bone regeneration than 
iliac bone marrow (IBM) (Akintoye et al., 2006, Osyczka et al., 2009). The OBM may 
contain less hematopoietic marrow cells compare to the IBM. Comparison of four 
differences cell sources from rabbits; JPO: periosteum from mandible, JBM: bone 
marrow from mandible, LPO: periosteum from tibia, and LBM: bone marrow from 
tibia indicated the stem cell potential of these cells in vitro, this study found that JPO 
showed the highest osteogenic differentiation (Park et al., 2012). The JPO have been 
recommended to be a first choice for repairing a maxillofacial region. Previous work 
within our group has showed that hBMSCs incubated with 10nM of Dex undergo 
osteogenic differentiation in vitro study (Sittichokechaiwut et al., 2010). Therefore, 
hBMSCs were not included in this chapter for evaluating the suitable osteogenic 
induced culture condition. 
Chen et al., (2011) compared the osteogenic potential of between human MSCs from 
periosteal and bone marrow derived cells at the same harvesting site (metaphyseal 
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region) from the same donors found that the MSCs from periosteal derived cells 
showed the higher osteogenic gene expression (BMP-2, OPN, and OCN) and 
mineralization than the hBMSCs. Age of donor also influence the MSCs potential as 
younger IBM have a more osteogenic response than the older IBM when they were 
cultured under recombinant human BMP-2 (Osyczka et al., 2009). HJPs could be used 
as an autologous cell source in the treatment of cleft palate defects due to their 
potential to undergo osteogenic differentiation in a laboratory for clinical use. 
Therefore, it would be ideal to test the osteogenic potential of HJPs from higher 
number of patients in order to compare the outcome and from child donors. 
Unfortunately we had insufficient human jaw periosteum supply. 
3.7. Summary of results 
One important part of bone tissue engineering is the cell source which should have 
osteogenic potential. The aims of this chapter were to evaluate suitable culture 
conditions for both hESMPs and HJPs for osteogenic differentiation. From these 
studies we found that; 
 A suitable concentration of AA is 50µg/mL which produces the highest collagen 
per HDF cell of the concentrations tested. This concentration will be used for the 
future experiments.  
 Dex induced a change in morphology of hESMPs from a fibroblastic fusiform 
shape to an osteoblastic cell shape.  
 Dex stimulated osteogenic differentiation by increasing ALP activity and calcium 
deposition, whereas it also reduced cell number, collagen production, and VEGF 
secretion in a dose-dependent manner.  
 The SM+Dex100 medium condition will be used for osteogenic differentiation of 
hESMPs in future experiments due to the significantly higher ALP and calcium 
deposition induced in this medium. 
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 Both donors of HJPs have the ability to undergo osteogenic differentiation showing 
similar outcomes to the hESMP osteogenic progenitors. 
 The α-MEM media and SM+Dex10 media conditions will be used for culturing 
and inducing osteogenic differentiation of HJPs in the future experiments due to 
having the same or even a more stimulatory effect on ALP and calcium deposition 
compared to SM+Dex100.  
HJPs collected form 2 different donors showed variability in growth rate and 
differentiation ability, therefore it would be ideal to test the osteogenic potential of 
HJPs from more patients to compare the outcomes. Unfortunately the insufficient HJP 
tissue supplied to do this, however, these cell characterizations and selected suitable 
culture conditions will be used in future experiments described in subsequent chapters. 
3.8. Future work 
Characterisation of all cells from individual donors to evaluate surface antigen 
expression of known MSCs markers. 
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CHAPTER FOUR: THE EFFECT OF A SIMPLE FLUID SHEAR 
STRESS STIMULUS OF OSTEOGENIC PROGENITOR MATRIX 
PRODUCTION. 
4.1 Introduction 
MSCs have been used in bone tissue engineering for several years. The work reported in 
chapter 3 showed that hESMPs and HJPs differentiate into osteoblastic cells by 
biochemical stimulation by adding Dex supplementation. Behnia et al., (2009) and Hibi 
et al., (2006) reported that a patient‟s own MSCs from bone marrow could be used as 
the cell sources in bone tissue engineering for alveolar reconstruction. Therefore, all 
three cell types will be used in these studies to evaluate osteogenic differentiation. Cells 
can be stimulated by many pathways to differentiate into osteoblastic lineage cells, for 
example biochemical, mechanical and environmental stimulation. Many studies have 
shown that fluid flow created mechanical stress can enhance MSC‟s osteogenic 
differentiation (Yourek et al., 2010, Bancroft et al., 2002, Sikavitsas et al., 2003, 
Delaine-Smith et al., 2012). These studies have used different types of flow stimulus for 
example laminar flow versus pulsatile flow versus oscillatory flow both in monolayer 
and through 3D porous scaffolds. OFF is thought to be similar to the flow found in the 
canalicular system in mature bone structure (see chapter1) and flow in the bone marrow 
(Gurkan and Akkus, 2008). Previous work from our group, Delaine-Smith et al, (2012) 
studied the effects of OFF in vitro on hESMPs cultured in a typical 6-well plate using a 
standard see-saw rocker to produce the OFF (described in chapter 2). They found that 
the OFF successfully increased collagen production and mineralized matrix in 
osteoprogenitor cells in monolayer culture. Our group found that a suitable OFF loading 
regime, using a standard see-saw rocker to increase osteogenic differentiation is a speed 
of 45 rounds per minutes, flip angle of 6º, for 1 hour per day, 5 days per week. 
Therefore this regime will be used in the experiments (Delaine-Smith et al., 2012). 
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Therefore this simple mechanical stimulation system was chosen for all of the following 
experiments in this chapter. This method may increase osteogenic differentiation and 
mineralization of osteoprogenitor cells for use for the construct for cleft palate patients. 
The advantages of this system are cost effectiveness, straight forward pre-treatment 
method, and high throughput for bone tissue engineering.  
Therefore the aim of these experiments is to evaluate the effects of OFF, using a 
standard see-saw rocker, on cell proliferation, osteogenic differentiation, extracellular 
matrix production and VEGF secretion by hESMPs, hBMSCs, and HJPs in monolayer.  
4.2 Methods 
4.2.1 Cell culture 
Three cell types were used for each study; hESMPs, HJPs, and hBMSCs. The HJPs and 
hBMSCs isolation methods were descripted in chapter 2. hESMPs (passage number 4 to 
8), 2 different donors HJPs (passage number 6 to 8), and 3 different donors of hBMSCs 
(as described and characterized in chapter 3) (passage number 2 and 3) were used for 
OFF studies. Media which was used in all studies was basal α-MEM supplemented with 
AA and β-GP medium which will be designated „SM‟ group, SM supplemented with 
10nM of Dex will be designated „SM+Dex10‟, and the SM supplemented with 100nM 
of Dex will be designated „SM+Dex100‟. 
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4.2.2. OFF application 
For experiments, hESMPs were cultured in gelatine-coated standard circular 6-well plates at 
a density of 10
4 
cells per well, the other cells were cultured on the non-coated well plates. 
All cell types were cultured in their basic culture medium on the day of seeding cell (day 0). 
The following day, the culture media were changed to either SM, SM+Dex10 or 
SM+Dex100. From day 4 of culture, the samples were divided into 2 different groups: 1] the 
„Rocking group‟ is the cells subjected to continuous OFF with 45 cycles/minutes for an 
hour/day, and 5 days/week, 2] the static group is cells that were moved to the laboratory 
bench when the rocking group was undergoing OFF then they were moved back to the cell 
incubator. Delaine-Smith et al, (2012) calculated the OFF stress on the 6-well plate in 3 
different points parallel to the diameter (x/L=0.25. 0.5, and 0.75, where „x‟ is a distance 
from the reference point to the edge of the well and „L‟ is a diameter of the well) 
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Figure 4.2.1: (A) The calculated OFF stress in 3 different points parallel the with 
diameter at the circular culture surface of the 6-well plate for one cycle; x/L = 0.25, 0.5, 
and 0.75. (B) Where x is a distance from the reference point to the edge of the well and L 
is the diameter of the well in the axis of rotation. (C) The value of fluid flow stress on the 
circular culture dish received from the formula. Where µ is the fluid viscosity (10
-3
 Pa s), 
max is the maximum flip angle. (6.8 degree in the 2 ml of media condition),  is the ratio 
between the depth of fluid and the length of well, T is the period of time per one cycle. 
Reprinted from (Delaine-Smith et al., 2012) for figure A and (Zhou et al., 2010) for 
figure C with kind permission of European Cells and Materials and Elsevier, 
respectively.          
 
(A) 
(B) x/L = 0.25 
x/L = 0.50 
x/L = 0.75 
(C) 
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4.3. The effect of OFF on osteogenic differentiation of hESMPs on 
monolayer culture. 
4.3.1. Results   
On day 7, the cell morphology of the rocking (upper row) and static (lower row) groups 
cultured under SM medium (A,D) showed a more fibroblastic fusiform shape (red arrow 
heads), while the cells cultured under both SM+Dex10 (B,E) and SM+Dex100 (C,F) 
media were more cuboidal in shape which is similar to a typical osteoblastic cell (white 
and yellow arrow heads, respectively) (Figure 4.3.1). The DNA increased at all 
conditions (SM and SM with varying concentrations of Dex) from day 7 to 21. However 
the SM+Dex100 group had a slight decrease in DNA after 14 to 21 days in both the 
rocking and static groups indicating that there were lower cell numbers than the other 
groups (Figure 4.3.2 A). The SM group showed the lowest ALP activities normalized to 
DNA from day 7 to 21. By day 21, the highest ALP activity in the rocking group was in 
the SM+Dex10 condition but this was not significantly different from the SM+Dex100 
group. The highest ALP activity of the static group was the SM+Dex100 condition 
(Figure 4.3.2 B). The secretion of VEGF (during a 48 hour collection period) increased 
in all conditions at all time-points. By day 14, the SM groups showed higher VEGF 
secretion than others while the SM+Dex100 groups showed the lowest, indicating that 
Dex inhibits VEGF. After day 21 the highest VEGF secretion was in the SM+Dex10 
groups; for both the rocking and static groups (Figure 4.3.3) although there was no 
statistically significant difference between any treatments groups in VEGF secretion by 
this time-point (p≤0.05). Total calcium deposition by the SM+Dex100 rocking group 
was significantly higher than for any other group by day 21 (p≤0.05). The SM group 
produced the lowest calcium deposition in both the rocking and static groups (Figure 
4.3.4 A). The effect of Dex on collagen production confirmed the results of chapter 3 
and rocking had no further statistically significant effect (Figure 4.3.4 B). The 
SM+Dex100 group under rocking conditions (upper row) had the darkest alizarin red 
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staining after 21 days compared to the other groups indicating that there was more 
calcium deposition than the other groups. For the SM+Dex10 group under rocking 
conditions there was a small area of staining whereas there was none present on the 
static group (Figure 4.3.4 C) and this matched the small but not statistically significant 
difference in quantitated alizarin red between the two groups. The picro-sirius red 
staining of SM groups was the darkest staining whereas the SM+Dex100 groups were 
the lightest staining compared to the other both the rocking and static conditions (Figure 
4.3.4 D).  
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Figure 4.3.1: Microphotographs of the morphology of hESMPs for the rocking group (upper row) which was subjected to OFF for 1 hour/day, 5 
days/week, and static group (lower row) at room temperature. The cells were cultured in the varying concentrations of Dex: supplemented media (SM) 
which contained AA and β-GP, supplemented media with 10nMDex (SM+Dex10), and supplemented media with 100nMDex (SM+Dex100) for 7 days. (A 
and D) The SM group were more fibroblastic in shape (red arrow heads) while the SM+Dex10 (B and E) and SM+Dex100 (C and F) groups were more 
cuboidal in cell shape similar to osteoblastic cells (white and yellow arrow heads, respectively). There were no differences between the rocking and static 
groups. Scale bar: 200µm 
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Figure 4.3.2: The effect of OFF on hESMPs between the rocking and static groups 
under varying concentrations of Dex: supplemented media (SM), supplemented media 
with 10nM of Dex (SM+Dex10), and supplemented media with 100nM of Dex 
(SM+Dex100) on monolayer culture after 21 days. DNA quantification (A), ALP 
activity normalised to DNA (µg/ml) (B). mean ± SE, (N=4, n=3), *=p<0.05 
comparison between SM and SM+Dex10, # = p<0.05 comparison between SM and 
SM+Dex100,  = p<0.05 comparison between SM+Dex10 and SM+Dex100, using 
Two-way ANOVA, Tukey’s multiple comparison test. 
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Figure 4.3.3: The effect of OFF on hESMPs between the rocking and static groups 
under varying concentrations of Dex: supplemented media (SM), supplemented media 
with 10nM of Dex (SM+Dex10), and supplemented media with 100nM of Dex 
(SM+Dex100) on monolayer culture  after 21 days. Data is a VEGF secretion (during a 
48 hour collection period) normalised to DNA (ng/ml) presented as mean ± SE, (N=2, 
n=3), # = p<0.05 comparison between SM and SM+Dex100, using Two-way ANOVA, 
Tukey’s multiple comparison test. 
# # 
Static 
hESMPs VEGF secretion/DNA 
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Figure 4.3.4: The effect of OFF on hESMPs between the rocking and static groups 
under varying concentrations of Dex: supplemented media (SM), supplemented media 
with 10nM of Dex (SM+Dex10), and supplemented media with 100nM of Dex 
(SM+Dex100) on monolayer culture after 21 days. Total calcium deposition (A) using 
alizarin red staining and total collagen production (B) using picro-sirius red staining. 
The photoimages show representative sets of alizarin red staining (C) and picro-sirius 
red staining (D) on monolayer cultured of hESMP. (A,B) Data is presented as mean ± 
SE, (N=4, n=3), *=p<0.05 comparison between the SM and SM+Dex10 groups, # 
=p<0.05 comparison between the SM and SMDex100 groups, =p<0.05 comparison 
between rocking and static groups, using two-way ANOVA, Tukey’s multiple 
comparison test. 
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4.4. The effect of OFF on osteogenic differentiation of hBMSCs on 
monolayer culture. 
4.4.1.  Results 
The cell morphology of the rocking (upper row) and static (lower row) groups cultured 
under the SM medium (Figure 4.4.1 A,C) were more fibroblast fusiform in shape (red 
arrow heads). While the cell morphology cultured under SM+Dex10 medium were 
more cuboidal in shape which is similar to a typical osteoblastic cell shape (white arrow 
heads, Figure 4.4.1 B,D) similar to hESMPs (Figure 4.3.1 C,F). The DNA increased at 
all conditions (SM and SM+Dex10) from day 7 to 14 while the SM+Dex10 groups had 
higher DNA than the other by day 14. The SM+Dex10 group under rocking condition 
had slightly lower DNA by day 21 indicating that they were fewer cells than the other 
groups (Figure 4.4.2 A). The SM group showed the lowest ALP activity normalized to 
DNA from day 7 to 21. By day 21, the highest ALP activity in the rocking group was 
the SM+Dex10 condition but they were no differences between the rocking and static 
groups (Figure 4.4.2 B). The secretion of VEGF (during a 48 hour collection period) 
increased overtime at all conditions over 21 days. By day 14, the SM groups showed 
higher VEGF secretion than other group in both the rocking and static conditions, 
indicating that Dex inhibits VEGF secretion. On day 21, they were no significant 
differences between any treatments groups by this time-point (Figure 4.4.2 C). Total 
calcium deposition by the SM+Dex10 rocking group was higher than for any other 
groups by day 21. The SM group produced the lowest calcium deposition in both the 
rocking and static groups (Figure 4.4.3 A) whereas the SM groups gave no staining by 
day 21. The SM and SM+Dex10 groups had no significant differences in collagen 
production. The rocking groups produced the highest collagen compared to the static 
groups after 21 days. However, the SM+Dex10 groups had lower collagen production 
than in the SM medium (Figure 4.4.3 B). The SM+Dex10 group subjected to OFF 
showed the darkest staining, compared to the SM+Dex10 static group after 21 days. The 
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SM+Dex10 group under rocking conditions was the darkest and most uniform alizarin 
red staining after 21 days, compared to the other groups, indicating that there was more 
calcium deposition (Figure 4.4.3 C). The picro-sirius red staining of the rocking group 
gave a darker staining than the SM+Dex10 group. There were no differences between 
the SM and SM+Dex culture media (Figure 4.4.3 D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1: Microphotographs of the morphology of hBMSCs under the rocking and static 
groups for 1 hour/day, 5 days a week. The cells were cultured in the supplemented media 
(SM), which contained AA and β-GP and supplemented media with 10nMDex (SM+Dex10) 
of hBMSCs on monolayer culture after 7 days. (A and C) The SM group were more 
fibroblastic in shape (red arrow heads) while the SM+Dex10 (B and D) groups were more 
cuboidal in cell shape, similar to osteoblastic cells (white arrow heads). Scale bar: 200µm 
SM SM+Dex10 
Static  
Rocking 
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C D 
A B 
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Figure 4.4.2: The effect of OFF on hBMSCs under supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) of hBMSCs on monolayer culture 
after 7, 14, and 21 days. DNA quantification (A), ALP activity normalised to DNA (B), 
and VEGF secretion (during a 48 hour collection period) normalised to DNA (ng/ml) 
(C). Data is presented as mean ± SE, (N=3, n=3),*=p<0.05 comparison between SM 
and SM+Dex10, using Two-way ANOVA, Tukey’s multiple comparison test.  
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Figure 4.4.3: The effect of OFF on hBMSCs under the supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) on monolayer culture after 21 
days. Total calcium deposition (A) using alizarin red staining and total collagen 
production (B) using picro-sirius red staining. (C) The photoimages show 
representative set of alizarin red staining and (D) picro-sirius red staining on 
monolayer cultured of hBMSCs. (A,B) Data is presented as mean ± SE, (N=3, n=3), 
*=p<0.05 comparison between the SM and SM+Dex10 groups, =p<0.05 
comparison between the rocking and static groups, using Two-way ANOVA, Tukey’s 
multiple comparison test. 
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4.5. The effect of OFF on osteogenic differentiation of HJPs on monolayer 
culture. 
4.5.1. Results  
This experiment evaluated the effect of OFF on 2 different donors of HJPs: HJPs-1 and 
HJPs-2 which showed different responses, therefore, we present them in separate 
results. 
Results of HJPs-1 
The DNA of HJPs-1 increased at all conditions (SM and SM+Dex10 groups) from 7 to 
28 days (Figure 4.5.1 A). The SM groups were slightly higher than the SM+Dex10 
groups both for rocking and static groups, implying that the SM groups had higher cell 
proliferation than the SM+Dex10 groups. The SM groups showed a lower ALP activity 
normalized to DNA than the SM+Dex10 groups in both rocking and static groups at all 
time-points (Figure 4.5.1 B). By day 14, the highest ALP activity in the rocking group 
was the SM+Dex10 condition, compared to any other groups, then this gradually 
decreased after 14 to 28 days. By day 21, the highest ALP activity was the SM+Dex10 
in the static group which was followed by a slight decrease afterwards. Total calcium 
deposition by the SM+Dex10 rocking group was higher than for any other groups by 
day 21 (Figure 4.5.2 A). The SM group produced the lowest calcium deposition in both 
the rocking and static groups. The SM+Dex10 groups produced the lowest amount of 
collagen indicating that Dex inhibits collagen production compared to the other group in 
both the rocking and static groups on day 21 (Figure 4.5.2 B). The SM+Dex10 group 
under rocking conditions (upper row) gave the darkest alizarin red staining after 28 days 
compared to the other groups indicating that there was the more calcium deposition than 
the other groups (Figure 4.5.2 C). The SM static group (lower row) contained patchy 
staining and was faint at the center and periphery indicating that there was lower 
calcium deposition. The picro-sirius red staining images of the SM+Dex10 groups 
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indicated lighter staining compared to the SM groups in both of the rocking and static 
groups (Figure 4.5.2 D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.1: The effect of OFF on HJPs-1 under supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) on monolayer culture  
after 7 to 28 days. DNA quantification (A) and ALP activity normalised to DNA 
(B). mean ± SE, (N=2, n=3), *=p<0.05 comparison between SM and 
SM+Dex10, #=p<0.05 comparison between rocking and static groups, Two-way 
ANOVA, Tukey’s multiple comparison test.  
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Figure 4.5.2: The effect of OFF on HJPs-1 under the supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) on monolayer culture after 28 
days. Total calcium deposition (A) using alizarin red staining and total collagen 
production (B) using picro-sirius red staining. (C) The photoimages show 
representative set of alizarin red staining and (D) picro-sirius red staining on 
monolayer cultured of HJPs. (A,B) Data is presented as mean ± SE, (N=2, n=3), 
*=p<0.05 comparison between the SM and SM+Dex10 groups), Two-way ANOVA, 
Tukey’s multiple comparison test. 
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Results of HJPs-2 
The DNA of HJPs-2 increased at all conditions (the SM and SM+Dex10 groups) from 7 
to 21 days (Figure 4.5.3 A). The SM+Dex10 groups were higher than the SM groups in 
both the rocking and static groups indicating that there were higher cell numbers than 
the other group. The SM groups showed the lower ALP activity normalized to DNA 
than the SM+Dex10 groups in both the rocking and static conditions at all time-points 
(Figure 4.5.3 B). Both rocking and static groups were not significantly different. Total 
calcium deposition by the SM+Dex10 rocking groups was the highest than for any other 
groups by day 21 (Figure 4.5.4 A). The SM+Dex10 groups produced a higher amount of 
collagen than the SM groups in both the rocking and static groups after 21 days (Figure 
4.5.4 B). The SM+Dex10 group under rocking condition (upper row) had the darkest 
alizarin red staining after 21 days compared to the other groups indicating that there was 
more calcium deposition than for the other groups (Figure 4.5.4 C). The picro-sirius red 
staining images of the SM+Dex10 groups (right column) were darker stained compared 
to the SM groups (left column) in both the rocking and static conditions (Figure 4.5.4 
D). 
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Figure 4.5.3: The effect of OFF on HJPs-2 under supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) on monolayer culture  after 7 to 21 
days. DNA quantification (A) and ALP activity normalised to DNA (B). mean ± SE, 
(N=2, n=3), *=p<0.05 comparison between SM and SMDex10, Two-way ANOVA, 
Tukey’s multiple comparison test.  
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Figure 4.5.4: The effect of OFF on HJPs-2 under the supplemented media (SM) and 
supplemented media with 10nM of Dex (SM+Dex10) on monolayer culture after 21 
days. (A) Total calcium deposition by using alizarin red staining and (B) total collagen 
production by using picro-sirius red staining. (C) The photoimages show representative 
sets of alizarin red staining and (D) picro-sirius red staining on monolayer culture of 
HJPs. (A,B) Data is presented as mean ± SE, (N=2, n=3),*=p<0.05 comparison 
between the SM and SM+Dex10 groups, Two-way ANOVA, Tukey’s multiple 
comparison test. 
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4.6.  The effect of temperature on osteogenic differentiation of hESMPs 
compared between room temperature and physical cell culture temperature 
of 37ºC and Carbon dioxide (CO2) on monolayer. 
4.6.1. Introduction 
Because the standard see-saw rocker available in our laboratory could only operate at 
room temperature all our static controls were also placed at room temperature for the 
same length of time. Therefore, we set another group of samples to compare between 
continuous static incubator culture and static at room temperature to certain whether this 
switch to a short period of time at room temperature and standard atmospheric gas 
concentrations (0.04% CO2) in itself had any relevant effects on the cells. These 
temperature effect tests were performed on hESMPs and HJPs. For the purposes of the 
rest of this chapter, „static‟ means the cultured cells were moved to room temperature 
for the same time of rocking and „static incubator‟ means a continuous culture in the 
cell incubator at 37ºC, 5% CO2.  
4.6.2. Results  
On day 7, the cell morphology of the static incubator (upper row) and static (lower row) 
groups cultured under the SM medium (A,D) was more fibroblast fusiform in shape (red 
arrow heads), while the cells cultured under the SM+Dex10 (B,E: white arrow heads) 
and SM+Dex100 media (C,F: yellow arrow heads) were more cuboidal shaped, similar 
to a typical osteoblastic cell (Figure 4.6.1). There were no differences between the static 
incubator and static groups. DNA quantification (Figure. 4.6.2 A), ALP activity 
normalized to DNA (Figure. 4.6.2 B), VEGF secretion (during a 48 hour collection 
period) normalized to DNA (Figure. 4.6.2 C), total calcium deposition (Figure. 4.6.3 A), 
and total collagen production (Figure. 4.6.3 B) of the static compared to the static 
incubator groups (dashed line) showed that they were no differences in any culture 
media: SM, SM+Dex10 or SM+Dex100 over 21 days of culture. 
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While the total calcium deposition was significantly different between the static and 
static incubator groups under the SM+Dex10 medium this difference was less than 20% 
at day 21 (p<0.05). The alizarin red stained cells of SM+Dex100 groups after 21 days 
showed the darkest staining for both the static and static incubator groups, confirming 
that the SM+Dex100 groups deposited the highest amount of calcium compared to the 
others (Figure. 4.6.3 C). The picro-sirius red staining images of the SM+Dex100 group 
indicate there was less collagen production (lighter staining) compared to SM and 
SM+Dex10 in both the static and static incubator groups, this confirmed that the high 
concentration of Dex inhibited collagen production by cells (Figure 4.6.3 D) 
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Figure 4.6.1: Microphotographs of the morphology of hESMPs under different temperatures for the static incubator group and the static group at room 
temperature for 1 hour/day after 7 days. The cells were cultured in the varying concentrations of Dex: supplemented media (SM) which contained AA and β-
GP, supplemented media with 10nM of Dex (SM+Dex10), and supplemented media with 100nM of Dex (SM+Dex100) of hESMPs. The SM group (A,D) were 
more fibroblastic in shape (red arrow heads) while the SM+Dex10 (B, E) and SM+Dex100 (C, F) groups were more cuboidal in shape similar to osteoblastic 
cells (white and yellow arrow heads, respectively). Scale bar : 200µm 
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Figure 4.6.2: The effect of different temperature for hESMPs cells cultured between the 
static and static incubator groups. The cells were cultured in the SM, SM+Dex10, and 
SM+Dex100 media on monolayer and collected at 7, 14 and 21 days. DNA 
quantification (A), ALP activity normalised to DNA (B), and VEGF secretion (during a 
48 hour collection period) normalised to DNA (ng/ml) (C) of the static groups were 
normalised to static incubator groups presented as mean ± SE, (N=3, n=3:for DNA and 
ALP activity, N=2, n=3:for VEGF), *=p<0.05 comparison between the static and the 
static incubator groups (dashed line), using One sample T test. 
(A) hESMPs DNA quantification 
* 
* 
(B) hESMPs ALP activity/DNA 
* 
(C) hESMPs VEGF secretion/DNA 
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Figure 4.6.3: The effect of different temperature for hESMPs cells cultured between the 
static and static incubator groups. The cells were cultured in the SM, SM+Dex10, and 
SM+Dex100 media on monolayer culture after 21 days showed total calcium deposition 
(A) using alizarin red staining and total collagen production (B) using picro-sirius red 
staining. The photoimages show representative set of alizarin red staining (C) and 
picro-sirius red staining (D) on monolayer cultures of hESMPs. (A,B) Data is presented 
as mean ± SE, (N=4, n=3), *=p<0.05 comparison between the static and the static 
incubator groups (dashed line), using One sample T test. 
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4.7. The effect of temperature on osteogenic differentiation of HJPs 
compared between room temperature and physical cell culture temperature 
of 37ºC and CO2 on monolayer. 
4.7.1. Results 
In HJPs-1, DNA quantification (Figure. 4.7.1 A) and total collagen production (Figure. 
4.7.3 A) of static compared to the static incubator groups (dashed line) showed that they 
were no significant differences or differences were less than 20%, (p<0.05). There were 
no differences between the static and the static incubator groups for the cell 
proliferation or collagen production. The picro-sirius red staining of the cells show no 
differences between the static and static incubator groups (Figure 4.7.3 C). ALP activity 
normalized to DNA of the SM+Dex10 groups were significantly different (p<0.05), or 
about 35% differences (Figure 4.7.1 C). Calcium deposition by the static normalized to 
the static incubator groups under the SM medium showed a highly significant difference 
(Figure 4.7.2 A). HJPs-1 under the SM medium deposited much more calcium in the 
static condition (moved to room temperature for short periods) compared to the static 
incubator. The alizarin red staining was also visibly darker for the static group staining 
compared to the static incubator group (Figure 4.7.2 C).   
In contrast, HJPs-2, DNA quantification (Figure. 4.7.1 B), ALP activity normalized to 
DNA (Figure. 4.7.1 D), total calcium deposition (Figure. 4.7.2 B), and total collagen 
production (Figure. 4.7.3 B) of the static compared to the static incubator groups 
(dashed line) showed that there were no differences (p<0.05) or less than 20% 
differences in all culture media: SM, and SM+Dex10 over 21 days of culture. The 
alizarin red staining of the cells under the SM+Dex10 static group did appear darker 
compared to the static incubator group and the quantification indicated higher calcium 
content however there was large variability within this group and no statistically 
significant effect (Figure 4.7.2 D). The picro-sirius red staining of the cells showed no 
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difference between the static and static incubator groups in all media: the SM and 
SM+Dex10 (Figure 4.7.3 D). 
  
Figure 4.7.1: The effect of different temperatures for HJPs-1 and HJPs-2 cells cultured 
between the static and static incubator groups. The cells were cultured in the SM and 
SM+Dex10 media in monolayer and collected at 7, 14, 21, and 28 days, however, the 
HJPs-2 samples were collected untill day 21. DNA quantification (A,B), ALP activity 
normalised to DNA (C,D) of static groups were normalised to static incubator groups 
of the HJPs-1 and HJPs-2, respectively, presented as mean ± SE, (N=2, n=3), 
*=p<0.05 comparison between the static and the static incubator groups (dashed line), 
using One sample T test. 
* 
(A) HJPs-1 DNA quantification 
* * * * 
(C) HJPs-1 ALP activity/DNA 
* 
* 
* 
(B) HJPs-2 DNA quantification 
(D) HJPs-2 ALP activity/DNA 
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Figure 4.7.2: The effect of different temperature for HJPs-1 and HJPs-2 cells 
cultured between the static and static incubator groups. The cells were cultured in the 
SM and SM+Dex10 media on monolayer surface showed total calcium deposition 
after 21 days for HJPs-2 (B) and 28 days for HJPs-1 (A) using alizarin red staining. 
The photoimages show  representative set of alizarin red staining of HJPs-2 (D) and 
HJPs-1 (C) on monolayer surface. Data is presented as mean ± SE, (N=2, n=3), 
*=p<0.05 comparison between the static and the static incubator groups (dashed 
line), using One sample T test. 
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Figure 4.7.3: The effect of different temperatures for HJPs-1 and HJPs-2 cells 
cultured between the static and static incubator groups. The cells were cultured in 
the SM and SM+Dex10 media in monolayer. Total collagen production after 21 days 
for HJPs-2 (B) and 28 days for HJPs-1 (A) using picro-sirius red staining. The 
photoimages show representative set of picro-sirius red staining of HJPs-2 (D) and 
HJPs-1 (C) on monolayer surface. Data is presented as mean ± SE, (N=2, n=3), 
*=p<0.05 comparison between the static and the static incubator groups (dashed 
line), using One sample T test. 
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4.8. Discussion  
It is known that hESMPs and HJPs can differentiate into osteogenic cells by adding 
Dex. These are promising cell sources for bone tissue engineering. OFF can enhance 
osteogenic differentiation and therefore may be of use as a pre-treatment in cleft palate 
bone tissue engineering. It was previously shown that OFF, using a standard see-saw 
rocker, performed at room temperature for 1 hour a day, 5 days per week up-regulates 
ALP, collagen and calcium in monolayer culture on hESMPs, the fluid flow stress 
between 0-0.051 Pa (Delaine-Smith et al., 2012). Others also applied OFF to monolayer 
cultures of hBMSCs or human fetal osteoblastic cells with the parallel plate flow 
chamber at a peak shear stress of up to 2 Pa (Jacobs et al., 1998, Li et al., 2004). 
hESMPs act as a model cells for evaluating a cell viability and effects on differentiation 
of a treatment on material. The HJPs from periosteum tissue and hBMSCs have been 
used clinically for bone reconstruction by using tissue engineering strategies. Therefore, 
the main objective of the work described in this chapter was to evaluate the effect of 
OFF on osteoprogenitor cells such as hESMPs, HJPs, and hBMSCs by using a standard 
see-saw rocker to mechanically stimulate cells. The three cell types have already been 
well demonstrated to have osteogenic differentiation potential (see chapter 3). This is 
the first study that I know of to subject HJPs to OFF using a standard see-saw rocker to 
enhance mineralized matrix production. Based on previous work on hESMPs we 
expected that this technique could enhance osteogenesis of HJPs whether they were 
cultured under osteogenic induction medium (Dex supplement) or supplemented 
medium (without Dex supplement). This may be a promising technique to enhance 
mineralization in bone tissue engineering and benefit patients who need bone graft for 
cleft palate reconstruction.  
Applied OFF using a standard see-saw rocker was chosen in this study because this 
method has been showed to increase osteogenic differentiation in osteoprogenitor cells 
(Zhou et al., 2010, Lim et al., 2013, Delaine-Smith et al., 2012, Tucker et al., 2014). It is 
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a simple method, with high throughput, convenient to observe the cell morphology, and 
mineralized matrix production and it is cost effective. Several studies have used a 
parallel plate flow chamber to exert the fluid flow on the monolayer cell cultures in 
previous works (Nauman et al., 2001, Kreke et al., 2005, Jacobs et al., 1998), but this 
chamber has the weakness: 1] tubing at the inlet and outlet ports can leak and lead to 
cell culture infection, 2] stability of a fluid flow stress due to long distance from the 
pump, 3] high amount of cells, culture media, and reagents are required so studies of 
rare cell populations and using expensive chemical reagents are difficult (Brown and 
Larson, 2001), and 4] low throughput (Nauman et al., 2001). The parallel plate flow 
chamber is usually used to produce OFF stress ranging from 0-2 Pa, trough to peak. The 
critical fluid flow level which could remove half of attached cells on monolayer culture 
is typically is more than 1 Pa (McCoy and O'Brien, 2010). Therefore, the OFF induced 
by the standard see-saw rocker is less likely to detach cells from the culture surface. 
Delaine-Smith et al., (2012) used equations developed in Zhou et al., (2010) to calculate 
the shear stress in the circular 6 well-culture plate used in our lab and found that, for the 
rocking conditions used in these studies the peak shear stress at the center was at 0.041 
Pa and at the periphery was 0.051 Pa. The oscillatory movement mimics the typical 
fluid flow in bone at the lacunar-canalicular system (Orr et al., 2006) and also in bone 
marrow on the endosteal surface which hBMSCs reside (Gurkan and Akkus, 2008, Yin 
and Li, 2006).  
In studies to estimate shear stress on osteocytes within bone matrix it has been 
suggested that they are subjected to OFF at a peak shear stress of 2 Pa in vivo 
(Weinbaum et al., 1994), however, how that relates to the shear stress an 
osteoprogenitor would be subjected to in vivo is completely unknown. Birmingham et 
al., (2013) calculated the fluid flow on trabecular bone in the healthy bone marrow 
environment by using computational models and found that the fluid flow stress should 
range between 0.02-0.4 Pa depending on trabecular bone porosity. Studies on the in 
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vitro effect of OFF on osteocytes, osteoblasts, and MSCs have used the peak shear 
stresses of up to 3 Pa for cell stimulation (Weinbaum et al., 1994, Case et al., 2011, 
Birmingham et al., 2013). However if the Birmingham study is correct then the lower 
shear stress that we use may be more relevant for MSCs.  
A limitation of this study is that in many cases only 2 experiments were performed in 
triplicate, however, some interesting differences were identified were found to be 
significant as follows. In this study DNA quantification indicated cell proliferation was 
not different between the rocking and static groups in all cell types (hESMPs, hBMSCs, 
and HJPs). This implies that OFF has not damaged the cells on monolayer culture but it 
also does not stimulate cell proliferation. These results are consistent with the study by 
Kreke et al., (2005) in which MSCs were subjected the steady fluid flow with the shear 
stress of 0.16 Pa had no effect on cell proliferation, but is in contrast to the studies of 
Nauman et al, (2001) in which on the rat tibial and femoral osteoprogenitor cells were 
subjected pulsatile fluid flow with the shear stress between 0.1 to 1.1 Pa and showed an 
increased cell proliferation on day 21. This study initiated the fluid flow stress on day 
14 and further stimulated for 7 days whereas our study subjected the fluid flow stress to 
the cells on day 4 and further stimulated for 14 days (see chapter 2). These different 
time points of mechanical stimulation on the cells may affect cell proliferation. The 
response of immature osteoblastic cells to mechanical stimuli may depend on species of 
origin, fluid flow magnitude, and mode of flow such as steady, pulsatile, and oscillatory 
(Kreke et al., 2005). In our studies, a cell attachment time of 4 days was allowed before 
subjecting the cells to OFF to be consistent with 3D cultures for the next chapter 
(chapter 5). These time periods were previously observed to allow cell attachment to the 
culture surface before initiation of mechanical stimuli (McCoy and O'Brien, 2010).  
The ALP activity in our study increased over time of culture, except that ALP activity 
of HJPs-1 on day 28 was significantly lower while at the same time-point they showed 
high calcium deposition. There were no effects of OFF on ALP activity between the 
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rocking and static groups under either the SM or SM with Dex supplements in all cell 
types (hESMPs, hBMSCs, and HJPs). This is consistent with the study of Nuaman et 
al., (2001) who found that the unidirectional pulsatile fluid flow on the rat 
osteoprogenitor cells had no effect on ALP activity whether they were cultured in the 
static condition or various magnitudes of flow with a parallel plate flow chamber on day 
14. One potential reason is that ALP activity normally decreases before the beginning of 
mineralization (before day 21), therefore the ALP activity may lead to an apparent lack 
of response to OFF in conditions where mineralisation has been accelerated (Lian and 
Stein, 1995). Here we did measure ALP at three time points to try to capture any peak in 
activity and we did not appear to have reached the peak before 21 days. Due to 
problems with cell density (the cells became over confluent) we were only able to 
measure ALP at day 28 in HJPs-1, this data showed lower ALP at day 28 indicating that 
peak activity may have occurred around day 21. Therefore it is unlikely that we do not 
see higher ALP in rocked cultures just because the ALP peak occurred earlier in these 
cells. Yourek et al., (2010) found that the unidirectional fluid flow on hBMSCs under 
100nM of Dex did not affect ALP in the cell lysate but did increase ALP levels in the 
media. He hypothesized that fluid flow may remove ALP from the cell membrane 
explaining why there is no apparent increase in ALP levels in the cell lysate even when 
other osteogenic markers are present. It would be interesting to measure media ALP in 
future studies.  
Calcium deposition indicates the late state of osteogenic differentiation. Our study 
found that calcium deposition in the rocking groups under the 100nM of Dex medium in 
the hESMPs and the 10nM of Dex medium in both hBMSCs and HJPs was higher than 
the SM media. The combination of OFF and Dex supplementation can enhance 
osteoblastic differentiation especially in the late state by increasing calcium deposition. 
The 100nM of Dex medium allowed a higher calcium deposition than 10nM of Dex. It 
indicated that the concentration of Dex was directly related to the calcium deposition of 
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cells. Wozniak et al., (2000) and Sodek et al., (2000) stated that the osteogenic cells 
may respond to mechanical stimuli by secreting OPN in the extracellular matrix. OPN is 
a protein which is necessary for cellular proliferation and regulation of calcium 
deposition of cells on the ECM. Moreover, Wozniak et al., (2000) applied strain stress 
on hBMSCs using a 6-well Flexcell strain apparatus and reported that gap junctions 
increased, there are a cell-cell connection network. It has been suggested by several 
groups that even it only a few cells sense a mechanical stress it is passed to other cells in 
the culture via gap junctions leading to a co-ordinated response, this may be the reason 
for the more uniform calcium deposition observed in the OFF groups. Lastly, the OFF 
can stimulate the mineralization of cells either via mechanical or by secondary effects 
on nutrient distribution. In addition many study on bone cells OFF also increased 
intracellular calcium mobilization which is an important intracellular signals (Li et al., 
2004). In this study we did not determine the pathway of OFF to induce osteogenic 
differentiation. Possible mechanisms of mechanotransduction have been studied and 
many researchers have noted mechanical stimulation of the mitogen activated protein 
kinase (MAPK) pathways which regulate the cell proliferation and osteogenic 
differentiation (see chapter 1) (Jaiswal et al., 2000, Pommerenke et al., 2002). Fluid 
flow has been shown to enhance osteogenic differentiation of osteoprogenitor cells and 
calcium deposition by several pathways such as the stretch-activated ion channels on the 
plasma membrane, the cell-cell interaction: gap junction, the cell-ECM interaction: 
focal adhesion complex, the biochemical signaling: PGE2 (Einhorn, 2003) and OPN 
(Reilly et al., 2003, Bonnet and Ferrari, 2010), and the extracellular structure: primary 
cilia (Janmey and McCulloch, 2007, Orr et al., 2006). 
Collagen production is also a marker of osteogenic differentiation on osteoprogenitor 
cells. Our studies showed that there were no differences between the rocking and static 
groups in total collagen production, indicating that the OFF had no effect in any cell 
type. This result is similar to the study by Li et al., (2004) who subject MSCs to OFF by 
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using a parallel plate flow chamber and found the gene expression of collagen type I 
was not affected by OFF. Nohutcu et al., (1997) reported that the gene expression of 
collagen type I was at the high level, following by reducing of this gene expression 
before the mineralization state. However, the opposite result was found with rat MSCs 
from bone marrow cultured on 3D scaffold using micro-vibration chamber, Zhou et al., 
(2011) found that the mechanical stimuli could enhance the collagen matrix production 
in osteoprogenitor cells although they were supplemented with Dex. Interestingly 
pulsatile fluid flow in a parallel plate flow chamber on rabbit tendon fibroblasts 
increased the expression of matrix metalloproteinase (MMP-1 and MMP-3) which act 
as collagen degradation in the enzymes remodelling of extracellular matrix (Kjaer et al., 
2006, Archambault et al., 2002). This may be a reason why the collagen production in 
the rocking group was no different from the static group.  
VEGF is an important cytokine to recruit endothelial cells for vasculogenesis. Our study 
showed no differences between the rocking and static groups, indicating that the OFF 
had no effect on VEGF secretion by hESMPs or hBMSCs. Lim et al‟s (2013) study on 
human MSCs derived from alveolar bone showed a similar result that the cells subjected 
to OFF by using rocking platform for 1 hour in the maximum magnitude at 0.00205 Pa 
slightly increased the VEGF secretion but by only 18.75% compared to the static group. 
In contrast, Thi et al‟s (2010) study on the osteoblastic mouse cell (MC3T3-E1), 
showed that the VEGF secretion was dramatically increased by pulsatile fluid flow (0.5 
Pa) for 5 hours in vitro. They described that the increasing of PGE2 production from 
OFF could stimulate the VEGF production. We did not measure PGE2 secretion from 
the osteoprogenitor cells (hESMPs and hBMSCs), however, our group found that 
murine mature osteoblast cells (MLO-A5) respond to OFF by increasing PGE2 secretion 
(Delaine-Smith et al., 2014b). Further studies consistently showed that osteoprogenitor 
cells can produce and accumulate PGE2 in response to fluid flow (Nauman et al., 2001). 
However this increase PGE2, if it also occurred in these experiments does not seem to 
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enhance VEGF secretion. The shear stress in our system may be too low to stimulate 
VEGF secretion compared to other studies on hBMSCs in monolayer using the pulsatile 
parallel plate flow chamber. Using a high shear stress (2Pa) (Yuan et al., 2013) found 
that the VEGF secretion was higher than in the static conditions. In the HJPs study 
SM+Dex100 condition was not investigated due to the previous result that HJPs under 
various Dex supplementations on monolayer culture showed that the highest osteogenic 
differentiation was in the SM+Dex10 conditions (see chapter 3).  
Cells were subjected to OFF at room temperature. Therefore there was some concern 
that the switch to room temperature and atmospheric CO2 may in itself affect the cells. 
Temperature and CO2 are a key environmental factor for cell culture and may have 
affected the cells. In order to check whether there was an effect of the switch to room 
temperature alone, regardless of rocking I tested the effect of temperature and CO2 by 
comparing static cells cultured at room temperature, atmosphere (0.04%CO2) (static 
group) and continuous culture in the cell incubator at the 37 ºC, 5%CO2 (static incubator 
group). The results showed that that the DNA quantification which indicates cell 
number were not difference between the static and static incubator groups. Similarly, 
ALP activity, calcium deposition, and collagen production of both hESMPs and HJPs 
showed no differences. In all conditions of culture media without cells (SM, 
SM+Dex10, and SM+Dex100 media) in the static and static incubator groups showed 
no calcium precipitation. Therefore, all media required cells for mineralization. If cells 
are exposed to room temperature and atmosphere for a short enough period of time and 
moved back to the cell culture incubator, cell alteration can be prevented. Moreover, it 
would have taken some time for the cell culture medium to cool down, disturbing pH 
balance which involved a dissolved CO2, and affect the temperature of cell culture due 
to the medium volume were larger amount than the cell volume (Klein et al., 1996). 
Interestingly, the calcium deposition of HJPs-1 under the SM medium at the static 
conditions was much higher than the static incubator groups, these are the same cells 
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that did not show a significant response to rocking, however calcium levels were very 
high in all conditions, this effect of room temperature may explain the lack of effect of 
rocking, calcium deposition was already highly stimulated and therefore could not be 
further stimulated. HJPs-1 may be more sensitive to stress and produce higher amount 
of heat shock protein (HSP). Several studies on the culturing cells at low temperature 
(25-32ºC) found that the cells increase the levels of heat shock protein (HSP-27, 70, and 
90) which enhance osteogenic differentiation (Chen et al., 2013, Stolzing and Scutt, 
2006, Neutelings et al., 2013, Fujita, 1999). The reason that this only occurred in HJPs-
1 must be because of patient variation and site of tissue harvesting (Marolt et al., 2010, 
Akintoye et al., 2006). Therefore we would need more HJPs cell to evaluate the effect 
of OFF to osteogenic differentiation. A limitation of this study was that the effect of 
temperature and CO2 on hBMSCs was not investigated. The hESMPs, hBMSCs, and 
HJPs showed similar results in osteogenic potential and the OFF effects. Therefore the 
results of room temperature and CO2 effects on hBMSCs should be similar to the 
hESMPs and HJPs results on monolayer culture but would requires further 
investigation.  
4.9. Conclusion 
Isolated hBMSCs and HJPs can be autologous cell sources for bone tissue engineering. 
All cell types (hESMPs, hBMSCs, and HJPs) responded to OFF by using a standard 
see-saw rocker to stimulate osteogenic differentiation. The cells were more sensitive to 
OFF when subjected to biochemical stimulation, using Dex supplementation for 
enhancing calcium deposition. This may be a cost effective, high throughput, and 
simple pre-treatment for bone tissue engineering for small defects such as cleft palate. 
In general the cells were not affected by culturing in a short period of time at room 
temperature when considering cell morphology, cell proliferation, and osteogenic 
differentiation. It was important to test this as the specific rocker that we used was 
operated on the bench top at room temperature. 
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4.10. Summary 
 Subjecting osteoprogenitor cells to short periods of OFF during culture results in 
increased calcium deposition.  
 The hESMPs, hBMSCs, and HJPs cells all responded to OFF, confirming that 
hESMPs are a useful model and bone marrow derived MSCs and periosteum derived 
HJPs could be an autologous cell sources for future mechanical stimulation studies. 
 Cell proliferation, ALP activity, VEGF secretion, and collagen production were not 
responsive to OFF. 
 Calcium depositions in all cell types were enhanced by the combination of applying 
OFF and Dex supplementation. 
 The cell morphology, cell proliferation, and osteogenic differentiation of both 
hESMPs and HJPs were not different between the static (room temperature, atmosphere 
CO2) and static incubator groups (37ºC, 5% CO2).  
 Therefore, the static group will be used as the control group (not subjected to OFF) 
to compare with the rocking group in OFF experiments. 
4.11. Future work 
The study showed a successful in enhancing osteogenic differentiation and calcium 
deposition on human osteogenic progenitor cells. This method could be used in the 
future studies, for example; 
 Studying the response to OFF by cells in monolayer in order to better identify the 
optimal shear stresses for 3D bioreactor cultured and implanted tissues  
 Studying the OFF responses on cells sourced from different aged donors, for 
example, children‟s periosteal cells may respond more robustly than adult periosteal 
cells.  
CHAPTER FOUR 
176 
 
 Studying the osteogenic differentiation of the cells is a wider range of OFF regimes 
such as loading period, loading day, and various biochemical supplementations (BMP-
2, PGE2). 
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CHAPTER FIVE: THE EFFECT OF OSCILLATORY FLUID FLOW AND 
NANOHYDROXYAPATITE ELECTROSPUN SCAFFOLD TO ENHANCE 
OSTEOGENIC DIFFERENTIATION OF OSTEOGENIC PROGENITOR 
CELLS 
5.1 Introduction 
Tissue engineering could be an optional choice for bone reconstruction for cleft palate 
repair. The three basic principles of tissue engineering include firstly a promising cell 
source, secondly an appropriate engineered scaffold and lastly cultured under a suitably 
biochemical reagent. The promising cell sources and suitable biochemical reagent have 
been described in the previous chapters. Therefore this chapter will describe some 
prospective scaffold materials.  
Electrospinning fabrication is a straightforward method to produce fibres in various 
diameters from 5nm to several micrometres (Zargarian and Haddadi-Asl, 2010). The 
effect of the physical properties of a scaffold has been of strong interest recently due to 
the development of novel scaffold materials with unique characteristics depended on the 
polymer chemistry. When bone tissue engineering is targeted, materials should have 
sufficient strength and flexibility and be able to support and promote the proliferation of 
osteoprogenitor cells. In recent studies, poly-D-lactide (PLA), poly(-caprolactone) 
(PCL), and polyhydroxybutyrate-co-polyhydroxyvalerate (PHBV) have been evaluated 
as biocompatible and biodegradable for tissue engineering materials. All materials: 
PLA, PCL, and PHBV are approved by the U.S. FDA for medical use (Hutmacher et al., 
2001, Sikavitsas et al., 2005, Ji et al., 2008). These polymers were chosen for this 
studies due to their higher mechanical strength and lower rate of biodegradability than 
natural materials such as collagen type I (Jha et al., 2011) which could also be produced 
by electrospinning.   
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Recently, many biodegradable polymer electrospun scaffolds have been used for bone 
tissue engineering however they was no evidence for osteoconductivity or 
osteoinductivity (Polini et al., 2011). A bone graft substitute probably requires an active 
property to stimulate bone tissue regeneration which also does not have an adverse 
effect on the surrounding tissue. There have been many recent studies aimed at 
developing bioactive materials to enhance osteoconduction and osteoinduction using 
HA (Lao et al., 2011, Fang et al., 2009, Yin et al., 2010). HA is a calcium-phosphate 
which is non-toxic, osteoinductive, and osteoconductive. Nano particle hydroxyapatite 
(nHA) has been reported to enhance osteogenic differentiation of mouse MSCs 
compared with micro particle hydroxyapatite (µHA) (Li et al., 2009). They reported that 
the calcium atoms of nHA exposed on the mixture between chitosan and gelatine 
casting film scaffold surface could enhance osteogenic differentiation potential. 
Therefore the hypothesis of this study is that nHA included in electrospun scaffolds 
could enhance their ability to support osteogenesis of MSCs.   
Bone is a natural composite material consisting of cells and the ECM which is 
composed of a collagen protein and HA based mineral plates. The microstructure of 
bone consists of the lacunocanalicular structure and ECM. As described in the 
introduction, bone is a dynamic tissue which responds to the mechanical stimuli that act 
on it. It has been reported in several studies that the osteogenic differentiation of human 
osteoprogenitor cells is enhanced by mechanical stimuli (Bancroft et al., 2002, 
Sikavitsas et al., 2003, Delaine-Smith et al., 2012). In vitro studies have estimated the 
effect of OFF on the osteogenic progenitor cells in monolayer culture. The cells cultured 
on electrospun scaffold are surrounded by fibres and connect to other cells in all 
direction therefore one could speculate that this environment better mimics their in vivo 
environment. Therefore, by subjecting cells to OFF in 3D culture the outcomes may be 
more similar to in vivo than monolayer culture and this may be a good model system for 
mechanotransduction studies.      
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In the chapter 4 have been demonstrated in chapter 4 that (OFF of human 
osteoprogenitor cells including; hESMPs, hBMSCs, and HJPs in monolayer culture 
enhances calcium deposition under supplementation with Dex, although there was no 
effect on ALP activity (an early marker of osteogenic differentiation) or VEGF 
secretion. Therefore these studies are a further investigate the potential of OFF to 
stimulate hESMPs and hBMSCs by subjecting cells to OFF in 3D culture to stimulate 
osteogenic differentiation. The calcium deposition of the cells was evaluated by using 
micro computed tomography (micro-CT).   
The first objective of this chapter was to produce and characterise the selected polymer 
electrospun micro fibre scaffolds including PLA, PCL, and PHBV for bone tissue 
engineering. The second objective was to enhance osteogenic differentiation of 
mesenchymal progenitors by using an OFF and nHA incorporated into electrospun PCL 
scaffolds.  
5.2. Fabrication and characterization of PLA, PCL, and PHBV electrospun 
scaffolds. 
5.2.1. Methods 
Preparation of polymer solution 
3.5g of polymer pellet (PLA, PCL, and PHBV) was added into 31.5 g or 23.7 mL of 
DCM (DCM density = 1.33g/cm
3
). The mixture was stirred using a magnetic stirrer and 
dissolved at room temperature overnight to obtain the well mixed polymer solution with 
a concentration of 10wt%. The polymer solutions were spun using the electrospinning 
technique (see chapter 2). The scaffold morphology was measured from SEM images. 
The fibre diameter and their distribution were measured over 100 randomly selected 
fibres from 4 recorded SEM micrographs by using the image analysis software 
(ImageJ). Each picture was randomly overlaid with a square grid side 2500µm
2
 using 
automatic ImageJ function and selected for 25 points (Figure 5.2.1). The fibre diameter 
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was measured for each fibre which was underneath the intersections of the lines. The 
volumetric porosity of the PCL, PDLA, and PHBV electrospun scaffolds were analysed 
from the ratio of the scaffold density and their bulk density. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2500µm
2
 
Figure 5.2.1: Schematic of fibre diameter measuring from SEM image. The square 
grid lines size 2500µm
2 
were overlaid on the image by using automatic image J 
function. The selected 25 points of underneath or nearest of the intersections of the 
lines had the fibre diameter measured.  
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5.2.2 Results  
PLA and PCL successfully produced fibres with a smooth fibre morphology without 
bead formation while the PHBV had a number of beads along with the fibres. 
Representative SEM images of the 10wt% PLA, PCL, and PHBV randomised 
electrospun scaffolds spun using DCM as a solvent are shown in Figure 5.2.2 A,B,C, 
respectively.  The average fibre diameter of the three scaffolds (PLA, PCL, and PHBV) 
were significantly different (p<0.05) (Figure 5.2.2 G). PLA formed the thickest fibres 
with mean of 4.840 µm, with a normal distribution between 1-7 µm (Figure 5.2.2 D). 
The average fibre diameter of PCL was 2.682 µm. The average of fibre diameter of 
PHBV was the lowest at about 0.773 µm. The PHBV beads exhibited an average 
diameter of 8.783±0.620µm (average±SE), showing the narrowest size distribution 
(Figure 5.2.2 F). However, there were no significant differences between the volumetric 
porosity of the scaffolds (Figure 5.2.2 H).  
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Figure 5.2.2: 10wt% PLA, PCL, and PHBV electrospun scaffold characterisations; SEM 
images of electrospun fibrous morphologies (A,B,C, respectively), fibre diameter 
distributions (D,E,F, respectively), average fibre diameter (G), and porosity of the 
scaffolds (H). The polymer pellets were dissolved in DCM and spun in the 40µL/min flow 
rate, 17kV, 17cm working distance, 300 rpm (rotating collector). The SEM images scale 
bar 50 µm for PLA and PHBV scaffolds and 20 µm for PCL scaffolds. The maximum 
value y-axis of the fibre diameter distributions bar graph D and E is 40 and graph F is 
100. mean±SE (n=6 for porosity measurement and n=50 for fibre diameter measurement), 
*=p<0.05 compared between PLA and PCL, #=p<0.05 compared between PLA and 
PHBV, =p<0.05 compared between PCL and PHBV, One way ANOVA, Tukey’s multiple 
comparison test. 
 
PCL 
 
Polymer (wt%) Porosity (%) 
PLA (10) 89.706±0.157 
PCL (10) 86.069±0.677 
PHBV (10) 86.980±1.257 
 
(H) 
(B) (A) (C) 
(D) (E) (F) 
* 
# 
 
(G) 
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5.3 Optimizing cell seeding methods on scaffolds 
5.3.1 Methods 
The cut PLA electrospun scaffolds and CellCrown™ inserts were sterilized, then the 
scaffolds were mounted into CellCrown™ and immersed in basal culture media (α-
MEM) overnight in the incubator at 37°C, 5% CO2, and a humidified atmosphere. 10
5 
hESMPs were seeded on top of PLA scaffolds using 4 different methods; 1] small 
volume technique+1 hour: the small volume of cell suspension (no more than 100 µL) is 
seeded on top of the scaffold, then left for 1hour in an incubator then the appropriate 
media are added into the well plate (Figure 5.3.1 A), 2] small volume technique +2 
hours (Figure 5.3.1 B), 3] low volume media technique: basal culture media was added 
up to the bottom surface of the scaffolds, then small volume technique used for cell 
seeding and cells left for attachment for 2 hours then the appropriate media are added 
into the well plate (Figure 5.3.1 C); and 4] large volume media technique: 1mL of basal 
culture media was added to cover the scaffolds, then the small volume technique was 
used for cell seeding and left for 24 hour for cell attachment (Figure 5.3.1 D) in the cell 
culture incubator.  
The cell seeded scaffolds were removed to fresh well plates after 1 day, cell seeding 
efficiency was measured using the resazurin reduction assay. The number of viable cells 
which remained on the original tissue culture wells (fluorescence relative units: FRU) 
were compared with the FRU of the cells on tissue culture plates which were seeded 
with equivalent numbers as a control. Equation (1) adapted from (Seebach et al., 2010). 
Percentage of cell attachment (%) = (FRU of control-FRU of remaining cells) X100  
      FRU of control                                   (1) 
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The number of cells growing in the scaffolds was estimated by resazurin reduction 
assay on day 3, 5, and 7, which gives an indication of cell proliferation. Live/Dead 
staining was performed to visualize the cell distribution on scaffolds at day 7.   
 
 
 
 
 
 
 
5.3.2 Results 
Cell viability for all groups increased over-time points, however, the results were a 
quarter of the control result. No significant differences were found between the various 
conditions except for the TCP control group which was significantly higher than the 
others p<0.05 (Figure 5.3.2 A). The large volume of media group showed less variation 
compared to the other groups. Live/Dead staining images visualized by fluorescence 
microscopy showed viable (green) and died (red) cell distribution on the scaffolds. The 
1 hour group showed isolated cells distributed on scaffolds (Figure 5.3.2 B-E). In the 
large volume of media cell seeding technique, there was less variability compared to the 
other methods (Figure 5.3.2 F). Therefore, the large volume media technique was 
selected for cell seeding in all future experiment. 
 
 
Figure 5.3.1: Schematic of cell seeding methods. A: small volume technique+1 hour, 
B: small volume technique+2 hours, C: low volume of media technique, and D: large 
volume of media technique. In the technique A, B, and C, after the samples were 
incubated, the appropriate media were added up to 1mL into the well plate. The cells 
were allowed to attach overnight in the cell culture incubator. 
Low 
media 
Large 
media 
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Figure 5.3.2: (A) The effect of 4 different cell seeding methods: 1] 1hour technique, 2] 2hours 
technique, 3] low media, and 4] large media groups of hES MP cells on PLA scaffold 
compared with the tissue culture plastic (TCP) group. The cell viabilities assayed using 
resazurin reduction test after 3, 5, and 7 days. mean±SE, (N=1, n=3), Two-way ANOVA, 
Tukey’s multiple comparison test, p<0.05. The fluorescence images of hESMPs on PLA 
scaffolds in 4 different cell seeding methods using Live/Dead staining assay to examine cell 
viability after 7 days. B: tissue culture plate (TCP) group, C: 1hour, D: 2hours, E: low media, 
and F: large media groups. Scale bar = 200µm.   
 
(B) TCP (C) 1 hour (D) 2 hours 
(E) Low media (F) Large media 
(A) 
Low media 
Large media 
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5.4 To evaluate cell viability on selected electrospun scaffolds (PLA, PCL, 
and PHBV) for hESMPs  
5.4.1 Methods 
 Scaffold preparation 
Samples were divided into 3 groups depending on scaffold material; electrospun PLA, 
PCL, and PHBV scaffolds. The same amount of cells were cultured on TCP as a 
control. PCL, PLA, and PHBV were cut into disks using a cork borer with a diameter of 
1.5 cm. The scaffolds were steriled with 0.1% peracetic acid in PBS in steady rocking 
conditions for 3 hours then washed three times with PBS to remove the peracetic acid. 
The scaffolds were placed on top with sterilized stainless steel rings, then 1mL of basal 
culture media was added to each well and cell-scaffold constructs were cultured 
overnight to allow for serum protein attachment under sterile condition at 37ºC, 5% 
CO2, and a humidified atmosphere incubator. Before cell seeding, the cell culture media 
was removed.  
 Cell seeding 
The 32.5μL mixture of 5x104 hESMP cells were seeded onto scaffolds with the large 
volume media technique as described previously. 5x10
4 
cells were used in this 
experiment to complement an existing experiment for use as a figure in a publication 
(Bye et al., 2013). The samples were observed for their ability to support cells using a 
25.1µg/mL (0.1mM) resazurin reduction test on days 1 and 7. 
5.4.2. Results 
Cell viability was used to evaluate cell attachment and cell proliferation of hESMPs on 
various types of scaffolds by using the resazurin reduction test at day 1 and 7 (Figure 
5.4.1). The results showed that cell attachment between all groups was not significantly 
different on day 1 (p<0.05). By day 7, the cell viability was significantly higher for the 
control TCP group, however, the results of the PCL and PLA groups were less than half 
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of the TCP group. Moreover, they were not significantly different from day 1, indicating 
that cells had not proliferated. The cell viability on the PHBV group on day 7 was 
significantly lower than the other groups (PCL, PLA, and TCP groups), however, their 
cell viabilities on day 7 were also lower than at day1 with no significant difference, 
indicating cells didn‟t attach to the scaffold and there was cell arrest or even cell death.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4.2: The ability of different electrospun scaffolds: PLA, PCL, PHBV, and 
TCP (tissue culture plastic control) to support cell viability over 7 days. The cell 
viability was assayed by resazurin reduction test after 1 and 7 days. mean±SE, (N=2, 
n=3 in all conditions except the TCP group N=1, n=3), * = p<0.05 comparison 
between the TCP group with the other groups, # = p<0.05 comparison between the 
PHBV group with the other groups, Two-way ANOVA, Tukey’s multiple comparisons. 
 
# 
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5.5 To compare osteogenic differentiation of HJPs cultured on PCL and 
PLA scaffolds. 
5.5.1 Methods 
PCL and PLA were cut into circular disks (diameter 1.5cm). The steriled scaffolds were 
seeded with 10
5
 human jaw periosteal (HJP) cells from 2 donors (HJP-1 and HJP-2), 
passage numbers between 7 and 8 were used in this experiment. 10
5
 cells were seeded 
using the large volume of media technique as described previously. The samples were 
cultured either in supplemented medium (SM group) which contained AA and β-GP, or 
in SM media with 10nM of Dex added, denoted „SM+Dex10‟ group. The cell viability 
and osteogenic differentiation of the HJPs were measured using resazurin reduction test 
after day 7, 14, 21, and 28 and alizarin red staining after day 28. The scaffold 
sterilization and cell seeding as proceeded experiment 5.4.  
5.5.2. Results  
A study was carried out to compare the osteogenic potential of HJPs-1 and HJPs-2 on 
PCL and PLA scaffolds. The resazurin reduction test was used to evaluate cell 
attachment on day 1 and cell viability on day 7, 14, 21, and 28 to compare PCL and 
PLA scaffolds. HJPs from both donors exhibited higher cell viability on PCL scaffolds 
than on PLA scaffolds (Figure 5.5.2). For both cell types the numbers increased over 
time in all conditions for 28 days indicating that cells proliferated (Figure 5.5.3). The 
cell viability of HJPs-1 under the SM+Dex10 medium was higher than the SM medium 
on both PCL and PLA scaffolds (Figure 5.5.3 A). This implies that the HJPs-1 on both 
PCL and PLA scaffolds under the SM+Dex10 medium underwent higher cell 
proliferation than in the SM medium. The cell viability of HJPs-2 on the PCL scaffold 
under the SM medium was higher than the Dex containing medium, in contrast, on the 
PLA scaffold cell viability was higher in SM+Dex10 medium than non Dex containing 
medium (Figure 5.5.3 B). Indicating that for HJPs-2 the PCL scaffold supported cell 
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proliferation better in SM but the PLA scaffold supported proliferation better under 
SM+Dex10 medium. The total calcium deposition of HJPs-1 was significantly higher in 
the PCL under SM+Dex10 medium (PCL-SM+Dex10) (Figure 5.5.4 A), however for 
HJPs-2, there was no significant difference between the 4 different groups (Figure 5.5.4 
B). Alizarin red staining of HJPs-1 cell-deposited matrix showed darkest staining for the 
PCL-SM+Dex10 group (Figure 5.5.4 C), while the intensity of HJPs-2 staining was not 
different between the groups (Figure 5.5.4 D), indicating the HJPs were better support 
on PCL scaffolds.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5.2: The ability of different electrospun scaffolds (PCL and PLA) to support 
HJPs attachment. The cell viability was measured using resazurin reduction results on 
day 1. mean±SE, (N=2, n=3), * = p<0.05 comparison between PCL and PLA, One 
way ANOVA, Tukey’s multiple comparison test.  
* 
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Figure 5.5.3: The ability of different electrospun scaffolds (PCL and PLA) to support 
HJPs growth under the supplemented media (SM) and the SM with 10nM of Dex 
(SM+Dex10). Cell viability was measured using resazurin reduction tests after 7, 14, 
21, and 28 days. (A) First donor of HJPs: HJPs-1, and (B) second donor of HJPs: 
HJPs-2. mean ± SE, (N=2, n=3), *=p<0.05 comparison between SM and SM+Dex10, # 
= p<0.05 comparison between PCL and PLA electrospun scaffolds, Two-way ANOVA, 
and Tukey’s multiple comparison test.  
 
* * 
* 
PCL SM+Dex10 
PLA SM+Dex10 
(A) (B) 
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Figure 5.5.4: The ability of different electrospun scaffolds (PCL and PLA) to support 
osteogenic differentiation of HJPs under the supplemented media (SM) and the SM with 
10nM of Dex (SM+Dex10). Deposited calcium was measured by alizarin red staining at 
day 28. Total calcium deposition normalized to cells cultured on the PCL under the SM 
medium (PCL-SM) groups (A) the first donor of HJP cells: HJPs-1, and (B) the second 
donor of HJP cells: HJPs-2. The photoimages show a representative set of alizarin red 
staining of HJPs-1(C) and HJPs-2 (D). mean ± SE, (N=2, n=3), and *=p<0.05 
comparison between the SM and SM+Dex10 groups in the same scaffold, One-way 
ANOVA, Tukey’s multiple comparison test.   
 
(B) 
(C) (D) 
* 
(A) 
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5.6 Osteogenic differentiation of hESMPs on PCL scaffold 
5.6.1 Methods 
Circular PCL scaffolds with a diameter of 1.5cm were seeded with 10
5
 hESMPs, 
passage numbers in the range 6 to 7. Samples were divided into 2 groups either the 
supplemented medium (SM) which contained basal α-MEM supplemented with AA and 
β-GP, or the SM medium with 100nM of Dex added (SM+Dex100). The cell viability 
and osteogenic differentiation of the hESMPs were measured using resazurin reduction 
test after day 7, 14, 21, and 28 and alizarin red and picro-sirius red stainings after day 
28, respectively. The scaffold sterilization and cell seeding as proceeded as experiment 
5.4.  
5.6.2 Results 
The resazurin reduction test was used to evaluate cell viability on day 7, 14, 21, and 28. 
The cell viability of hESMPs increased overtime for 28 days at all conditions (Figure 
5.6.2 A). Total calcium deposition by hESMPs was significantly higher in the 
SM+Dex100 than the SM group after 21 days and it was further significantly increased 
by 28 days (p<0.05) (Figure 5.6.2 B). Total collagen production of the SM medium 
after 21 days was significantly lower than the other groups. However, there were no 
differences between the SM and SM+Dex100 groups after 28 days, (p<0.05) (Figure 
5.6.2 C). Alizarin red staining was darkest on the SM+Dex100 group after 28 days 
(Figure 5.6.2 D). The picro-sirius red stained images showed lightest staining on the SM 
group after 21 days (Figure 5.6.2 E). The intensities of picro-sirius red staining after 28 
days were not different between the SM and SM+Dex100 groups, indicating that, 
although collagen deposition was slower in SM, Dex was not necessary to induce 
collagen production by 28 days of culture. 
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Figure 5.6.2: The ability of electrospun PCL scaffolds to support osteogenic 
differentiation of hESMPs under SM and SM+Dex100. (A) The cell viability of 
hESMPs was measured by using resazurin reduction test after day 7, 14, 21, and 28. 
Total calcium depositions (B) and total collagen production (C) were measured for 
hESMPs seeded on PCL scaffolds after day 21 and 28 using alizarin red and picro-
sirius red staining assay, respectively. The photoimages show representative set of 
alizarin red staining (D) and picro-sirius red staining (E) on the hESMPs seeded on 
PCL scaffolds after 21 and 28 days. mean±SE, (N=2, n=3), #=p<0.05 comparison 
between the SM and SM+Dex100 groups in the same day, *=p<0.05 comparison 
between day 21 and 28 in the same medium, Two-way ANOVA, Tukey’s multiple 
comparison test.   
Day21 
Day28 
SM SM+Dex100 
(D) Alizarin red staining 
SM SM+Dex100 
Day21 
Day28 
(E) Picro-sirius red staining 
(A) 
# 
# * 
(B) 
* # 
(C) 
CHAPTER FIVE 
194 
 
5.7: To evaluate the effect of OFF on hESMPs cultured on PCL electrospun 
scaffold. 
5.7.1. Methods 
10
5
 cells of hESMPs in the passage number between 6 and 7 were seeded on PCL 
scaffolds. All cell seeded scaffolds were cultured with basal culture media along with 
the required supplements on day1. The samples were divided into 2 groups; SM 
medium and SM medium with 100nM of Dex (SM+Dex100). The scaffold sterilization 
and cell seeding as proceeded as experiment 5.4. All samples were divided into two 
groups 1] Rocking and 2] Static groups at room temperature and atmospheric condition 
(0.04% CO2). The samples were subjected to OFF by using a standard see-saw rocker at 
room temperature for 1 hour a day, 5 days a week for 28 days (see chapter 2). The cell 
viability of the hESMPs were measured using resazurin reduction test after day 7, 14, 
21, and 28. The osteogenic differentiation of the cells were measured using alizarin red 
and picro-sirius red staining for calcium deposition and collagen production after day 
28. 
5.7.2 Results 
The cell viability of hESMPs was assessed using resazurin reduction test after 7, 14, 21, 
and 28 days (Figure 5.7.2). Cell viability increased over time in all conditions (rocking 
SM, rocking SM+Dex100, static SM and static SM+Dex100 groups) except for in the 
rocking SM+Dex100 group where it was slightly decreased from day 21 to 28, and there 
were no significant differences between treatments (p<0.05). This implies that the cells 
in the rocking SM+Dex100 had lower cell proliferation than the other groups (Figure 
5.7.2). Total calcium deposition by the rocking SM+Dex100 group was significantly 
higher compared to the other groups (P<0.05) (Figure 5.7.3 A). The SM groups 
deposited less calcium than the SM+Dex100 groups regardless of whether they were 
rocked. There were no differences in collagen production between any conditions 
(Figure 5.7.3 B). The alizarin red staining images confirmed these results with the 
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darkest staining in the rocking SM+Dex100 group (Figure 5.7.3 C) whereas the 
intensities of picro-sirius red staining images not different between conditions (Figure 
5.7.3 D). VEGF secretion by the cells in SM media (during a 48 hours collecting 
period) was higher than in the SM+Dex100 media in both the rocking and static groups 
(Figure 5.7.4). At the day 28 time point, the static SM group had more secreted VEGF 
more than the others (p<0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.7.2: The effects of OFF to enhance osteogenic differentiation of hESMPs 
culture on PCL electrospun scaffolds under supplemented medium (SM) and SM 
added 100nM of Dex (SM+Dex100). The viability of hESMPs was measured using 
resazurin reduction test after 7, 14, 21, and 28 days. mean±SE, (N=2, n=3), Two-
way ANOVA, Tukey’s multiple comparison test. 
 
SM+Dex100 
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Figure 5.7.3: The effects of OFF to enhance osteogenic differentiation of hESMPs 
culture on PCL electrospun scaffolds under supplemented medium (SM) and SM with 
100nM of Dex (SM+Dex100). Total calcium deposition in hESMPs was measured using 
alizarin red staining assay (A) and total collagen production using picro-sirius red 
staining assay (B) after 28 days. The photoimages show  representative set of alizarin 
red (C) and picro-sirius red staining (D) of hESMPs. mean±SE, (N=2, n=3), *=p<0.05 
comparison between the SM and SM+Dex100 in the same condition, # =p<0.05 
comparison between the rocking and static groups in the same medium, One-way 
ANOVA, Tukey’s multiple comparison test. 
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Figure 5.7.4: The effects of OFF on osteogenic differentiation of hESMPs cultured on 
PCL electrospun scaffolds under supplemented medium (SM) and SM added 100nM of 
Dex (SM+Dex100). VEGF secretion (during a 48 hour collection period) normalised to 
cell viability was measured using VEGF ELISA and resazurin reduction test, 
respectively after 7, 14, 21, and 28 days. mean±SE, (N=1, n=3), *=p<0.05 comparison 
between SM and SM+Dex100 in the same condition, # = p<0.05 comparison between 
rocking and static groups in the same medium, Two-way ANOVA, Tukey’s multiple 
comparison test. 
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5.8: To evaluate the effect of OFF on hBMSCs cultured on PCL electrospun 
scaffolds. 
5.8.1 Methods 
10
5
 cells of hBMSCs (passage numbers between 2 and 3) were used in these 
experiments which were seeded on the PCL scaffold. All cell seeded scaffolds were 
cultured with basal culture media along with the required supplements on day1. The 
samples were divided into 2 groups; SM medium and SM  medium with 10nM of Dex 
(SM+Dex10). The methods were as described for experiment 5.7.  
5.8.2 Results 
The cell viability increased in all conditions (rocking SM, rocking SM+Dex10, static 
SM, and static SM+Dex10 groups) from day 7 to 28 (Figure 5.8.2). The rocking group 
in both the SM and SM+Dex10 media had lower cell proliferation than the static 
groups. There was no difference in cell viability between the SM and SM+Dex10 
groups. Total calcium deposition by the rocking SM+Dex10 group was significantly 
higher compared to the other groups (P<0.05) (Figure 5.8.3 A). The SM groups 
deposited less calcium than the SM+Dex10 groups regardless of whether they were 
rocked. There were no differences in collagen production between any conditions 
(Figure 5.8.3 B). The alizarin red staining images confirmed these results with the 
darkest staining in the rocking SM+Dex10 group (Figure 5.8.3 C) whereas the 
intensities of picro-sirius red staining images were no different between conditions 
(Figure 5.8.3 D). VEGF secretion (during a 48 hours collecting period) by the cells in 
SM+Dex10 media was lower than the SM media in both the rocking and static groups 
with no significant differences (Figure 5.8.4). 
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Figure 5.8.2: The effects of OFF cultured under osteogenic media: supplemented 
media (SM) and SM with 10nM of Dex (SM+Dex10) of three donors of hBMSCs on 
PCL cultured after 7, 14, 21, and 28 days. The viability of hBMSCs was measured 
using resazurin reduction test. mean±SE, (N=3, n=3), Two-way ANOVA, Tukey’s 
multiple comparison test. 
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Figure 5.8.3: The effects of OFF and osteogenic media (SM and SM+Dex10 media) on 
the three donors of hBMSCs on PCL scaffolds cultured after 28 days. Total calcium 
deposition hBMSCs was measured using alizarin red staining assay (A) and total 
collagen production using picro-sirius red staining assay (B). The photoimages showed 
representative sets of alizarin red (C) and picro-sirius red staining (D) of hBMSC cells. 
mean±SE, (N=3, n=3), *=p<0.05 comparison between the SM and SM+Dex10 in the 
same group, # = p<0.05 comparison between the rocking and static groups in the same 
medium, One-way ANOVA, Tukey’s multiple comparison test. 
(B) 
(C) (D) 
(A) 
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Figure 5.8.4: The effects of OFF and osteogenic media (SM and SM+Dex10 media) on 
the three donors of hBMSCs on PCL scaffolds cultured after 7, 14, 21, and 28 days. 
VEGF secretion (during a 48 hours collection period) normalised to cell viability. 
mean±SE, (N=3, n=3), *=p<0.05 comparison between SM and SM+Dex10 in the same 
condition, Two-way ANOVA, Tukey’s multiple comparison test. 
 
* 
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5.9. To incorporate nHA with PCL electrospun scaffolds for bone tissue 
engineering. 
5.9.1. Methods 
 Scaffold preparation 
Various methods have been developed to fabricate calcium phosphate particles with 
poly(-caprolactone) electrospun scaffold (HA-PCL) for bone tissue engineering. This 
study will compare the three different fabrication methods of HA-PCL which have been 
used for bone tissue engineering; group 1: electrospinning (Lao et al., 2011, Fang et al., 
2009), group 2: surface etching using a protocol modified from Choong et al., (2012) 
and Araujo et al., (2008), group 3: the alternate soaking process using a protocol 
modified from Jaiswal et al., (2012) and Taguchi et al., (2001).  
(Group 1) Electrospinning process  
0.35g of nHA with a particle size of no more than 200 nm was added into 31.5 g of 
DCM. The mixture was stirred using a magnetic stirrer for 15 minutes to disperse the 
nHA, followed by adding 3.5g of PCL pellet (80,000 Da) and dissolved at room 
temperature overnight to obtain a well mixed nHA-PCL suspension with a PCL 
concentration of 10wt%. 1wt% HA-PCL was the final concentration of the scaffold. The 
spinning parameter and process was the same as standard PCL (Figure 5.9.1 A). 
(Group 2) Surface etching process.  
The PCL scaffolds were submerged into a 0.1NaOH solution at 37ºC for 1 hour. The 
scaffolds were then removed and washed with dH2O five times. The NaOH-treated PCL 
scaffolds were dipped in 1wt%HA in dH2O overnight. The scaffolds were then removed 
to a new container and left them dry. The HA-PCL was kept in the dry environment to 
be used in this experiment (Figure 5.9.1 B).    
 
CHAPTER FIVE 
203 
 
(Group 3) Alternate soaking process.  
The PCL electrospun scaffold was functionalised on the surface by soaking in two different 
solutions as follows; The electrospun PCL scaffold was first submerged in 0.5M calcium 
chloride solution (CaCl2) in 0.05M Tris-HCL buffered solution at pH 7.4 for 30 minutes at 
37ºC, followed by washing with deionised water (dH2O) repeatedly. The PCL was then 
submerged in 0.3M disodium hydrogen phosphate (Na2HPO4) in the 0.05M Tris-HCL 
buffered solution at pH 9 for 30 minutes at 37ºC, followed by washing with dH2O 
repeatedly. After this step the PCL was left in dH2O for 1 hour at 37ºC and dried for 24 
hours. The HA-PCL was kept in the dry environment prior to use in this experiment 
(Figure 5.9.1 C). 
 
 
 
 
 
 
 
 
 
 
 
  
A. Group1 B.        Group 2 C.        Group 3 
Figure 5.9.1: Schematic of the three different fabrication processes of hydroxyapatite 
incorporation with poly(-caprolactone) electrospun scaffold (HA-PCL) and the SEM 
images of the HA-PCL products in each process. (A) group1: electrospinning, (B) group2: 
surface etching, and (C) group3: alternated soaking process.  
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 Cell preparation 
10
5
 cells of hESMPs in the passage number in the range 6 to 7 were seeded on each type 
of nHA-PCL scaffold (standard PCL, electrospinning HA-PCL, surface etching process, 
and alternative soaking process). All cell seeded scaffolds were cultured with basal 
culture media along with the required supplements on day1. The samples were divided 
into 2 groups; SM medium and SM+Dex100 medium. The scaffold sterilization and cell 
seeding as proceeded as experiment 5.4. Cell viability of hESMPs was measured using 
resazurin reduction test on day 1, 4, and 7 and ALP activity was measured by using 
Alkaline Phosphatase Yellow (pNPP) Liquid Substrate System for ELISA on day 7 (see 
chapter 2).  
5.9.2. Results 
The study characterised the samples from group 3 (alternate soaking process) using XPS 
survey spectra. Ca, P, and O peaks were present (Figure 5.9.2). The spectra analysed the 
chemistry and measured the amount of the chemical components in the samples by 
presenting in the percentage atomic concentration (At%) as shown in the table 5.9.2. 
Carbon (C), silicon (Si), boron (B), and sulphur (S) were impurities found in the sample 
surface in various At% from 0.24-26.79%. The mole fractions of the samples were 
received from percentage atomic concentration (At%) of the Ca and P as acronym 
“Ca/P” to distinguish the calcium phosphate phases. The measured Ca/P in this sample 
is 1.09 indicating that there is dibasic calcium phosphate dehydrate (DCPD or brushite) 
on the scaffold surface (Chusuei et al., 1999, Lu et al., 2000).  
The XRD patterns for the various fabrication methods of HA-PCL scaffolds were 
detected in the 2 = 20 to 45 region (Figure 5.9.3). Standard PCL can be detected by 
specific XRD peaks at 2 =21.5º and 23.8º  indicated by the black arrows (Rezaei and 
Mohammadi, 2012). The HA and brushite patterns were matched with the database in 
the STOE STADI P diffractometer software (blue and red arrows, respectively). The 
CHAPTER FIVE 
205 
 
peaks for the alternative soaking process scaffolds corresponded to standard PCL, HA, 
and brushite, indicating that the brushite and HA components were on the scaffold. The 
XRD analysis of the electrospun HA-PCL scaffolds (group 1) indicated that the HA 
deposited in the scaffold and showed peaks corresponding to HA-PCL which had not 
change its chemical composition during the process.  
The cell viability of hESMPs on HA-PCL scaffolds fabricated by the three methods and 
cultured in the SM or SM+Dex100 media was assayed using resazurin reduction tests to 
evaluate cell attachment on day 1 and cell viability on days 4 and 7 (Figure 5.9.4). The 
result showed that the cell viability for group 3 was lower than the other groups in both 
the SM and SM+Dex100 media on day 1. This implies that the cell attachment was the 
lowest on alternate soaked scaffolds. The cell viability for group 3 decreased after 4 and 
7 days indicating that the cells must have died or detached from the scaffolds. Whereas 
the cell viabilities for the other groups (standard PCL, and group 1 and 2) increased 
overtime for 7 days. The cell viability for group 1 under the SM+Dex100 medium was 
higher than the other groups over time, indicating that group 1 supported the highest cell 
proliferation, compared to the other groups. The cells cultured under SM medium 
exhibited lower ALP activities at all conditions by day 7 (Figure 5.9.5). The group 3 
cells under SM+Dex100 medium had a significantly lower ALP activity compared to 
the other groups (p<0.05).  
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Figure 5.9.2:  XPS survey spectrum of the HA-PCL samples from alternate soaking 
process (group 3). (N=1, n=2) 
Table 5.9.2: Chemical components, spectral line, binding energy and percentage atomic 
concentration (At%) of the sample in group 3 (alternate soaking process).  
Chemical 
components 
Spectral line Binding energy 
(eV) 
At% 
O 1s 531 31.06 
Ca 2p3/2 347 11.18 
C 1s 285 26.79 
Si 2s 152 0.51 
B 1s 190 20.01 
S 2p3/2 169 0.24 
P 2p3/2 133 10.2 
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Figure 5.9.3: X-ray diffraction (XRD) patterns of the different HA fabrication techniques 
(alternate soaking: black line, electrospinning: red line, and standard PCL: green line). 
The red, blue, and black arrows present the identification of dibasic calcium phosphate 
dehydrate (DCPD, brushite), HA, and PCL, respectively. (N=1, n=3).  
Alternate soaking  
Electrospinning  
Standard PCL 
Figure 5.9.4: Comparison of the effect of three different fabrication techniques for 
hydroxyapatite poly(-caprolactone) electrospun scaffolds (HA-PCL) and standard 
PCL as a control. hESMPs seeded on HA-PCL scaffolds cultured under osteogenic 
media: supplemented medium (SM) and SM with 100nM of Dex (SM+Dex100) after 1, 
4, and 7 days. The cell viabilities of hESMPs cultured on the scaffolds were measured 
using resazurin reduction test. mean±SE, (N=1, n=3), *=p<0.05 compare between the 
soaking with the other groups, Two-way ANOVA, Tukey’s multiple comparison test.  
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Figure 5.9.5: Comparison of the effect of four different HA-PCL fabrication 
processes (Standard PCL and group 1 to 3). hESMPs seeded on the HA-PCL 
scaffolds cultured under the SM and SM+Dex100 media. ALP activity normalised 
to DNA was measured after 7 days. mean±SE, (N=1, n=3), * = p<0.05 
comparison between the group 3 and the other groups within the SM+Dex100 
medium, # = p<0.05 comparison between the group 1 and the other groups within 
the SM medium, Two-way ANOVA, Tukey’s multiple comparison test. 
CHAPTER FIVE 
209 
 
5.10: To select an appropriate concentration of nHA incorporated with PCL 
electropun scaffold for enhancing osteogenic differentiation of hESMPs 
5.10.1. Methods 
 Preparation of HA-PCL scaffolds 
A pre-determined amount of the nHA powder for which the particle size was no more 
than 200 nm was added into 31.5 g of DCM. The mixture was stirred using a magnetic 
stirrer for 15 minutes to disperse the nHA, followed by adding 3.5g of PCL pellet 
(80,000 Da) and dissolving at room temperature overnight to obtain a well mixed nHA 
and 10wt% PCL suspension. The following is tabulated list of all the conditions for 
producing electrospun scaffolds in this study (table 5.10.1).   
 
 
 
 
 
   
 
 Characterization of HA-PCL scaffolds 
The surface morphologies and fibre diameters of the HA-PCL scaffolds were observed from 
SEM images using ImageJ software. The compositions of scaffolds were determined by 
using FTIR and XRD analysis. The mechanical properties of the scaffolds were measured 
using the uni-directional tensile testing. The porosity of the scaffolds was determined by 
using micro-CT (Skyscan). The process, briefly, was that the scaffolds were scanned with 
Table 5.10.1: Complete list of components and experiment parameters for electrospinning 
of PCL and HA-PCL scaffolds. PCL is Poly(-caprolactone), DCM is dichloromethane, 
nHA is nano particle hydroxyapatite. A rotating collector was used in all conditions.  
 
nHA PCL 
(wt%) 
Solvent 
system 
Flow rate 
(µL/minute) 
Voltage 
(kV) 
Working 
distance 
(cm) 
Collector 
speed 
(rpm) 
Figure 
wt% g 
0 0 10 DCM 40 17 17 300 5.10.2A 
1 0.35 10 DCM 40 17 17 300 5.10.2B 
5 1.75 10 DCM 40 17 17 300 5.10.2C 
10 3.50 10 DCM 40 17 17 300 5.10.2D 
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micro-CT and analysed using CTanalyzer software package. The scaffold porosity was 
estimated from the empty space of the scaffold. The ROI volume of the scaffold was 
subtracted to obtain the empty space. Dividing the empty space volume by the ROI volume 
gives the volumetric porosity of the scaffolds.      
 Cell culture 
10
5
 cells of hESMPs were cultured on the four different concentrations of nano-
hydroxyapatite polycaprolactone electrospun scaffolds (HA-PCL); 1] standard PCL, 2] 
1%HA-PCL: 1wt%HA incorporating 10wt%PCL, 3] 5%HA-PCL: 5wt%HA 
incorporating 10wt%PCL, and 4] 10%HA-PCL: 10wt%HA incorporating 10wt%PCL. 
The scaffold sterilization and cell seeding as proceeded as experiment 5.4. The cell 
attachments and cell viabilities were assayed using resazurin reduction tests by day 1, 4, 
7, 10, and 14. The osteogenic differentiation potential was evaluated using ALP activity 
after 7 and 14 days.    
5.10.2 Results 
The morphology and fibre diameter of the HA-PCL scaffolds was observed by SEM 
(Figure 5.10.2). The electrospun scaffolds were successfully fabricated without any 
bead formation in all ranges of compositions (Figure 5.10.2). The average fibre 
diameter of standard PCL was 2.682 µm (Figure 5.10.2 A,E). PCL had a smaller 
average fibre diameter and more uniform fibre diameter distribution than the other 
groups (Table 5.10.2). The average fibre diameter of 10%HA-PCL was 3.012 µm 
(Figure 5.10.2 D,H). It was bigger in fibre diameter than the other groups with a broader 
fibre diameter distribution. Both standard PCL and HA-PCL scaffolds contained a mix 
of micro- and nano-fibres. In standard PCL and 1%HA-PCL, fibre diameters of less 
than 1µm (nano-fibres) were less frequent or about 1% (Figure 5.10.2 E,F, 
respectively). In the 5% and 10%HA-PCL, the more frequent fibre diameter of nano-
fibres were about 5% and 7% (Figure 5.10.2 G,H), respectively. The standard PCL had 
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the highest porosity and porosity decreased with increasing percentage of HA in the 
PCL (Figure 5.10.3 C, Table 5.10.2).  
All HA-PCL scaffolds were stretched in unidirectional tension to generate stress/strain 
curves (Figure 5.10.4) to calculate their Young‟s modulus and Yield strength. The 
Young‟s modulus of the standard PCL was higher than the other groups. Whereas 
Young‟s modulus was lower in the HA groups and 5%HA-PCL had the lowest Young‟s 
modulus (Figure 5.10.3 A). The Yield strength was also lower in the HA groups in a 
similar pattern to Young‟s modulus results (Figure 5.10.3 B, Table 5.10.2).  
The FTIR spectra of the various percentages of HA-PCL, standard PCL, and nHA 
powder (before electrospinning) provide details of the presence of the functional groups 
in the fibres to detect any possible chemical phase interaction or modification in the 480-
3850 cm
-1
 region (Figure 5.10.5). The typical FTIR bands of standard PCL are observed: 
the methylene group (CH2) stretching region was present as two bands, centre at 2945.2 
cm
-1
 which was assigned to the asymmetric CH2 stretching: green arrow and 2865.6 cm
-1
 
which was assigned to the symmetric CH2 stretching: green arrow. The peak at 1731.1 cm
-1
 
was assigned to the ester carbonyl stretching (C=O): pink arrow. The FTIR spectra 
bands of nHA are observed: the phosphate group presented as two bands, centre at 
574.2 and 1056 cm
-1
 (black arrows). The peak at 3569 cm
-1
 is assigned to the hydroxyl 
group (blue arrow). FTIR spectra of all various percentages of HA-PCL exhibited the 
strong absorbance band of PCL at 1731, 2945.2, and 2865.6 cm
-1 
while the strong 
absorbance band of nHA at 574.2, 1056 and 3569 cm
-1
.
 
The assignments of FTIR absorbance 
bands are tabulated in 5.10.3.  
The XRD patterns of the various compositions of HA-PCL were detected in the 2 = 20 
to 45 region (Figure 5.10.6). PCL can be detected by specific XRD peaks at2 =21.5º 
and 23.8º  indicating by black arrows (Rezaei and Mohammadi, 2012). The HA patterns 
were matched with the database in the STOE STADI P diffractometer software (red 
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arrows). Peaks corresponding to both of HA and PCL were observed in the HA-PCL 
scaffolds indicating that the nHA was exposed in the electropun PCL scaffolds. The 
intensities of HA peaks increased with the increasing in the percentage of HA. Both 
FTIR spectra and XRD patterns in the 1wt%, 5wt%, and 10wt% HA-PCL scaffolds did 
not show a new band on both results indicating that there was not a new chemical 
component. Both FTIR spectra and XRD patterns of HA-PCL could be superimposed 
on the pure PCL and nHA traces. The relevant peak intensities may change depending 
on the concentration of HA in the compositions. 
Cell viability using resazurin reduction test was used to evaluate cell attachment of 
hESMPs on scaffolds with various concentrations of HA on day 1 (Figure 5.10.7) and 
determine cell proliferation after day 4, 7, 10, and 14 (Figure 5.10.8). The results 
showed that the cell viabilities were not significantly different between all groups after 
1 day, indicating that there were no differences in cell attachment. The cell viability of 
hESMPs on all HA-PCL scaffolds increased overtime from day 1 to 14, notably, the 
standard PCL groups had lower cell viability than the other groups in both the SM and 
SM+Dex100 media by day 14. This implies that the standard PCL groups supported cell 
proliferation less well than the other groups. Cells cultured under the SM medium had 
lower ALP activity than SM+Dex100 on day 14 (control) (Figure 5.10.9). The ALP 
activity of the 5%HA-PCL was highest whereas the 10%HA-PCL was significantly 
lower than the other groups (p<0.05). The results indicated that 5%HA-PCL can 
stimulate cells to osteogenic differentiation more than the other scaffolds.      
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Figure 5.10.2: SEM images showed fibrous morphology of various percentages of nHA 
incorporated with 10wt% PCL dissolved in DCM (10wt% PCL) on the left column. The 
histogram shows fibre diameter distribution on the right column. (A,E):standard PCL, 
(B,F):1%HA-PCL, (C,G):5%HA-PCL, and (D,H):10%HA-PCL. Fibre diameter 
distributions are for 100 measured fibres (N=1, n=100).  
(G) 
(H) 
(C) 
(D) 
(A) 
(B) 
(E) 
(F) 
Standard PCL 
Fibre diameter (µm) 
Fibre diameter (µm) 
Fibre diameter (µm) 
Fibre diameter (µm) 
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Figure 5.10.3: (A) Young’s modulus, (B) Yield strength, and (C) percentage of porosity 
of various concentrations of nHA-PCL electrospun scaffolds (standard PCL as ‘PCL’), 
1%, 5%, and 10%HA-PCL). mean ± SE, (N=1, n=3), *= p<0.05 comparison between 
the 5%HA-PCL and the other groups, = p<0.05 comparison between PCL and 
10%HA-PCL, α = PCL group was significantly higher than the others (p<0.05), # = 
10%HA-PCL group was the significantly higher than the others (p<0.05), One-way 
ANOVA, Tukey’s multiple comparison test. 
 
α 
# 
(C) 
(A) (B) 
 
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Figure 5.10.4: Stress-strain curves of various percentages of HA incorporated with 
PCL electrospun scaffolds: All percentages of HA incorporate with PCL: standard 
PCL (black line), 1%HA-PCL (red line), 5%HA-PCL (green line), and 10%HA-PCL 
(purple line). Scaffolds were cut into 20mm by 5mm and uni-tensile stretched at 
0.1mm/sec to 100% strain. (N=1, n=3). 
 
Standard-PCL 
1%HA-PCL 
10%HA-PCL 
5%HA-PCL 
 
Conditions Fibre diameter 
(µm) 
Young’s 
modulus 
MPa 
Yield strength 
 
%Porosity 
Standard PCL 2.682±0.129 3.027±0.600 0.392±0.068 86.79±0.475 
1%HA-PCL 2.609±0.153 2.423±0.490 0.332±0.026 75.51±2.392 
5%HA-PCL 2.734±0.173 0.630±0.094 0.104±0.015 73.21±1.707 
10%HA-PCL 3.012±0.239 1.727±0.313 0.206±0.011 53.48±1.935 
 
Table 5.10.2: Physical and mechanical properties of the various HA-PCL electrospun 
scaffolds. mean±SE, (N=1, n=3). 
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2945.2, 
2865.6 cm
-1
 
3569 cm
-1
 
1731.1 cm
-1
 
1056 cm
-1
 
574.2 cm
-1
 
Figure 5.10.5 : Photoacoutic amplitude spectra in the length between 480-3850 cm
-1
 
of the various percentages of HA-PCL (standard PCL, 1%, 5%, and 10% HA-PCL 
groups) and nHA powder. At 2945.2cm
-1
 represent to CH2 stretching (green arrows), 
at 2865.6cm
-1
 represent to symmetric CH2 stretching (green arrow), at 1731.1cm
-1
 
represent to carbonyl stretching (pink arrow), at 574.2 and 1056 cm
-1
 represent to 
phosphate group (black arrow), and at 3569 cm
-1
 represent to hydroxyl group (blue 
arrow). (N=1, n=3). 
Standard 
PCL 
 
Stretching modes FTIR spectral band (cm
-1
) References 
PCL 
CH2 (asymmetric stretching) 
CH2 (symmetric stretching) 
C=O (carbonyl stretching) 
 
2945.2 
2865.6 
1731.1 
(Doustgani et al., 2012) 
HA 
PO4
-3 
(Phosphate group) 
-OH (hydroxyl group) 
 
574.2 and 1056 
3569 
(Doustgani et al., 2012, 
Rehman and Bonfield, 
1997) 
 
Table 5.10.3: Observed infrared band positions from the nHA powder, and the various 
concentrations of HA-PCL electrospun scaffolds: standard PCL, 1%, 5%, and 10% by 
weight.  
 
CHAPTER FIVE 
217 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.10.6: X-ray diffraction (XRD) pattern of the various concentrations of 
HA-PCL electrospun scaffolds. The red arrows referred to HA and the black 
arrows referred to PCL. The red arrows indicate that HA is clearly present in all 
scaffolds (1%, 5%, and 10% HA-PCL groups) except the standard PCL scaffolds. 
(N=1, n=3)  
Standard PCL 
Figure 5.10.7: The effect of various concentrations of HA in PCL scaffolds on their 
ability to support hESMPs- (standard PCL, 1%, 5%, and 10% HA-PCL groups) 
cultured under basal culture medium α-MEM after 24 hour cell seeding. The cell 
viabilities of hESMPs cultured on the scaffolds were measured using resazurin 
reduction test to indicate cell attachment. mean±SE, (N=2, n=3), Two-way ANOVA, 
Tukey’s multiple comparison test).  
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Figure 5.10.8: The effect of various concentration of HA-PCL (standard PCL, 1%, 5%, 
and 10% HA-PCL groups) cultured under osteogenic media: supplemented media (SM) 
and supplemented media with 100nMDex (SM+Dex100) of hESMPs after 1, 4, 7, 10, and 
14 days. The cell viabilities of hESMPs cultured on the scaffolds were measured using 
resazurin reduction test. mean±SE, (N=2, n=3), * =p<0.05 comparison between standard 
PCL and 10%HA-PCL groups within the SM medium , # =p<0.05 comparison between 
standard PCL in the SM medium and 10%HA-PCL in the SM+Dex100 medium, Two-way 
ANOVA, Tukey’s multiple comparison test.  
 
# 
* 
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Figure 5.10.9: The effect of various concentrations of HA-PCL (standard PCL, 1%, 
5%, and 10% HA-PCL groups) cultured under osteogenic media (the SM and 
SM+Dex100 groups) of hESMPs after 7 and 14 days. The bar graph showed ALP 
activity per DNA normalized to the results of the standard PCL under SM+Dex100 
groupon day 14. mean±SE, (N=2, n=3), * =p<0.05 comparison between the standard 
PCL and the 5%HA-PCL groups, #=p<0.05 comparison between the 10%HA-PCL and 
the other groups in the SM+Dex100 medium, Two-way ANOVA, Tukey’s multiple 
comparison test. 
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5.11: To evaluate the effect of oscillatory fluid shear stress and nHA PCL 
electrospun scaffold for enhancing osteogenic differentiation of hESMPs 
5.11.1 Methods 
 Cell culture 
10
5
 cells of hESMPs were seeded on either electrospun PCL or 5wt%HA-PCL scaffolds 
under the SM and SM+Dex100 media. Half of them were subjected to rocking using a 
standard see saw rocker and the others were cultured under static condition. The 
experimental method as proceeded as experiment 5.7. Samples were subjected to OFF 
as described for experiment 5.7. Cell viabilities and VEGF secretion were measured at 
the day 7, 14, 21, and 28 time-points using resazurin reduction test, and ELISA, 
respectively. The mineralized deposition was evaluated by using micro-computed 
tomography (micro-CT).   
 Application of micro-computed tomography (micro-CT) to analysis mineralized 
matrix deposition 
Micro-CT was used in this study because the HA-PCL scaffold itself stains with alizarin 
red with high background. It would be difficult to evaluate calcium deposition from 
cells on the HA-PCL scaffolds. The software package for analysing and reconstruction 
3D realistic visualizations were used CTan and CTvol (both from Skyscan), 
respectively.  
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 Region of interest (ROI) 
The region of interest (ROI) was cubic with dimensions of 18 mm in length and 35mm 
in width which covered the entire samples stack chosen for scanning. For measuring 
percentage bone volume (%BV), a cylindrical ROI with a diameter of 1.2 mm (inner 
diameter of metal ring) and height of 390µm (approximate scaffold thickness) was 
chosen. The ROI was sectioned into top, mid, and bottom portions with 130 µm in each 
(Figure 5.11.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Top 
Middle 
Bottom 
1.2mm 
130µm 
Figure 5.11.1: The sectioning of the electrospun scaffold was used to analyse calcium 
deposition (%BV). The cylindrical ROI was diameter 1.2mm. The scaffold was divided 
into 3 layers with 130 µm in each layer: top, middle, and bottom.  
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Figure 5.11.2: A window from CTanalyze software. The grey scale index (GSI) of the 
grey scale distribution (circle red) was used in the threshold ranges of standard PCL 
without cells, 5wt%HA-PCL without cells, and the rocking with SM+Dex100 group 
which showed mineralization from hESMPs on standard PCL scaffolds. (Circled red) 
The grey scale distribution histogram (a GSI: X-axis versus a percentage of brightness 
area: Y-axis) was used for evaluating threshold.   
 Thresholding 
Three samples of standard PCL without cells, 5wt%HA-PCL without cells, and the 
rocking with SM+Dex100 group which showed mineralization from hESMPs on the 
standard PCL scaffolds were analysed with the aid of the CTanalyze software (Figure 
5.11.2) to obtain the grey scale distributions (Figure 5.11.3 A). The mineralized 
deposition in a particular volume of ROI was expressed as %BV.    
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5.11.2 Results 
The grey scale distribution of all samples : standard PCL, HA-PCL, and mineralized 
deposition of hESMPs cultured on PCL scaffolds in the rocking, SM+Dex100 group 
were plotted to evaluate the threshold (Figure 5.11.3 A). The hESMPs cultured on PCL 
scaffolds in the rocking, SM+Dex100 group was chosen because it definitely has 
calcium deposition based on alizarin red staining (experiment 5.7). The first and second 
interception points of three lines were at the GSI 30 and 70, respectively. The threshold 
was set in the range of 30-70 GSI to view the standard PCL, the threshold range above 
than 70 GSI was set to view a mineralized deposition and HA (Figure 5.11.3 B). It was 
possible to measure the scaffolds without any cells (background), subtraction of the 
background was used to determine a mineralized deposition on the samples.  
The cell viability of hESMPs on either standard PCL and HA-PCL scaffolds was 
assayed using resazurin reduction test after 1 day (Figure 5.11.4 A). The cell viability of 
the HA-PCL scaffold was higher than the standard PCL group indicating that the HA-
PCL scaffolds supported higher cell attachment than the standard PCL. The cell 
viability increased in all conditions over-time points for 28 days with no significant 
differences, indicating an increased cell proliferation whether in the standard PCL or 
HA-PCL scaffolds. The static-SM group was significantly higher than the rocking-SM 
group on the standard PCL scaffold (p<0.05). VEGF secretion (during a 48 hour 
collection period) normalized to viable cells increased over-time points for 28 days 
(Figure 5.11.5). The SM groups secreted dramatically higher VEGF than the 
SM+Dex100 groups, as in our previous experiments 5.7 and 5.8. However, there was no 
effect either of HA in the scaffold or rocking, confirming our previous rocking data. The 
%BV indicated that there was mineralized deposition in the standard PCL after 28 days 
(Figure 5.11.6 A). The rocking SM+Dex100 group had significantly higher %BV in the 
top region than the middle and bottom regions within the same group and compared 
with the other groups (p<0.05). The middle region of the rocking SM+Dex100 group 
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had significantly higher %BV than the SM both rocking and static groups, indicating 
that this group has most mineralized deposition in the top and middle levels. This 
difference can be visualised in the three-dimensional (3D) reconstruction micro-CT 
images (Figure 5.11.6 B-K). The top surface of the rocking SM+Dex100 group has 
more yellow area (mineral) than the other groups (Figure 5.11.6 D). A side view image 
of a transverse cut through the scaffold from the rocking SM+Dex100 group shows that 
the top region is more yellow area than the other layers (red arrow head, Figure 5.11.6 I) 
and the top layer of the static-SM+Dex100 group (red arrow head, Figure 5.11.6 K). 
There were no significant differences in %BV of HA-PCL scaffolds between groups 
(rocking SM, rocking SM+Dex100, static SM, and static SM+Dex100) or in distribution 
through the layers (top, middle, and bottom) (Figure 5.11.7 A). Surprisingly, the %BV 
of the rocking SM+Dex100 on the standard PCL scaffold was higher than the rocking 
SM+Dex100 on the HA-PCL scaffold. The total %BV of the HA-PCL group was higher 
than the standard PCL group in all conditions except the standard PCL scaffolds were 
higher than the HA-PCL scaffold in the rocking SM+Dex100 group, indicating that the 
HA-PCL can enhance mineral deposition of hESMPs (Figure 5.11.8). In addition OFF 
also enhance mineralized deposition on standard PCL under Dex containing medium.  
The SEM images of hESMPs seeded on the standard PCL scaffolds after 28 days 
showed that the cells were well adhered and spread on the surface and underneath of the 
scaffolds (Figure 5.11.9). The rocking SM+Dex100 group showed the more round 
particles on the ECM than the static SM+Dex100 group (Figure 5.11.9 C, E, 
respectively). These results indicate that the presence of OFF and Dex lead to enhance 
mineralized deposition confirming the previous results. The SEM images of HA-PCL 
also showed round particles on both ECM and fibres at all conditions, however, the 
rocking SM group showed fewer round particles than the others (Figure 5.11.10 B).  
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Figure 5.11.3: (A) The grey scale distribution showed the relationship between a grey 
scale index (GSI) and percentage of brightness area and (B) threshold range table of 
standard PCL, HA-PCL, and the rocking with SM+Dex100 group of hESMPs which 
showed calcium deposition on the scaffolds. The orange square from 30-70 GSI served 
to identify standard PCL scaffold. The purple square from 70-125 GSI served to 
identify calcium deposition and HA. (N=1, n=3) 
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Figure 5.11.4: (A) The effect of OFF with the hESMPs cultured on standard PCL and 
HA-PCL scaffolds assayed by using resazurin reduction test on day 1 to evaluate cell 
attachment. (B) To evaluate cell viability of the cells seeded on the scaffolds under the 
supplemented media (SM) and supplemented media with 100nM of Dex (SM+Dex100) 
were subjected to OFF after day 7, 14, 21, and 28. mean±SE, (N=2, n=3), # = p<0.05 
comparison between the rocking and static under the SM medium in the same scaffold, 
Two-way ANOVA, Tukey’s multiple comparison tests).     
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Figure 5.11.5: The effects of OFF with the hESMPs cultured on standard PCL and 
HA-PCL scaffolds under the SM and SM+Dex100 media by day 7, 14, 21, and 28. 
VEGF secretion (duration a 48 hour collection period) normalised to cell viability 
which measured using VEGF ELISA and resazurin reduction test, respectively. 
mean±SE, (N=2, n=3),* = p<0.05 comparison between SM and SM+Dex100 in the 
same condition and scaffold, Two-way ANOVA, Tukey’s multiple comparison test. 
 
* 
* 
* 
CHAPTER FIVE 
228 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Standard 
PCL(control)   
K 
B C D E F 
H G J
 
I 
hESMPs mineralized deposition 
# 
* 
# 
 
(A) 
Figure 5.11.6: The effects of OFF on hESMPs cultured on standard PCL scaffolds under the osteogenic media (SM and SM+Dex100 media) after 28 days. (A) The %BV 
with subtraction of standard PCL scaffolds measured using micro-CT analyser. mean ±SE, (N=2, n=3), # = p<0.05 comparison between SM and SM+Dex100at the 
same level and condition, * = p<0.05 the top level is higher than the other levels in the same group,  = p<0.05 comparison between the rocking and static conditions in 
the same level and medium, Two-way ANOVA, Tukey’s multiple comparison test).  
Microcomputed tomograph images of calcium deposition (orange area) in the scaffolds within the cylindrical region of interest. The upper row images show the top 
surface of the scaffolds (B-F) and lower row images showed the side view of half cut scaffolds (G-K). (I) The top level of the rocking-SM+Dex100 group contained more 
calcium than (K) the static-SMDex100 group (red arrow heads).   
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Figure 5.11.7: The effects of OFF on hESMPs cultured on HA-PCL scaffolds under osteogenic media (SM and SM+Dex100 media) after 28 days. (A) The %BV with 
subtraction of the nHA particles of the HA-PCL scaffolds measured using micro-CT analyser. mean ±SE, (N=2, n=3), p<0.05, Two-way ANOVA, Tukey’s multiple 
comparison test.  
Microcomputed tomograph images of calcium deposition (orange area) in the scaffolds within the cylindrical region of interest. The upper row images show the top 
surface of the scaffolds (B-F) and lower row images showed the side view of half cut scaffolds (G-K).   
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Figure 5.11.8: The effects of OFF on hESMPs cultured on both standard PCL and HA-PCL scaffolds under the osteogenic media (SM and SM+Dex100 
media) after 28 days. (A) The %BV of standard and HA-PCL scaffolds presented the mineralized deposition on the scaffolds using micro-CTanalyser. 
mean ± SE, (N=2, n=3), * = p<0.05 comparison between the standard PCL and HA-PCL scaffolds in the same medium and conditions, # = p<0.05 
comparison between rocking and static groups in the same medium and scaffold, Two-way ANOVA, Tukey’s multiple comparison test.  
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Figure 5.11.9: The SEM images of the hESMPs cultured on standard PCL scaffolds under the osteogenic media (SM and SM+Dex100 media) and 
subjected to OFF after 28 days. (C) The rocking group under the SM+Dex100 medium showed more white round particles (the red arrow heads) which 
indicated calcium nodules than the other groups. Scale bar = 20µm  
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Figure 5.11.10: The SEM images of the hESMPs cultured on HA-PCL scaffolds under the osteogenic media (SM and SM+Dex100 media) and subjected 
to OFF after 28 days. The red arrow heads point to calcium depositions. Scale bar = 20µm  
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5.12 Discussion  
Bone tissue engineering aims to provide a biocompatible material capable of 
substituting autologous bone grafts for surgical reconstruction. The requirements of 
biodegradable polymer scaffolds are the mechanical strength and biological properties 
similar to native ECM for stimulating cell behaviour as a temporary ECM until 
regeneration occurs. The interaction from both the temporary ECM and the environment 
influence the cell behaviour by direct and indirect signalling.  
The main aims of this study were to fabricate electrospun scaffolds for the bone part of 
a cleft palate reconstruction which would allow normal facial development. In order to 
do this first, I selected biodegradable polymer electrospun scaffolds were fabricated 
using FDA approved polymers such as PLA, PCL, and PHBV. Depending on the 
polymer type, the range of fibre diameter distribution was different. The results showed 
that both electrospun PLA and PCL micro fibre scaffolds were successfully fabricated 
with smooth fibre morphology without bead formation. PCL fibrous morphology was 
more uniform than for PLA scaffolds. In contrast, the PHBV electrospun scaffolds 
exhibited nano-fibres with a number of bead formations. These defects usually depend 
on the viscosity and surface tension of the polymer solution while spinning (Spasova et 
al., 2006). The bead formation is usually considered to be a defect in electrospun 
scaffolds. It decreases the ratio between surface area and volume of the scaffold, as a 
result, provides less surface for cell attachment and leads to reduce proliferation rate 
(Chen et al., 2007), indicating that a uniform fibre of electrospun scaffold is required for 
tissue engineering. We need a better understanding of this technique to improve 
fabrication in the PHBV scaffolds.  
A limitation of this study is that in many cases only 2 experiments were performed in 
triplicate, however, some interesting differences were identified were found to be 
significant as follows. In these studies we used hESMPs as a cell model to detect cell 
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attachment and viability. Results of the cell seeded PCL and PLA groups showed good 
support for cell attachment, whereas, PHBV groups showed less cell attachment. This is 
in contrast to the good attachment of fibroblasts seen by my colleague (Bye et al., 
2013). In the literature (Baek et al., 2012), PHBV was described as being supportive of 
the attachment of a mouse osteoblastic cell line but it has never been used for hESMPs. 
Discrepancy between this result and others may reflect the difficulty of handling PHBV. 
The cell viability in this experiment was detected while metal rings were placed on the 
samples, but these might limit the reaction between the resazurin salt solution and cells 
underneath the metal rings. The metal ring was removed for the cell viability method for 
subsequent experiments. The PHBV scaffold could be modified to increase cell 
attachment and proliferation to facilitate osteogenic differentiation. Firstly, the PHBV 
could overcome the bead formation which has a major effect on cell behaviour, for 
example adding methanol to increase permittivity of the polymer solution (Zuo et al., 
2005). Moreover, various surface treatments could be used to modify the PHBV; 1] 
chemical modification: plasma polymerization or plasma spray, 2] coating materials: 
collagen, fibronectin and laminin (Cooke et al., 2008), 3] Incorporation of bioactive 
glass in to the scaffold (Levy et al., 2007) in order to enhance biocompatibility and 
osteogenic differentiation. However for my purposes, PCL and PLA were more likely 
candidate electrospun scaffolds so the PHBV was not continue working, and the ability 
of PCL and PLA scaffolds to support osteoprogenitor cells was investigated. 
PLA and PCL scaffolds were selected to compare their ability to support osteogenesis 
of both groups of periosteal cells used in the previous chapter (see chapter 3 and 4) with 
the SM and SM+Dex10 media. PCL and PLA fibrous scaffolds were not significantly 
different in their ability to support HJPs and facilitate osteogenic differentiation. This is 
in contrast to a previous study in rat bone marrow cells, which found that the cell 
attachment and cell proliferation on PLA was higher than on PCL scaffolds (Conconi et 
al., 2009). PLA is an aliphatic polyester similar to PCL, however PLA has a different 
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chemical structure in the same molecular formula (isomer) (P-D-LA, P-L-LA, and P-
DL-LA) and this lead to their different properties such as biodegradation and melting 
points. Although, PLA showed greater biocompatibility in other studies (Teresa et al., 
2009), there are concerns about the effect of their degradation products in vivo, lactic 
acid, and they collapse and are difficult to handle when they are wet (Bye et al., 2013). 
This may affect cell growth when PLA scaffolds are used in long-term devices and 
cause difficulties for the surgeon when placing such a scaffold in the body. Whereas 
PCL has only one chemical structure, it may be less variable in material properties. 
From the fabrication point of view, PCL is a more straightforward polymer to blend 
with a wide range of bioactive materials due to its low melting temperature. The use of 
PCL scaffolds has been increases in tissue engineering research over last decade and 
they are clinically used in suture materials (Monocryl®, Ethicon, UK) and drug delivery 
devices under FDA approval (Cipitria et al., 2011). Therefore PCL was chosen to 
support human osteoprogenitor cells for cell proliferation and differentiation to 
osteoblast-like cells in the remaining experiments. HJPs are the good cell sources for 
future study, unfortunately, we lacked cell supply for further experiments. Schmelzeisen 
et al.,(2003), Schimming and Schmelzeisen, (2004) two clinical studies found HJPs 
could produce bone on the 3D scaffolds as a combination polymer of polyglactin and 
poly-p-dioxanone (Ethisorb, Ethicon, Germany) for maxillary augmentation and dental 
implant replacement afterward in majority of cases. Additionally, Ryu et al., (2011) in 
vitro study showed HJPs could mineralized on collagen scaffolds. Their studies showed 
results consistent with our study is that HJPs required 10nM of Dex for mineralization. 
It was confirmed that hESMPs, hBMSCs, and HJPs show similar results on both 
monolayer and 3D cultures is that they required Dex for osteogenic differentiation. 
Therefore, hESMPs and hBMSCs were used as model osteogenic cells. 
PCL electrospun scaffolds were chosen for this study to evaluate cell supporting and 
osteogenic differentiation on hESMPs in long term culture for 28 days. Micro-fibrous PCL 
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scaffolds can mimic the architecture of ECM to enhanced cellular adhesion, proliferation 
and migration (Reed et al., 2009). This study presented that PCL scaffolds can support 
proliferation and osteogenic differentiation of hESMPs which is similar to the results of my 
colleague (Delaine-Smith, 2013). Calcium staining in the PCL scaffolds increased overtime 
at days 21 and 28. Calcium deposition of the SM+Dex100 group was higher than in the SM 
groups on the PCL scaffolds. Collagen staining in the SM+Dex100 groups was not 
difference compared to the SM groups. Therefore Dex was also required to stimulate 
osteoblastic differentiation in 3D culture. 
To the best of our knowledge, no study has used a standard see-saw rocker as a method 
for mechanically stimulating cell culture on electrospun scaffolds. Having measured 
positive effects of the standard see-saw rocker induced OFF on cells in monolayer 
(Delaine-Smith et al., 2012). This technique was decided to investigate that could also 
be a way to further stimulate the osteogenic differentiation of the cells on a 3D scaffold.   
Our study showed that the effect of OFF from a standard see-saw rocker applied to both 
hESMPs and hBMSCs (3 donors) on porous PCL scaffolds (3D culture) under the 
presence of Dex supplemented media caused greater calcium deposition compared to 
the static cultures. The results presented here suggest that the combination of OFF and 
Dex during culture synergistically stimulates the osteogenic differentiation of both 
hESMPs and hBMSCs on PCL scaffolds. The OFF may benefit nutrients and oxygen 
transportation to cells in the scaffolds compared to the static culture (McCoy and 
O'Brien, 2010). For electrospun PCL scaffolds in our study are thin (about 300 µm 
thickness) compared to typical porous scaffold (about 5 mm thickness) 
(Sittichokechaiwut et al., 2010) therefore a nutrient diffusion should be less of an issue. 
But cells should be 150 µm from the nutrient source therefore cells in the centre would 
still have limited diffusion, especially as matrix forms and fills up the pores in longer 
term static cultures. In addition the OFF may enhance osteogenic marker expression 
such as OCN, OPN and mineral deposition by mechanotransduction (see chapter 1). 
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Regardless of the mechanism by which osteogenesis is stimulated it is clear that the use 
of osteoprogenitor cells seeded on the electrospun PCL scaffolds can produce a bone 
matrix structure. The 3D cultured results were parallel to the monolayer culture results 
(see chapter 4) which showed the rocking group under Dex supplemented medium had 
highest calcium deposition.  
PCL was show to be a promising material for bone tissue engineering, however, the 
disadvantages of PCL are not only hydrophobic properties but also no osteoinductive 
potentials. It is well known that a bioactive properties of HA can enhance cell attachment, 
cell proliferation, and osteogenic differentiation (Li et al., 2007, Li et al., 2009). A 
hypothesis of this study is that incorporating HA into electrospun scaffold could enables 
accelerated osteogenesis compared to a polymer scaffold alone. Moreover, HA has been 
shown to improve compressive mechanical properties in other scaffolds (Chim et al., 2006). 
nHA incorporated with PCL scaffold (HA-PCL) was created to overcome the 
limitations of the standard electrospun PCL scaffolds for bone tissue engineering. The 
result of this study showed that the nHA incorporated with PCL using electrospinning 
technique was the best technique to create a composite HA-PCL scaffold with the best 
biocompatibility and to the ability to support osteogenic differentiation, compared to the 
etching or alternate soaking techniques. The electrospun HA-PCL showed reducing 
tensile mechanical properties with increasing percentage of HA. This result is consistent 
with some other studies, which have reported the reduction of tensile mechanical 
properties in the composite electrospun HA-PCL may reflect from the amount of HA 
loading, bad dispersion of nHA may cause insufficient interphasic mechanical interlock 
between the nHA and PCL (Zhang et al., 2010, Deb et al., 1996). Frohbergh et al., 
(2012) reported that the mechanical strength was not reduced if nHA is dispersed on or 
near the surface on the fibres. Therefore the alternate soaking technique was included in 
this study because it had previously been shown to improve the mechanical property of 
materials by coating on the surface of fibres (Jaiswal et al., 2012). In contrast, our 
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studies showed that this technique reduced their biocompatibility. The possible reasons 
for this could be an impurity of chemical components or a too high concentration of 
calcium phosphate particles on the processed scaffold.  
XPS and XRD showed that other components excluding calcium and phosphate such as 
Boron, Silicon, and sulphur may form from the alternate soaking solution. In addition 
the XRD result showed that the alternate soaking process formed brushite (DCPD) on 
the fibre surfaces. Brushite was a more soluble than the nHA, therefore concentration of 
free calcium and phosphate ions in culture media may change and influence the cellular 
behaviour by reducing cell viability and osteogenic differentiation (Klammert et al., 
2009). The etching technique used an aqueous hydroxide (0.1 M of NaOH) to improve 
the adhesive strength between the PCL and nHA by hydrolysing ester bond (R-COOR) 
of standard PCL to produce carboxylate group (R-COO
-
) on the surface, R referring to 
the rest of the molecule (Choong et al., 2012). The carboxylate group attracts calcium 
ions of the nHA and anchors them on the fibre surface (Oyane et al., 2005). Although 
this technique worked to a certain extent cell viability and osteogenic differentiation 
were not as good as with the electrospinning technique which showed a higher 
biocompatibility and allowed cells to undergo osteogenic differentiation under Dex 
supplementation media. 
Having established that electrospinning was the best method of incorporating HA into 
the electrospun scaffold further work was undertaken to select the best concentration of 
HA for cell growth and differentiation. Different concentrations of HA-PCL solutions 
were spun using the same parameters as the PCL solution. HA-PCL electrospun 
scaffolds were successfully fabricated with no bead formation on the fibres. The 
average fibre diameter increased with increasing in the percentage of HA. The 
increasing percentage of HA can lead to higher concentration of solution and can 
restrict movement in the jet extruded from the metal needle and make it more difficult 
to eject the polymer solution. Although the nHA has no effect on the electrical 
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conductivity of the solution (Zargarian and Haddadi-Asl, 2010, Fridrikh et al., 2003). 
Fibre diameter distributions were more spread with increasing percentage of HA 
according to the unstable phase (whipping movement) of the polymer jet. The resulting 
mixture of nano and micro sized fibres is more similar to the natural ECM and may 
provide a more suitable environment for cell adhesion, proliferation, migration and 
differentiation (Borjigin et al., 2012, Vasita and Katti, 2006). However increasing the 
concentration of HA in HA-PCL scaffolds lead to lower Young‟s modulus (stiffness) 
and yield strength. It would be implied that the standard PCL electrospun scaffold has 
more stiffness and rigidity than the HA-PCL and the lowest mechanical property was 
the 5%HA-PCL. The high amount of HA can decrease a tensile property of the bio-
composite material attribute to disrupt the stable of polymer formation and the 
intermediate adhesion between nHA and polymer was a very weak (Yang et al., 2008, 
Zhang et al., 2010). In addition, this may because of incomplete nHA dispersion along 
the fibres leading to tension distribution (Zargarian and Haddadi-Asl, 2010). 
Interestingly we have contrasting results in our group, where my colleague found that 
the composite electrospun PU either µHA or nHA scaffold improved tensile mechanical 
properties, Young‟s modulus and yield strength, compared to standard electrospun PU 
scaffold, this work is submission for publication (Tetteh et al., 2014). This indicates that 
the effect of HA can vary in different types of polymer, for instance PU is a much more 
elastic polymer than PCL. Moreover, their porosity and fibre size will also affect the 
scaffold mechanical properties and these were quite different for PU versus PCL. 
Ultimately for cleft palate repair we do not yet know what the ideal mechanical property 
would be. It would be the combination between flexibility, hand able and strength 
which extendable and does not break. Therefore, it may not necessary be the one with 
the highest Young‟s modulus and yield strength.   
Estimating the porosity of the scaffolds by using micro-CT has many advantages. It is a 
non-destructive method requiring minimal sample preparation. The 3D morphology of 
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the scaffold can be visualized (Tuan and Hutmacher, 2005) enabling examination of the 
internal part of the scaffold. We compared the porosity measurements of standard PCL 
scaffold between gravitational porosity method (conventional method, see experiment 
5.2) and using micro-CT. Both methods showed a similar porosity for the standard PCL 
scaffolds. The results showed that they were no differences in the porosity percentage 
from those methods, about 86%. Our results showed that the increase in HA 
concentration created less porous scaffolds. The nano-sized fibres accommodated in 
between the micro fibrous pore spaces lead to a decreased porosity of the scaffold. The 
high porosity is also crucial factor to enhance cells to migrate, attach, and access of cell 
culture media and removal of waste (Karageorgiou and Kaplan, 2005, Miao et al., 
2008). The results of PAS-FTIR and XRD techniques confirmed the presence of nHA 
on the HA-PCL surface. The XRD technique detected HA on the fibre surface 
indicating that the nHA was exposed and had access to serum proteins and cells. None 
of the HA-PCL scaffolds had any new peaks compared to the standard PCL scaffold and 
nHA, indicating that there were no chemical interactions between the materials. The 
increase in intensities for the HA peak corresponded to the HA concentration in the 
scaffold. hESMPs were used for evaluating the suitable concentration of HA in the PCL 
scaffolds as model cell to evaluate cell attachment, cell viability, and osteogenic 
differentiation. They were no differences in cells attachment and cell viability which 
indicated similar cell proliferations between the various percentages of HA after day 1 
and 14, respectively. Our results are similar to Kim et al, (2006b) who found that the 
MG63 (human osteosarcoma cell line) cultured on 12.5wt% HA in the PLA electrospun 
scaffolds improved cell attachment after day 1 however, the cell viabilities of the HA-
PLA group was no different compared to the standard PLA fibre after day 28. ALP 
activity is an early marker to evaluate the bone forming potential of the cells. Our study 
showed that the cells with the highest ALP activity were 5wt % HA-PCL whereas the 
least ALP activity was 10wt%HA-PCL under osteogenic medium. Calcium and 
phosphate ions can be released from the HA-PCL which are important factors for 
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promoting osteogenic differentiation activity by stimulating osteogenic marker genes; 
such as ALP, collagen type 1, and OCN (Lin et al., 2009, Klammert et al., 2009). The 
possible pathway of HA‟s ability to stimulate osteogenic differentiation is to activate the 
c-jun and c-fos genes that lead to increased ALP gene expression at the early stage 
osteogenic differentiation (Lin et al., 2009). Maeno et al.,(2005) and Lin et al., (2009) 
reported that an excessive calcium and phosphate ions in the culture medium (more than 
10mM of calcium) could be detrimental as they could lead to cell cytotoxicity. 
However, our study did not show any reduction of cell viability, although there was 
lower ALP in the high percentage of HA-PCL. The level of ALP activity can peak at 
matrix maturation, following by reducing of the activity in the mineralization period 
(Lian and Stein, 1995, Stein et al., 2004). Therefore the lower expression of ALP 
activity does not definitely lead to less differentiation of cells, it can because of the 
time-point of the collection of the sample. Considering the viability and osteogenic 
differentiation on the 5%wt HA-PCL may be useful to future experiments, regardless of 
its lower strength. 
To our knowledge this is the first study to investigate whether there are any synergistic 
effects between the effects of incorporate nHA with PCL electrospun scaffold and those 
of mechanical stimulation on osteogenesis. This in vitro study evaluated the 
osteoinductive potential of the HA-PCL on the proliferation and differentiation of 
hESMPs seeded on HA-PCL scaffolds and subjected them to OFF using a standard see-
saw rocker. The ultimate outcome of osteogenic differentiation is evaluated by the 
mineral deposition in the scaffolds which were scanned and analysed using micro-CT. 
The micro-CT has a benefit as a tool for real-time monitoring for tissue engineering as it 
is a non-destructive imaging technique to evaluate quantitative mineralization in the 
scaffolds is the %BV (Cartmell et al., 2004, Barbetta et al., 2012, Thimm et al., 2013). 
In addition it has been using widely in biomaterials for analysis of animal models 
because there is no need to biopsy the bone tissue for evaluation. The characterizations 
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of mineral deposition on electrospun scaffold using micro-CT have not been reported in 
many studies. The threshold for quantitative micro-CT analysis of bone usually used is 
the global threshold or automate global threshold such as Otsu‟s method (1979). 
However, this method has disadvantages as small amount of mineralized deposition 
would not be detected (Parkinson et al., 2008, Hahn et al., 1992). Individual threshold 
determinations were used in this study. The percentage porosity of the HA-PCL was 
less than the standard PCL (73.21 and 86.79%, respectively), indicating that the cells 
were more aggregated in the HA-PCL but this had no impact on cell proliferation. The 
presences of Dex have more effect on the mineral deposition on the standard PCL 
scaffold. The rocking SM+Dex100 group in the standard PCL scaffolds had the highest 
percentage of mineral deposition at the top level of the scaffolds than the middle and 
bottom levels. The reasons for this result were probably a greater cell density at the top 
of the scaffold, nutrient and oxygen transportation, waste removal, and an effective of 
OFF magnitude. The cells were seeded on the top of the scaffolds, as a result, more cells 
may adhere at the top of the scaffolds. Higher cell density can enhance osteogenic 
differentiation of human osteoprogenitor cells on the 3D culture by increasing ECM 
synthesis and cell-cell communication (Wang et al., 2010, Xue et al., 2013). Gap 
junction (cell-cell communication) plays a critical role in extracellular matrix in bone 
tissue engineering. Schiller et al., (2001) reported that the gap junctions stimulated OPN 
which promoted ECM mineralization.  
In 3D culture, the shear stress may more strongly affect on the top level of the scaffold 
because the strength of flow will gradually decrease with scaffold depth assuming the 
scaffold is firmly attached to the well base. The calculations of shear stressed in a 6-well 
plate may not be very relevant when considering an electrospun scaffold because the 
fibres and pores will redirect the flow. One would need a computational model of fluid 
flow through a porous medium to calculate what the shear stress is on the walls of the 
electrospun fibres, such as those used for other types of porous scaffolds (Sandino and 
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Lacroix, 2011, Birmingham et al., 2013). Fluid flow has been shown to increase 
osteogenic differentiation and mineralization in osteoprogenitor cells cultured in the 3D 
scaffolds (Sikavitsas et al., 2003, Yeatts et al., 2012). Yeatts et al., (2012) studied the 
effect of fluid flow shear stress on hBMSCs cultured on alginate bead 3D constructs and 
reported that fluid flow up-regulated OPN expression compared to static culture.  
In this study they appears to be a synergistic relationship between OFF and cell density 
which causes improved mineral deposition, especially at the top level of scaffold. It is 
interesting to note that in the middle level of the standard PCL the rocking with Dex 
group deposited higher mineral than both the rocking without Dex and the static with 
Dex groups, this implies that the rocking improved distribution of Dex to the middle 
level of the scaffold compared to static culture, where there was a surprisingly small 
effect of Dex.   
Our results show that the HA-PCL scaffolds show a greater cell attachment than the 
standard PCL scaffolds. nHA particle on fibre surfaces have been show to absorb more 
serum proteins such as fibronectin and vitronectin than standard scaffolds leading to 
increase cell attachment and differentiation of hESMPs (Li et al., 2009, Sawyer et al., 
2005). The mineralization of hESMPs on HA-PCL in our study showed no differences 
in the each level (top, middle, and bottom), indicating that the cells distributed 
throughout the HA-PCL scaffold. Incorporation nHA into PCL can enable it to be more 
hydrophilic, resulting in cells with a better distribution even they though less porous 
than the standard PCL (Choong et al., 2012, Oyane et al., 2005). In addition, the HA-
PCL scaffold also showed relatively stronger ALP activity than the standard PCL 
scaffold (experiment 5.10). Total mineral deposition in all levels within the HA-PCL 
scaffolds were higher than the standard PCL scaffolds, regardless culture media 
conditions (supplemented and supplemented media contained with Dex). This result 
agrees with many studies that reported that the HA releases calcium and phosphate ions 
into culture medium which there were the essential sources for mineralization (Chang et 
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al., 2000b, Ma et al., 2005). The rocking group cultured in the SM+Dex100 on both the 
standard PCL and HA-PCL scaffolds were not different. They may have reached their 
limitation for mineral deposition according to their pore space, accessibility of nutrient 
and waste. The lower porosity of the HA-PCL than the standard PCL scaffold may 
manipulate cells to aggregate, resulting in enhancement of osteogenic differentiation 
(Karageorgiou and Kaplan, 2005). They were no differences in mineralization between 
rocking and static groups. The rocking group under SM medium was lower 
mineralization than the static group, it may because the nHA came out from the HA-
PCL scaffold after rocking. To address this comparison of the HA-PCL scaffold before 
and after rocking could be measured. The effect of nHA on the tensile mechanical 
properties of fibres deceased in their stiffness and rigidity, however, the HA-PCL could 
enhance mineralization compared to the standard PCL scaffolds. A limitation of this 
study is that only two experimental repeats were performed. It is not quite clear that 
nHA have relevant effect or not. More repeats would have answered the question 
whether mineralization was influenced by OFF.  
Vasculogenesis is an important factor for bone repair by providing nutrients and 
excreting waste. VEGF secretion has been measured to evaluate the effect of 
incorporating HA into electrospun PCL scaffold (HA-PCL) and mechanical stimuli on 
undergoing. Our results showed that VEGF secretion decreased in the all Dex contained 
media, and there were no effects of OFF or HA-PCL. This is the same results as the 
experiments 5.7 and 5.8 of hESMPs and hBMSCs, respectively which showed that the 
OFF had no effect on VEGF secretion. Moreover, this result was as similar as the 
applied OFF on monolayer cultures (see chapter 4). However in the VEGF secretion of 
hESMPs under SM+Dex10 group increased to the same amount as the SM group on the 
late state of cell culture. Dex may be a crucial factor to reduce the VEGF secretion (see 
chapter 4). The further work could establish a concentration of Dex suitable for both 
mineral deposition and VEGF secretion.   
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5.13 Conclusion 
The main objective of this chapter is to evaluate suitable scaffold materials to repair the 
bone part of cleft palate and allow normal facial development. This objective was 
completed in that it was demonstrated that PCL could be a suitable material as it 
showed good biocompatibility and allowed osteogenic differentiation of osteogenic 
progenitor cells. The large volume of media of cell seeding method was shown to be 
suitable for future work. The next objective was to find a method of increasing 
osteogenic differentiation of osteoprogenitor cells on scaffold. This objective was a 
success in that OFF induced by a standard see-saw rocker could increase the 
mineralization of the cells on scaffolds and that fabricating the nHA incorporated with 
scaffold. 5%wt nHA-PCL electrospun scaffold was a suitable technique to investigate 
whether it is worthwhile to incorporate HA into a bone tissue engineering PCL scaffold. 
However, our study showed that there was no synergistic effect of OFF and HA 
incorporating into PCL scaffolds on mineralized matrix deposition. In addition, we have 
evaluated the cellular mineralization of scaffolds by using micro-CT to localize the 
effect of OFF either on standard PCL and HA-PCL. The top level of the standard PCL 
scaffolds showed the greatest response to OFF. HA-PCL increased matrix 
mineralization on the static group under both SM and SM+Dex100 media. 
Total mineral deposition of hESMPs within the HA-PCL was improved compared to the 
standard PCL regardless at mechanical stimulation.   
5.14 Summary 
 Electrospun PCL scaffolds are suitable for bone tissue engineering. 
 HJPs and hBMSCs are a good cell source for bone matrix production in electrospun 
scaffolds, hESMPs behave similarly to hBMSCs in electrospun scaffolds and are 
therefore a useful model cell with which to study the system.  
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 Both hESMPs and hBMSCs on PCL scaffolds are responsive to OFF by significantly 
increasing mineralization.  
 5wt% nHA incorporated with PCL scaffolds by using electrospun technique enhanced 
ALP activity of hESMPs under osteogenic medium although it did not affect 
mineralised matrix deposition. 
 Micro-CT is a minimally invasive technique to detect and locate cellular 
mineralization without any sample preparation. 
 The top level of the standard PCL scaffolds showed the greatest respond to OFF for 
enhancing the cellular mineralization of hESMPs. 
 Cells in HA-PCL scaffolds deposited more mineralised matrix over 28 days compared 
to standard PCL scaffolds however they did not exhibit any detectable increase in 
mineralisation in response to fluid flow. 
 The VEGF secretion of both hESMPs and hBMSCs were inhibited by Dex. Neither 
OFF or HA incorporation into PCL scaffolds had an effect on VEGF secretion. 
 The use of osteoprogenitor cells seeded on the electrospun PCL scaffolds can produce 
a bone matrix structure which can be implanted to the cleft palate bone defect. 
5.15. Future work 
 Future work could further evaluate osteogenic differentiation of the cells on HA-
PCL scaffolds by detecting osteogenic gene expression. 
 Different concentrations of HA-PCL could be produced to evaluate the suitable HA-
PCL electrospun scaffold for improving osteogenic differentiation such as 2.5 or 7.5 
wt% HA-PCL. 
 To determine the increasing mineralization related from OFF or the number of cells 
on the top level of scaffolds. The cell distribution should be determined throughout 
scaffolds in the both standard PCL and HA-PCL. 
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 To compare the effect of OFF on mineralization of cells present on the external and 
internal surfaces of the scaffold.  
 To develop a bioreactor to provide mechanical stimulation at 37ºC, 5%CO2 rather 
than room temperature, 0.04% CO2.  
 To evaluate the suitable Dex concentration for enhance osteogenic stimulation and 
VEGF secretion on osteoprogenitor cells.   
 To use computer models of fluid flow to estimate the shear stress applied on 
different regimes of the scaffold under flow conditions.
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CHAPTER SIX: A TRI-LAYER POLYCAPROLACTONE MEMBRANE 
FOR CO-CULTURE OF FIBROBLASTS AND OSTEOGENIC 
PRECURSORS FOR CLEFT PALATE REPAIR. 
6.1. Introduction 
The most common complication following palatal closure is a severe inhibition of mid-
face growth due to scar tissue formation at the palatal and alveolar regions (Smahel et 
al., 2009, Payne et al., 2014, Ross, 1987a). Many in the maxillofacial reconstruction 
field have stated that are alternative cell source for bone augmentation should be 
investigated further to improve cleft palate repair (Lohberger et al., 2013, Bueno et al., 
2009). Tissue engineering (cells combined with a supportive biomaterial scaffold) may 
be a suitable treatment for cleft palate repair. MSCs have been used for bone 
regenerative medicine due to their ability to differentiate into either osteoblasts, 
osteocytes, or adipocytes under specific culture media, and have shown satisfactory 
clinical outcomes (George et al., 2006, Hibi et al., 2006, Behnia et al., 2009). Recently, 
tissue engineering strategies using the patient‟s own MSCs as the cell source showed 
much promise for repairing a cleft defect on the alveolar ridge region; resulting in a 
successful repair and support of tooth eruption in the 2 following years (Hibi et al., 
2006). A suitable graft for cleft palate repair should separate the oral and nasal cavities, 
and allow normal facial development by supporting the bone growth and preventing the 
soft tissue intrusion into the bone formation site.  
PCL electrospun scaffolds are biocompatible, porous, biodegradable and have suitable 
mechanical properties to support both soft tissue and bone growth (Hutmacher et al., 
2001, Reed et al., 2009, Delaine-Smith et al., 2014a) as demonstrated in chapter 5. My 
colleague recently developed a method of spinning tri-layer scaffolds in which two 
micro-fibre layers were separated by a nano-fibre layer (Bye et al., 2013) The tri-layer 
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electrospun scaffold could support two different cell types and maintain their separation 
over 11 days of culture.  
The objective of this study was to test a facile one-step process to create a single-
polymer tri-layer electrospun scaffold and to investigate whether it can support cell 
attachment, proliferation and differentiation. The aim is to maintain separation between 
the bone and soft-tissue layers of a multi-tissue scaffold for cleft palate repair. 
Therefore, we addressed the question of whether the scaffold can support bone matrix 
formation and separate two different cell types; human osteoprogenitor cells and HDFs. 
6.2. Methods 
6.2.1. Micro/nano-fibre PCL tri-layer scaffold fabrication  
A PCL micro-fibre solution with a concentration of 10% w/w was prepared by 
dissolving PCL Mn=80,000 in DCM. A PCL nano-fibre solution with a concentration of 
5%w/w was prepared by dissolving PCL in a mixture of methanol and DCM in the 
weight ratio of 10/90 (methanol/DCM). Both solutions were stirred for a minimum of 
24 hours at room temperature.   
Scaffolds were fabricated using an electrospinning rig as previously described in 
chapter 2 (Bye et al., 2013, Delaine-Smith et al., 2014a). The fabrication was performed 
by my colleague Frazer Bye as part of his PhD project, briefly; a tri-layer of PCL micro-
fibres was fabricated at 17kV, with a flow rate of 40μL/min, a working distance of 
17cm, and a drum rotation speed of 300 rpm at room temperature. The syringe pumps 
were located on the left and right and left sides, of the collector. Voltage was applied 
independently to each syringe pumps. The electrospinning parameters were as for the 
micro-fibre scaffolds (above) except that for the nano-fibre fabrication the working 
distance was 10 cm. 2mls of micro-fibre solution per needle was used to create the first 
layer. Then 1ml of nano-fibre solution per needle was dispensed while the 1ml of 
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micro-fibre solution was continuously spun to create the second layer. This was followed 
by 2ml per needle of micro-fibre solution only to create the third layer.  
On receiving the tri-layer scaffolds were characterised it by using SEM to determine the 
size distribution and fibre diameter by measuring over 100 randomly selected fibres 
from 4 recorded SEM micrographs in each layer (width 200µm each layer) using image 
analysis software (ImageJ) (see chapter 5). To investigate the cell deposited matrix and 
mineralization, scaffolds were collected on day 7 and 28 of HDFs and hESMPs culture, 
respectively and were dehydrated in a series of alcohols (see chapter 2).   
6.2.2. Cell seeding on micro-fibre PCL scaffolds.  
Scaffolds were cut and sterilised with 0.1% peracetic acid in PBS for 3 hours then 
washed three times with PBS. The scaffolds were submerged overnight in the basal 
culture medium for serum protein coating. Before cell seeding, the cell culture media 
was removed. The cells were detached using Trypsin-EDTA. 10
5
 cells of HDFs in a 
100µl of media were seeded onto the scaffolds and left to attach for 24 hours in an 
incubator. The next day, the scaffolds were moved to fresh well plates. HDF cells were 
cultured either in DMEM basal culture medium or basal culture medium supplemented 
with 50µg/mL AA. The cell viability and collagen production tests used were MTS 
assay and picro-sirius red staining after 14 and 21 days of cultures. 
6.2.3. Cell seeding, proliferation on tri-layer electrospun PCL scaffold. 
Three different cell types were used in the present study: 1] hESMPs, 2] hBMSCs, and 
3] HDFs. The scaffolds were cut into 15mm diameter circles using a cork borer. The 
scaffolds and CellCrown™ culture inserts were sterilised with 0.1% peracetic acid in 
PBS under steady rocking. Scaffolds were placed within the CellCrown™ assembly and 
submerged overnight in the basal culture media. Before cell seeding, the cell culture 
media were removed. 10
5
 cells in a small volume suspension (no more than 100µl) were 
seeded on top of the scaffold within the inner diameter of  CellCrown™ and left for 24 
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hours for cell attachment in a cell culture incubator. The next day, the scaffolds attached 
to CellCrown™ inserts were removed to fresh well plates. hESMPs or hBMSCs were 
seeded on one side of the tri-layer scaffolds and grown in either SM+Dex100 or 
SM+Dex10 media, respectively from day 1 to 21. The HDFs were stained with 
CellTracker™ by adding 10µM CellTracker™Green (in media without serum) to HDFs 
cultured in T-75 flasks for 45 minutes, followed by removal of the CellTracker™Green 
solution, then washed twice with PBS. The cells were incubated for 30 minutes further 
under fresh basal medium. Trypsin-EDTA was added to the flasks, which were centrifuged 
at 1000 rpm to collect the cell pellet. 105 of labelled cells were seeded on the opposite side 
of the CellCrown™ to the hESMPs or hBMSCs and the entire constuct was cultured in 
SM medium for a futher 7 days. 
6.2.4. XO fluorescent staining for assessment of osteogenesis 
XO (C31H28N2O13SNa4) was added into culture medium in a 1:1000 dilution at a final 
concentration of 20µM, and incubated for at least 12 hours before imaging (Kuhn et al., 
2010). The XO solution was removed and washed with PBS twice and replaced with 
fresh medium without β-GP to reduce fluorescence backgroud from unbound XO. The 
location of mineralised tissue (containing osteogenic progenitor cells)  and HDFs co-
cultured on the tri-layer scaffolds was analysed using confocal laser scanning 
microscopy (CLSM). (see chapter 2) 
6.2.5. Sample preparation for CLSM 
The scaffolds were gently rinsed with PBS solution to remove non-attached dyes and 
cells until no more colour eluted into the PBS solution. After the rinsing step, the 
scaffolds were detached from the CellCrown™ insert and cut to a thickness of 0.5 mm 
by using a sharp sterilised surgical scalpel. The scaffolds were viewed with CLSM and 
not covered with a coverslip to avoid possible damage of the cells on the side view of 
the scaffolds. Consequenly, the CLSM consisted of a EC plan-Neofluar objective with 
magnification 20x. An Argon/2 laser with wavelength 488 nm and HeNe laser with 
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wavelength 543 nm  were used to visualize XO and CellTracker™Green statining 
respectively. The obtained digital images were merged into 515 KB RGB (red-green-
blue) images using Ziess LSM Image Browser software package  and the images were 
overlayed using the ImageJ.  
6.3. Results 
The cell viability of HDFs increased between days 14 to 21 in media supplemented with 
AA (basal+AA) (Figure 6.3.1 A). Total collagen production in the basal+AA group was 
similar to that in media without AA after 14 and 21 days (Figure 6.3.1 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) (A) 
Figure 6.3.1: The effect of ascorbic acid-2-phosphate (AA) on human dermal fibroblasts 
(HDFs) on PCL scaffolds. (A) The cell viability of HDFs were measured using MTS after 
day 14, 21. (B) Total collagen production was measured using picro-sirius red staining 
assay after day 14 and 21, mean±SE, (N=2, n=3), One-way ANOVA, Tukey’s multiple 
comparison test. 
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SEM images of the tri-layer scaffold showed there was a mixture of micro- and nano-
scale fibres present. However, as predicted there were differences in the frequency of 
size distribution depending on the parameters used for a specific layer (200µm per 
layer) (Figure 6.3.2). In the top layer, the most prevalent fibre diameter is between 7-9 
µm and more than 95% of fibres are micro-fibres (Figure 6.3.2 C). In the middle layer, 
the most frequent occurrence of fibre diameter range is less than 1 µm and more than 
40% are nano-fibres (Figure 6.3.2 B). In the bottom layer, the most prevalent fibre 
diameter is between 5-7 µm and more than 90% are micro-fibres (Figure 6.3.2 A). 
When either hESMPs or hBMSCs were co-cultured with HDFs they deposited calcium 
nodules by 28 days (Figure 6.3.3 upper and bottom rows, respectively). HDFs were 
clearly present on the opposite side in a dense layer after 7 days of culture (Figure 6.3.3 
B and E, respectively), indicating that soft tissue can be cultured in the adjacent layer to 
the mineralised tissue. SEM images of the side views of the scaffolds, hESMPs/HDFs 
and hBMSCs/HDFs (Figure 6.3.3 C,F) showed no cells present in the central nano-fibre 
layer. CLSM fluorescence images of the co-culture of hESMPs/HDFs and 
hBMSCs/HDFs (Figure 6.3.4 C,F, respectively) confirmed mineral deposition was only 
present on one side of the scaffold (Figure 6.3.4 B,E, respectively) and HDFs were only 
present on the other side (Figure 6.3.4 A,D, respectively). There is a black space in 
between the red fluorescent (mineralisation) and green fluorescent (fibroblast) surfaces 
indicating that there were no cells crossing over the nano-fibre central layer, confirming 
the evidence from the SEM images. 
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Figure 6.3.2: SEM image of the tri-layer electrospun PCL scaffold in side view (top). 
Frequency of distribution against fibre diameter in the bottom layer (A), the middle layer 
(B), and the top layer (C). The scale ≤1 on the X-axis indicates a fibre diameter of less than 
1µm (nano-fibre). average=mean±SE,(N=1, n=100), measurements from 4 SEM images in 
each layer). Scale bar: 200µm. 
Top Middle Bottom 
(B) Middle 
Fibre diameter (µm) 
Average=3.6±0.4µm 
(C) Top 
Fibre diameter (µm) 
Average=8.4±0.5µm 
Bottom 
O
c
c
u
rr
e
n
c
e
 (
%
) 
Fibre diameter (µm) 
Average=7.7±0.4µm 
(A) 
CHAPTER SIX 
255 
 
 
 
 
 
 
 
 
Figure 6.3.3: SEM images of the co-culture of hESMPs/HDFs (upper row) and hBMSCs/HDFs (bottom row) on tri-layer scaffolds. Matrix mineralization 
surfaces of hESMPs (A) and hBMSCs (D) on one side of the scaffolds on 28 days. (B,E) The opposite side of the scaffolds on 7 days culture with HDFs. Side 
views of the scaffolds co-cultured with hESMPs/HDFs (C) and hBMSCs/HDFs (F) showed the scaffolds could support two different cell types and maintain 
their separation over 7 days of culture.(N=2, n=2)  
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Figure 6.3.4: CLSM fluorescence images of the side views of the co-cultured hESMPs/HDF 
(upper row) and hBMSCs/HDFs (bottom row) on the tri-layer scaffolds. The matrix 
mineralization of both hESMPs and hBMSCs were assessed by labelling using xylenol orange 
XO (red colour) staining after 28 days of culture (B and E, respectively). The HDFs were 
labelled with CellTracker™Green (green colour) prior to 7 days of culture on the opposite side 
of the scaffolds of the co-cultured hESMPs/HDF (A) and hBMSCs/HDFs (D). Both images 
indicate there is a space (no cells or mineral deposition) in the central region of the scaffold 
corresponding to the nanofibrous layer over 7 days of culture (C and F). The PCL scaffold with 
no staining was visualized to show that it was no auto-fluorescence (G). (Scale bar =50 µm), 
(N=2, n=2).  
hESMPS/HDFs 
(A) (B) (C) 
hBMSCs/HDFs 
(D) (E) (F) 
(G) 
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6.4. Discussion  
As discussed in the previous chapters there are many limitations to current cleft palate 
repair. In this study we demonstrated the use of a tissue engineering approach for the 
treatment of cleft palate. Therefore the single-polymer tri-layer electrospun scaffold was 
created to support osteoblasts and fibroblasts with potential for filling the cleft defect 
while it maintained two different types of tissues.  
The electrospinning technique was chosen in this study for fabricating tissue 
engineering scaffolds because it is a versatile technique for producing the polymer 
fibres in diameters from a nano-scale to micro-scale and can be used with various types 
of polymers as described and shown in chapter 2 and 5. However, the disadvantage of 
the technique is the low production rate (Rim et al., 2013). My research group was 
previously successful in producing a tri-layer scaffold which contained a mixture of 
nano- and micro-scale fibre diameters using PHBV for the nano-fibrous layer and PLA 
for the micro-fibrous layers (Bye et al., 2013). However the polymers used in that 
preliminary work were probably not optimal for bone-forming tissue due to the high 
degradation rate of PLA. Here that procedure was modified to produce a tri-layer 
scaffold from PCL alone.  
Analysis of the tri-layer scaffold indicated that the top and bottom-layers showed a 
higher percentage of the micro-fibres than nano-fibres and were occupied by 
osteoprogenitor cells (hESMPs and hBMSCs) on the bone part. Whereas, the middle 
layer showed the highest percentage of nano-fibres which acted as separation membrane 
and did not allow the cells to cross-over to the opposite side of the scaffold.  
A limitation of this study is that in many cases only two experimental repeats were 
performed in duplicated or triplicate, however, some interesting appearances were 
identified as followed. HDFs cells were chosen to represent the soft tissue layer. The 
results showed that the PCL electrospun scaffold can support HDF proliferation and 
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allow ECM production in agreement with the study of Hutmacher et al., (2001). In the 
clinic, a potential approach may be to harvest oral fibroblasts from oral mucosa, similar 
to my colleague‟s previous work (Selim et al., 2011). The oral mucosa could be 
received through routine cleft lip and palate treatment. The first surgery for cleft 
treatment is a lip closure (cheiloplasty) and during this procedure a small amount of oral 
mucosa is usually discarded.   
CellTracker™Green was capable of enabling the tracking of HDF cells on the scaffold 
during 7 days of culture. XO, which becomes fluorescent when it chelates calcium, was 
used to indicate mineralization of the osteogenic cells. It has not commonly used for 
tissue engineering but may be a great technique to visualised mineralised tissue in 3D 
scaffolds. Animal model, in vivo the XO stain is used for continuous monitoring a new 
bone formation by injecting this stain into the blood stream in the curtained time-point 
where it likely newly mineralized formation (Kuhn et al., 2010, Wang et al., 2006).  
CLSM overlaid images showed that cells co-cultured on tri-layer scaffolds can maintain 
separation on their specific regions; the black space in the middle region visible in side 
view indicates that there were neither fibroblasts nor mineralising cells in this region. 
The SEM images of the scaffold cross sections confirmed that there were no cells 
present in this region. This supports our hypothesis that cells would not be able to 
penetrate the nano-fibrous layer due to their low porosity and is in agreement with my 
group previous results on tri-layer membranes made from other polymers. 
Although the XO staining data alone does not confirm that the osteoprogenitor cells did 
not cross the nano-fibrous membrane, an undergraduate student under my supervision 
undertook a separate experiment to verify this issue. Her results show that all hESMPs 
were only resident on the same side of the scaffold on which they were seeded and there 
was no evidence of the cells crossing over the central region of the tri-layer membrane. 
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Development of new blood vessels in this construct should be addressed as it is critical 
for the successful of this implant. Nutrient and O2 supply, and waste removal diffuse 
into the cell construct from surrounding environment (around 150-200µm) until the 
construct become vascularised (Kanczler and Oreffo, 2008). Hypoxia conditions may 
occur because the scaffold thickness (600µm) and could up-regulate VEGF secretion 
(see chapter 3). It would be beneficial to a new blood vessel formation in the construct. 
The suitable pore side of scaffold for blood vessel formation is 400µm (see chapter 1). 
Although the tri-layer scaffold was not measured the pore size in each layer, the top and 
bottom layers of the scaffold were micro-fibres, they may be a suitable pore size for a 
new blood vessel formation. Whereas, the middle layer of the scaffold was a majority of 
nano-fibre, lead to reduce the pore size. As the aim of this study is that the cells could 
not reside at the middle of the scaffold, therefore, the thickness and pore size of the 
scaffold may be an advantage for vascularisation of the construct.    
6.5. Conclusion 
Our study indicates that the tri-layer scaffold can support the co-culture of cells 
(between osteoprogenitor cells and HDFs) and allow osteogenic progenitor cell 
(hESMPs and hBMSCs) differentiation. The scaffold did not allow the cells to 
crossover for 28 days due to the low porosity in the middle layer of the scaffold. The 
benefit of this tri-layer scaffold design is that it could support and separate both soft and 
hard tissue repair until the new tissues are mature enough to maintain separation. We 
propose that as a result the soft tissue which is a fast healing would not intrude into the 
hard tissue region which is slower healing. This would reduce scar formation at the 
surgical site following a cleft palate surgery and the inhibition of palate growth that 
occurs when bone graft is performed too early. This scaffold may be useful for any oral 
maxillofacial reconstruction which involves more than one type of tissue such as guided 
tissue regeneration for periodontal surgical treatment and alveolar ridge augmentation 
for tooth implantation.    
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6.6. Summary 
 The single-polymer tri-layer electrospun scaffold was demonstrated to support cell 
attachment and allow cell proliferation and differentiation over 28 days while it 
maintained a separation of two tissue types between soft and bone forming tissues.  
 The tri-layer PCL electrospun scaffold is a promising material for cleft palate repair.   
6.7. Future work 
 Evaluate and localize the collagen production on both sides of the scaffold over long 
term culture. 
 Move on to in vivo study to test how both cells behave on the tri-layer membrane in 
short and long term, for example; detect their retention and maintain their separation 
between two cell types.  
 Incorporate VEGF into the membrane with VEGF for inducing vasculogenesis in the 
graft. 
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CHAPTER SEVEN: CONCLUSION AND FUTURE DIRECTIONS. 
Current treatments of cleft palate repair have many drawbacks such as multiple surgical 
steps, donor site morbidity from bone harvesting, and the long time over which 
complete treatment takes place. A bone tissue engineering strategy may overcome those 
drawbacks; such a strategy, consisting of cells, biomaterial scaffolds, and other 
chemical reagents has emerged as a new approach for maxillofacial reconstruction and 
cleft palate repair. 
7.1 Human mesenchymal progenitor/stem cells (human MSCs) 
Human MSCs have been used widely in bone tissue engineering and their 
differentiation stimulated by chemical reagents, the mechanical environment, scaffolds 
topography and chemical surface coatings. Our studies confirmed that hESMPs, 
hBMSCs, and HJPs have osteogenic potential and can be differentiated to osteoblastic-
like cells and deposit calcium on their ECM under Dex supplementation. Interestingly, 
all these cell types dramatically increased calcium deposition when they were subjected 
to OFF compared to static culture. The use of HJPs which can be easily harvested from 
the oral cavity would be a less invasive intervention at the donor site compared to the 
harvesting the hBMSCs from bone marrow. 
VEGF is an important protein produced by osteoblast-like cells which stimulates 
vasculogenesis. It aids to improve the success of bone tissue engineering at the 
implanted side by facilitating surrounding endothelial cells to produce new blood 
vessels. Our studies on both hESMPs and hBMSCs seeded on scaffolds showed that 
VEGF secretion was significantly suppressed in the Dex supplemented group. 
Therefore, we examined the effect of Dex concentration on monolayer culture and 
found that by 21 days of culture, cells with Dex were able to secrete as much VEGF as 
those without, indicating vasculogenesis may be delayed by Dex treatment but not 
completely inhibited.  
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The ideal cell source for bone tissue engineering has not yet to be identified and may 
well depend on the location of the defect (e.g. maxillofacial or long bone), the age of the 
patient and the disease state. In the case of cleft palate there is still more work needed to 
determine the most suitable cell source. Future work in this area could include: 
 Investigating other markers of osteogenic differentiation of the cells such as 
surface antigens, cytokines, and the expression of genes involved in the initial stages 
of differentiation e.g. Runx2, osterix (OSX), activating transcription factor 4 
(ATF4), collagen type I, ALP, BMP-2 (Malgorzata, 2012).   
 Investigate multiple donors of osteoprogenitor cells to better understand the 
variability between cells from different individuals. 
 Comparing the osteogenic differentiation of the osteoprogenitor cells from 
different anatomical harvesting sites 
 Mineral deposition analysis by FT-IR, XRD, or EDX to evaluate the quality of 
mineralization relative to a real bone and whether it‟s nano-structure and mechanical 
properties are sufficient to maintain the palate intact.   
 Mechanical properties analysis on the cells-seeded scaffold samples to evaluate 
whether the cell seeded scaffold construct could support cells and withstand 
mechanical force when they were implanted into the defected regions.  
7.2. 3D model for bone tissue engineering 
Many technologies have been used for fabricating a porous scaffold. Electrospinning 
has been proven to be a simple and adjustable method of producing fibres in a wide size 
range from nano- to micro- sized fibre diameters. Electrospun PCL scaffolds were used 
in our study due to their mechanical properties which are suitable for bone and their 
biocompatibility with surrounding tissue. PCL scaffolds can support hESMPs, 
hBMSCs, and HJPs for proliferation, and osteogenic differentiation with the addition of 
Dex. However their limitations are that they do not have osteoinductive nor 
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osteoconductive properties. Therefore, nHA was incorporated with PCL (HA-PCL) to 
overcome the limitations. Our study found that the 5wt%HA-PCL electrospun scaffold 
was a suitable material for cell support, proliferation, and enhancing osteogenic 
differentiation however it reduced scaffold mechanical properties. The cellular calcium 
deposition on both standard and HA-PCL scaffolds was evaluated by using micro-CT. 
HA-PCL scaffolds showed an increase of calcium deposition compared to standard PCL 
scaffold in the static culture in medium which did not contain Dex, however, there were 
no differences in the calcium deposition in the media supplemented with Dex, or the 
same media without Dex in the rocking groups. Moreover, there were no differences 
between standard-PCL and HA-PCL scaffolds in the cellular calcium deposition in the 
rocking under SM+Dex100 group. Further investigation will be needed to: 
 Analyse osteogenic gene expression on both standard PCL and HA-PCL 
scaffolds to indicate osteogenic differentiation, for instance, the early state: ALP, 
collagen type I, BMP-2 or late stage: OPN and OCN. 
 Quantify the amount of calcium and phosphate ions in the culture media to 
indicate the effect of nHA on matrix mineralization of cells on the HA-PCL scaffold.  
 Improve mechanical properties of HA-PCL scaffolds to be suitable for 
integration with the adjacent region and function until the mature development of 
tissue.  
 Compare the mechanical properties of the scaffold with ECM construct produced 
on standard and HA-PCL scaffolds. 
 Quantify nHA distribution in the HA-PCL scaffolds and degradation rate. 
  To evaluate a suitable amount of nHA particles for improving their mechanical 
properties. . 
7.3 External mechanical force 
OFF is a form of external mechanical stimulation has been reported to enhance cell 
proliferation, ECM, and calcium deposition in many cell types. Our study showed that 
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OFF applied by using a standard see-saw rocker with a requirement of Dex can enhance 
calcium deposition on both monolayer and 3D cultures in three cells types; 1] hESMPs, 
2] hBMSCs, and 3] HJPs. However, we did not test the effect of OFF on the HJPs in the 
3D culture, because of an insufficient cell supply. The hESMPs and hBMSCs on the 
standard PCL scaffolds responded to OFF resulting in increased calcium deposition at 
the top surface of the scaffolds, moreover, they showed a significantly higher %BV over 
the top layer of HA-PCL scaffolds under the osteogenic induction medium (Dex 
supplementation).  
Our study found that OFF had no effect on VEGF secretion for the osteoprogenitor cells 
seeded on either standard PCL or HA-PCL scaffolds. Therefore, this study did not solve 
a crucial limitation of a large scale tissue engineer graft, which is a lack of vasculature. 
The low cell survival rate which has been shown at the centre of the graft due to nutrient 
supply and excretion of waste may still exist.  
The future of OFF stimuli to enhance osteogenic differentiation of osteoprogenitor cells 
should clearly be investigated to fulfil the current void in knowledge around bone tissue 
engineering. Many factors will influence the cellular response such as the frequency, 
magnitude, and type of flow, the insertion of rest period, and chemical supplements to 
stimulate osteogenesis. These factors could be scaled-up to clinical application for bone 
graft substitutes for cleft palate repair and other bone tissue engineering constructs. To 
improve a method to enhance vasculogenesis by the cells, it would be beneficial to 
integrate between the bone graft and the surrounding implanted region. Characterisation 
of the fluid flow on the 3D scaffold from this loading system needs to be evaluated 
using mathematical and computer modelling of the loading system. This would 
hopefully enable a better characterisation of the local stresses and strains which are 
applied throughout the scaffold. In addition, the mechanism of OFF induced osteogenic 
differentiation in osteoprogenitor cells is very complex with many signalling pathways 
involved (Liu et al., 2010). To elucidate this mechanism it would be useful to provide a 
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better understanding of what mechanical signal the cells respond to or are sensing from 
this type of loading system. This could help to create the graft construction without the 
need for biochemical reagents such as Dex or by substituting with another chemical e.g. 
vitamin D or BMP-2 (Jorgensen et al., 2004). Substitution of Dex could overcome the 
Dex-dependant inhibition of VEGF secretion and reduce the concern about long term 
use of Dex which risks causing osteoporosis or osteonecrosis if it is included in the 
construct implanted into bone (Li et al., 2005).  
Future work 
 Characterise the stress and strain from OFF on the cell seeded PCL scaffolds 
using mathematics and computer modelling. 
 To evaluate the suitable percentage of HA in HA-PCL scaffolds to provide a 
more homogenous distribution of HA in the electrospun scaffold, to improve 
mechanical properties of HA-PCL scaffolds. 
 Another material e.g. PU which is a more flexible may also be a suitable scaffold 
for OFF stimulation. Such polymers should be compared with PCL to determine the 
best candidate for cleft palate repair. 
7.4 Tri-layer membrane scaffold 
Many studies have attempted to devise a tissue engineering approach for craniofacial 
reconstruction and determine what scaffold materials and architectures would work 
best. The design and fabrication of scaffolds can be controlled to mimic the natural 
craniofacial structure. Our proposed design is tri-layer scaffold of electrospun PCL 
attempts to mimic the structure of craniofacial organs by having soft tissue and bone 
separated by a membrane (in vivo this is the periosteum). HDFs were seeded on one side 
within a micro-fibre layer and human osteoprogenitor cells on the other side also within 
a micro-fibre layer and these were separated by the nano-fibrous layer at the middle of 
the scaffold. We found that this scaffold was can support cells and allowed the 
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osteoprogenitor cells to undergo osteogenic differentiation while the scaffold 
maintained separation of the two cells types in long term culture (28 days). Further 
work is required to: 
 Move to an animal model by using the co-culture graft at the non-bone 
environment (ectopic bone formation) to detect cell localisation, and cell-graft 
survival on the scaffold of both cell types. 
 Test the mechanical properties of the graft to address whether it is strong enough 
for loading within an oral cavity. 
 Optimise the degradation rate of the scaffold to match the new tissue formation 
of both soft and hard tissues in the body. 
 Incorporate drugs e.g. antibiotic (doxycycline, colistin) into the tri-layer 
membrane scaffold to prevent infection post-operation.  
7.5 Clinical applications of maxillofacial reconstruction 
The current cleft palate repair procedure recommends treatment when the child is 6-12 
months old, this may disrupt the development of craniofacial structure in many 
directions such as vertical, antero-posterior, and transverse directions, because of tissue 
fibrosis at the defect region. Then cleft repair at the alveolar (teeth bearing region on the 
palate) occurs later about 8-9 years using autologous bone graft which is recommended 
to take place before the permanent canine teeth erupt on the defect region, this can also 
can severely inhibit maxillary growth (Wolford and Stevao, 2002). The suitable timing 
for cleft palate repair is still controversial. Rochrich et al., (2004) studied the long-term 
follow up of the cleft palate patients who underwent palatal closer surgeries designed to 
complete the cleft palate repair before 2 years of age. As the reasons, are to establish 
normal speech development and reduce risk of hearing loss in the patients. The 
drawbacks of current autologous bone graph are insufficient quantity and quality of 
grafts, and of allografts is their immunogenic potential and the risk of pathogen 
CHAPTER SEVEN 
267 
 
transmission to the recipient. To reconstruct the function of cleft palate in the field of 
bone tissue engineering may overcome the drawbacks of the current treatment. An 
important advantage of bone tissue engineering is that a small healthy tissue biopsy can 
be taken from the body, the cells expanded under a cell culture conditions, incorporated 
with biocompatible materials, and re-implanted them back into patients.    
The ideal timing for cleft palate treatments using a tissue engineering strategy are not 
yet known. It would ideally be before 2 years of age to allow speech development and 
decrease risk of hearing loss, and also reduce the number of surgical treatments. 
Hopefully the patient would then avoid further surgery, for instance, autologous bone 
graft procedure. Alternatively, it would be at 8-9 years of age to prepare the bone 
support for tooth eruption. This procedure would reduce donor site morbidity and length 
of surgical time compared to autologous bone graft surgery from iliac bone (current 
treatment). In my opinion, the tissue engineering strategy can benefit cleft palate 
treatment whichever time point is selected compared to the current treatment.    
Meijer et al, (2008) reported a successful clinical study for bone augmentation (increase 
in alveolar ridge side) by using bone tissue engineering and placed the dental implants 
in the reconstructed bone afterwards. They reported no any adverse effects from the 
pathogen contamination from animal or corticosteroid while they cultured the cells 
under the 10%FBS and Dex to induce osteogenic differentiation. In contrast, using 
serum free medium for culturing the cells, resulting in a low cell adhesion and 
proliferation and also lead to cell apoptosis (Heng et al., 2004, Wong and Tuan, 1993). 
However, the development of the suitable hBMSCs culture conditions for clinical use is 
still required.   
Our study demonstrated that both HJPs and hBMSCs had multi-potent ability to 
differentiate to osteogenic cells and formed ECM and calcium deposition on the 
biocompatible and biodegradable 3D constructs. Moreover mechanical stimulation 
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using OFF with the requirement of Dex enhanced calcium deposition. OFF was most 
effective at stimulating mineralisation at the top surface of the scaffolds as detected by 
micro computed tomography (micro-CT). This method could be applied to evaluation 
bone formation on 3D constructs after implanting into patients by using clinical CT. 
There are still many obstacles to be overcome before bone tissue engineering can be 
used for routine clinical protocol. Both short and long-term studies of the bone tissue 
engineering after implantation are required to evaluate the effective outcome compared 
to the current approach with an important consideration being whether the new 
treatment improves patient outcome. 
7.6 Final conclusion   
 The human cell line (hESMPs) and primary osteoprogenitor cells (HJPs and 
hBMSCs) showed the osteogenic potential by producing calcium deposition on both 
monolayer (chapter 3) and 3D constructs (chapter 5) under culture condition with 
presence of Dex. 
 PCL is a suitable temporary ECM for bone tissue engineering (chapter 5). 
 VEGF secretion was reduced by Dex supplementation conditions in 3D culture 
(chapter 5) and was delayed in monolayer culture (chapter 4). 
 OFF enhanced the calcium deposition of all cell types on both monolayer (chapter 4) 
and 3D constructs (chapter 5) in Dex supplemented conditions. The strongest effect of 
OFF was at the top surface of the scaffolds. 
 The cellular calcium depositions on HA-PCL was increased compared to standard 
PCL under the supplemented medium. But there were no effects of OFF (chapter 5).  
 A tri-layer PCL scaffold could support and separate two different cell types HDFs 
and human osteoprogenitor cells: both hESMPs and hBMSCs) and allow osteogenic 
differentiation for 28 days (chapter 6).   
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Oral presentations 
1. Thai/UK stem cell meeting: „Optimising cell sources and materials for cleft palate 
repair‟, 29th March 2011, the University of Sheffield, Sheffield. 
2. Biomaterials and Tissue Engineering Group: „Oscillatory fluid shear stress enhances 
matrix production of Human embryonic mesenchymal progenitor stem cells (hES-MP) 
on biodegradable electrospun polycaprolactone scaffold‟, 17th December 2012, the 
University of York. 
Poster presentations   
1. The 6th UK Mesenchymal Stem cell meeting: „Optimizing cell sources and materials 
for cleft palate repair‟, 15th June 2012, University of Southampton, Southampton. 
2. Tissue and Cell Engineering 2012: „Optimizing cell sources and materials for cleft 
palate repair‟, 4th-6th July 2012, the University of Liverpool, Liverpool. 
3. 3rd World Congress Tissue Engineering International & Regenerative Medicine: 
„Optimizing cell sources and materials for cleft palate repair‟, 5th-8th September 
2012, Vienna, Austria.    
4. The 7th UK Mesenchymal Stem cell meeting: „Fluid shear stress enhances matrix 
production by Mesenchymal stem cells‟, 12th-13th September 2013, Aston 
University, Birmingham 
5. 5th International Conference on Mechanics of Biomaterials and Tissues: „Fluid shear 
stress enhances matrix production by mesenchymal progenitor cells on 
biodegradable electrospun scaffolds‟, 8th-12th December 2013, Sitges, Spain. 
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